<SEC-DOCUMENT>0001104659-25-025700.txt : 20250320
<SEC-HEADER>0001104659-25-025700.hdr.sgml : 20250320
<ACCEPTANCE-DATETIME>20250319204000
ACCESSION NUMBER:		0001104659-25-025700
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20250319
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250320
DATE AS OF CHANGE:		20250319

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PLUG POWER INC
		CENTRAL INDEX KEY:			0001093691
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTRICAL INDUSTRIAL APPARATUS [3620]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				223672377
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34392
		FILM NUMBER:		25754235

	BUSINESS ADDRESS:	
		STREET 1:		125 VISTA BOULEVARD
		CITY:			SLINGERLANDS
		STATE:			NY
		ZIP:			12159
		BUSINESS PHONE:		5187827700

	MAIL ADDRESS:	
		STREET 1:		125 VISTA BOULEVARD
		CITY:			SLINGERLANDS
		STATE:			NY
		ZIP:			12159
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm259816d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:plug="http://plugpoweinc/20250319">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03D_plug_plugpoweinc_20250319 -->
<!-- Field: Set; Name: xdx; ID: xdx_04E_20250319_20250319 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0001093691 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-03-19" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-03-19" id="Fact000004" name="dei:EntityCentralIndexKey">0001093691</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="plug-20250319.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-03-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001093691</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-03-19</xbrli:startDate>
        <xbrli:endDate>2025-03-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<p style="margin-top: 0pt; margin-bottom: 0pt"></p>
<p style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 8pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 18pt"><b>UNITED STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 18pt"><b>SECURITIES AND
EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, D.C. 20549&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 8pt"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 18pt"><b>FORM&#160;<span id="xdx_908_edei--DocumentType_c20250319__20250319_zD1FC6K6fCLd"><ix:nonNumeric contextRef="AsOf2025-03-19" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section&#160;13 or 15(d)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#8239;of
the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event reported):
<span id="xdx_904_edei--DocumentPeriodEndDate_c20250319__20250319_zptwYcOKvYUc"><ix:nonNumeric contextRef="AsOf2025-03-19" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">March 19, 2025</ix:nonNumeric></span> </b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_908_edei--EntityRegistrantName_c20250319__20250319_ziYxCOgE0Tk6"><ix:nonNumeric contextRef="AsOf2025-03-19" id="Fact000011" name="dei:EntityRegistrantName">Plug Power Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact name of registrant as specified in its
charter)&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 34%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityIncorporationStateCountryCode_c20250319__20250319_ziNhf7M427U6"><ix:nonNumeric contextRef="AsOf2025-03-19" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityFileNumber_c20250319__20250319_zix3RUhEJmP2"><ix:nonNumeric contextRef="AsOf2025-03-19" id="Fact000013" name="dei:EntityFileNumber">1-34392</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityTaxIdentificationNumber_c20250319__20250319_z1A1lZJliHFd"><ix:nonNumeric contextRef="AsOf2025-03-19" id="Fact000014" name="dei:EntityTaxIdentificationNumber">22-3672377</ix:nonNumeric></span></b></span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(State
    or other jurisdiction</b></span></td>
    <td style="vertical-align: bottom"><b>&#160;</b></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Commission
    File</b></span></td>
    <td style="vertical-align: bottom"><b>&#160;</b></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(IRS
    Employer</b></span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
    incorporation)</b></span></td>
    <td style="vertical-align: bottom"><b>&#160;</b></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number)</b></span></td>
    <td style="vertical-align: bottom"><b>&#160;</b></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identification
    No.)</b></span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 66%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityAddressAddressLine1_c20250319__20250319_zHe5yHRaTr0c"><ix:nonNumeric contextRef="AsOf2025-03-19" id="Fact000015" name="dei:EntityAddressAddressLine1">125 Vista Boulevard</ix:nonNumeric></span>,<br/> <span id="xdx_901_edei--EntityAddressCityOrTown_c20250319__20250319_zjlYrRTek7Tf"><ix:nonNumeric contextRef="AsOf2025-03-19" id="Fact000016" name="dei:EntityAddressCityOrTown">Slingerlands</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressStateOrProvince_c20250319__20250319_zKAi2kQZT4X6"><ix:nonNumeric contextRef="AsOf2025-03-19" format="ixt-sec:stateprovnameen" id="Fact000017" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: bottom; width: 32%; text-align: center"><span id="xdx_90B_edei--EntityAddressPostalZipCode_c20250319__20250319_z7jDBXAHqv1d" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2025-03-19" id="Fact000018" name="dei:EntityAddressPostalZipCode">12159</ix:nonNumeric></b></span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Address
    of principal executive offices)</b></span></td>
    <td style="vertical-align: bottom"><b>&#160;</b></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Zip
    Code)</b></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_904_edei--CityAreaCode_c20250319__20250319_zdxc6kcw91t7"><ix:nonNumeric contextRef="AsOf2025-03-19" id="Fact000019" name="dei:CityAreaCode">518</ix:nonNumeric></span>) <span id="xdx_902_edei--LocalPhoneNumber_c20250319__20250319_zoyO4qhsnnH3"><ix:nonNumeric contextRef="AsOf2025-03-19" id="Fact000020" name="dei:LocalPhoneNumber">782-7700</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Registrant&#8217;s telephone number, including
area code:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>N/A</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Former name or former address, if changed
since last report.)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Check the appropriate box below if the Form&#160;8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i>see </i>General Instruction
A.2. below):&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt"><span id="xdx_907_edei--WrittenCommunications_c20250319__20250319_z7uY5Vk14E63" style="font-family: Wingdings"><ix:nonNumeric contextRef="AsOf2025-03-19" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span>Written
communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt"><span id="xdx_905_edei--SolicitingMaterial_c20250319__20250319_zvZEgm6A67n" style="font-family: Wingdings"><ix:nonNumeric contextRef="AsOf2025-03-19" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span>&#160;&#160;Soliciting
material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt"><span id="xdx_909_edei--PreCommencementTenderOffer_c20250319__20250319_zQ7TN5Xvskha" style="font-family: Wingdings"><ix:nonNumeric contextRef="AsOf2025-03-19" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span>&#160;&#160;Pre-commencement
communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt"><span id="xdx_90D_edei--PreCommencementIssuerTenderOffer_c20250319__20250319_zmrfinhnTE1e" style="font-family: Wingdings"><ix:nonNumeric contextRef="AsOf2025-03-19" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span>Pre-commencement
communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to 12(b)&#160;of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="white-space: nowrap; border-bottom-width: 1pt; border-bottom-style: solid; border-image: none; width: 34%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title&#160;of&#160;each&#160;class</b></span></td>
    <td style="white-space: nowrap; width: 1%; text-align: center">&#160;</td>
    <td style="white-space: nowrap; border-bottom-width: 1pt; border-bottom-style: solid; border-image: none; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    <br/>
Symbol(s)</b></span></td>
    <td style="white-space: nowrap; width: 1%; text-align: center">&#160;</td>
    <td style="white-space: nowrap; border-bottom-width: 1pt; border-bottom-style: solid; border-image: none; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name&#160;of&#160;each&#160;exchange<br/>

    on&#160;which registered</b></span></td></tr>
<tr>
    <td style="text-align: center; vertical-align: top"><b><span id="xdx_907_edei--Security12bTitle_c20250319__20250319_znrObVjttJE4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-03-19" id="Fact000025" name="dei:Security12bTitle">Common
    Stock, par value $0.01 per share</ix:nonNumeric></span></b></td>
    <td style="vertical-align: bottom"><b>&#160;</b></td>
    <td style="text-align: center; vertical-align: top"><b><span id="xdx_90C_edei--TradingSymbol_c20250319__20250319_zgGaHncRTodf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-03-19" id="Fact000026" name="dei:TradingSymbol">PLUG</ix:nonNumeric></span></b></td>
    <td style="vertical-align: bottom"><b>&#160;</b></td>
    <td style="text-align: center; vertical-align: top"><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    <span id="xdx_90B_edei--SecurityExchangeName_c20250319__20250319_zaKJb5zAtSlb"><ix:nonNumeric contextRef="AsOf2025-03-19" format="ixt-sec:exchnameen" id="Fact000027" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
    Market</span></b></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule&#160;12b-2 of the Securities
Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging growth
company <span style="font-family: Wingdings"><span id="xdx_903_edei--EntityEmergingGrowthCompany_c20250319__20250319_z0iQtRIp30X6"><ix:nonNumeric contextRef="AsOf2025-03-19" format="ixt:booleanfalse" id="Fact000028" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="margin: 0pt 0; text-align: left; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act. </span><span style="font-family: Wingdings; font-size: 10pt">&#168;</span></p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 1.01 Entry Into a Material Definitive Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">On&#160;March
19, 2025, Plug Power Inc. (the &#8220;Company&#8221;) entered into an underwriting agreement (the &#8220;Underwriting
Agreement&#8221;) with Oppenheimer &amp; Co. Inc., as representative of the several underwriters named in Schedule I thereto (the
&#8220;Underwriters&#8221;), pursuant to which the Company agreed to issue and sell 46,500,000 shares (the &#8220;Shares&#8221;) of
its common stock, par value $0.01 per share (the &#8220;Common Stock&#8221;), </span><span style="color: #212529; background-color: white">pre-funded
warrants (the &#8220;Pre-Funded Warrants&#8221;) to purchase 138,930,464 shares of Common Stock, and accompanying warrants (the
&#8220;Common Warrants&#8221;) to purchase 185,430,464 shares of Common Stock (the &#8220;Offering&#8221;). Each Share is being
offered and sold together with an accompanying Common Warrant at a combined offering price of $1.51, and each Pre-Funded Warrant is
being offered and sold together with an accompanying Common Warrant at a combined offering price of $1.509, which is equal to the
combined offering price per share of each Share and accompanying Common Warrant less the $0.001 exercise price of each Pre-Funded
Warrant. The Underwriters have agreed to purchase each Share with an accompanying Common Warrant from the Company at a combined
price of $1.4458 and each Pre-Funded Warrant with an accompanying Common Warrant from the Company at a combined price of
$1.4449.</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
Company estimates that the net proceeds from the Offering, after deducting the underwriting discount and estimated Offering expenses
payable by the Company and excluding the proceeds, if any, from the exercise of the Common Warrants, will be approximately $267.0 million.
If all of the Common Warrants sold in this Offering were to be exercised in cash at their exercise price, the Company would receive additional
gross proceeds of approximately $371.0 million. The Company intends to use the net proceeds from the Offering for working capital and general
corporate purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Shares and the Warrants will be issued pursuant
to a prospectus supplement dated March 19, 2025 and an accompanying base prospectus that forms a part of the Company&#8217;s registration
statement on Form S-3 (File No. 333-265488), which was filed by the Company with the Securities and Exchange Commission (the &#8220;SEC&#8221;)
on June 8, 2022 and declared automatically declared effective by the SEC. The closing of the Offering is expected to take place on or
about March 20, 2025, subject to the satisfaction of customary closing conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Each Common Warrant will have an exercise
price per share of Common Stock equal to $2.00 and will be exercisable at any time on or after six months after the date of
issuance. Each Pre-Funded Warrant will have an exercise price per share of Common Stock equal to $0.001 and
will be immediately exercisable. Each Common Warrant or Pre-Funded Warrant is exercisable solely by means of a cash exercise, except that a
Common Warrant or Pre-Funded Warrant will be exercisable via cashless exercise if at the time of exercise, a registration statement
registering the issuance of the shares of Common Stock underlying the Common Warrants and Pre-Funded Warrants (the &#8220;Warrant
Shares&#8221;) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), is not then effective or the
prospectus contained therein is not available for the issuance of the Warrant Shares. The Common Warrants and Pre-Funded Warrants
include certain rights upon &#8220;fundamental transactions&#8221; as described in the Common Warrants and Pre-Funded Warrants,
including the right of the holders thereof to receive from the Company or a successor entity the same type or form of consideration
(and in the same proportion) that is being offered and paid to the holders of Common Stock in such fundamental transaction with
respect to the unexercised portion of the applicable Common Warrants or Pre-Funded Warrants immediately prior to such fundamental
transaction. Alternatively, the holder of a Common Warrant shall have the right to receive the cash value of the remaining
unexercised portion of its Common Warrants upon a fundamental transaction, such value to be calculated using the Black-Scholes
Option Pricing Model, as described in the Common Warrants. A holder of the Common Warrants or Pre-Funded Warrants (together with its
affiliates) may not exercise any portion of a Common Warrant or Pre-Funded Warrant to the extent that the holder would beneficially
own more than 4.99% (or, as may be increased upon written notice at the election of the holder, up to 9.99%) of the Company&#8217;s
outstanding Common Stock immediately after exercise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Underwriting Agreement
contains customary representations, warranties, covenants and agreements by the Company, customary conditions to closing and indemnification
obligations of the Company and the Underwriters, including for liabilities under the Securities Act. The representations, warranties,
covenants and agreements contained in the Underwriting Agreement were made only for purposes of such agreement and as of specific dates,
were solely for the benefit of the parties to such agreement and may be subject to limitations agreed upon by the contracting parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Copies of the Underwriting Agreement, the form
of Common Warrant and the form of Pre-Funded Warrant are attached as Exhibit 1.1, Exhibit 4.1 and Exhibit 4.2 hereto, respectively, and
are incorporated herein by reference. The foregoing descriptions of the terms of the Underwriting Agreement, the form of Common Warrant
and the form of Pre-Funded Warrant are each qualified in its entirety by reference to such exhibit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In connection with the filing of the Underwriting
Agreement, the Company is filing as Exhibit 5.1 hereto an opinion of its counsel, Goodwin Procter LLP, regarding the legality of the Shares,
the Common Warrants, the Pre-Funded Warrants and the Warrant Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Cautionary Note Regarding Forward-Looking Statements </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Any statements in this Current Report on Form 8-K about future expectations,
plans, and prospects for the Company, including the Company&#8217;s expectations and plans regarding the Offering, the anticipated net
proceeds from the Offering, the planned use of the proceeds of the Offering, the anticipated closing date of the Offering, and other statements
containing the words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend&#8221;,
&#8220;goal,&#8221; &#8220;may&#8221;, &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;target,&#8221;
&#8220;potential,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;continue,&#8221; and
similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995.
Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors.
Such forward-looking statements involve substantial risks and uncertainties that could cause the Company&#8217;s future results, performance
or achievements to differ significantly from those expressed or implied by the forward-looking statements. Such risks and uncertainties
include, among others, including but not limited to, the risks related to the Offering and uncertainties related to market conditions.
These and other potential risks and uncertainties that could cause actual results to differ from the results predicted are more fully
described in the &#8220;Risk Factors&#8221; section contained in the prospectus supplement related to the Offering filed with the SEC
on March 19, 2025, as well as other filings and reports that are filed by the Company with the SEC, including the Annual Report on Form
10-K for the year ended December 31, 2024. The forward-looking statements included in this Current Report on Form 8-K represent the Company&#8217;s
views as of the date of this Current Report on Form 8-K. Except as required by law, the Company undertakes no intention or obligation
to update or revise any forward-looking statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01. Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&#160;Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit<br/>
Number</b></span></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 90%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td></tr>
  <tr>
    <td style="vertical-align: top"><a href="tm259816d1_ex1-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="tm259816d1_ex1-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting Agreement, dated March 19, 2025, by and among Plug Power Inc. and Oppenheimer &amp; Co. Inc., as representative of the several underwriters named in Schedule I thereto.</span></a></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><a href="tm259816d1_ex4-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="tm259816d1_ex4-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Common Warrant.</span></a></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><a href="tm259816d1_ex4-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><a href="tm259816d1_ex4-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Pre-Funded Warrant.</span></a></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><a href="tm259816d1_ex5-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</span></a></td>
    <td>&#160;</td>
    <td><a href="tm259816d1_ex5-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Goodwin Procter LLP.</span></a></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><a href="tm259816d1_ex5-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></a></td>
    <td>&#160;</td>
    <td><a href="tm259816d1_ex5-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Goodwin Procter LLP (contained in Exhibit 5.1).</span></a></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded with the Inline XBRL document).</span></td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Plug Power Inc.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: March 19, 2025</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Paul Middleton</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Paul Middleton</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Chief Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKgkAQRb/Afxj2OUyXpPIxqYgsQiJ6XXKKJd2R2c3sk/rLNiUaBobh3nOvECOxppWukOG8KHI4Yt1UyiEUeEVGc0HvyDbbFPwt8KatY2Vc//7AjDyDnklCKS9e6K2ttlimEE3H8XwsJxDN0mQCh50IvnpG5qpLNE6rCpQp4cDUsEan+DUkHFVHhupXX3VCtppMCnEYDfIbZBRL2FOrnsR3C3meiWDUTyDWTI/Gu5adQ/MlYVlh7evsQP83+AAQCEqc -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>tm259816d1_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 1.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PLUG POWER INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>46,500,000
Shares of </B></FONT><B>COMMON STOCK, PAR VALUE $0.01 PER SHARE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Warrants
to Purchase 185,430,464 Shares of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>AND</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Pre-funded
Warrants to Purchase 138,930,464 Shares of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNDERWRITING AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">March&nbsp;19, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Oppenheimer&nbsp;&amp; Co. Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As representative of the several underwriters</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">named in Schedule I hereto</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">c/o Oppenheimer&nbsp;&amp; Co. Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">85 Broad Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">New York, New York 10004</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Plug Power Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;),
proposes to issue and sell to the several Underwriters named in Schedule I hereto (the &ldquo;<B>Underwriters</B>&rdquo;), for whom Oppenheimer&nbsp;&amp;
Co. Inc. (&ldquo;<B>Oppenheimer</B>&rdquo; or the &ldquo;<B>Representative</B>&rdquo;) is acting as representative, (i)&nbsp;46,500,000
shares of its common stock, par value $0.01 per share (the &ldquo;<B>Shares</B>&rdquo;), (ii)&nbsp;warrants to purchase 185,430,464 shares
of Common Stock at an exercise price of $2.00 per share (the &ldquo;<B>Common Warrants</B>&rdquo;) and (iii)&nbsp;pre-funded warrants
to purchase 138,930,464 shares of Common Stock at an exercise price of $0.001 per share (the &ldquo;<B>Pre-funded Warrants</B>&rdquo;
and, together with the Common Warrants, the &ldquo;<B>Warrants</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of Common Stock underlying the Warrants are hereinafter referred to as the &ldquo;Warrant Shares.&rdquo; The Shares, the Warrants
and the Warrant Shares are hereinafter referred to as the &ldquo;Securities&rdquo;.</FONT> The Securities in the transaction will be sold
as (i)&nbsp;one Share and one accompanying Common Warrant to purchase one Warrant Share or (ii)&nbsp;one Pre-Funded Warrant to purchase
one Warrant Share and one accompanying Common Warrant to purchase one Warrant Share. The respective amounts of the Shares, Pre-Funded
Warrants and Common Warrants to be purchased by each of the several Underwriters are set forth opposite their names on Schedule I hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Shares and Common Warrants will be issued separately but will be purchased together in this offering and each shall be </FONT>immediately
separable and severally transferable upon issuance. The Pre-Funded Warrants and Common Warrants will be issued separately but will be
purchased together in this offering and each shall be immediately separable and severally transferable upon issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of the Warrants shall be substantially similar to the Form&nbsp;of Warrant attached as <U>Exhibit&nbsp;B</U> hereto. The terms of
the Pre-Funded Warrants shall be substantially similar to the Form&nbsp;of Warrant attached as <U>Exhibit&nbsp;C</U> hereto.</FONT> To
the extent there are no additional Underwriters listed on Schedule I other than Oppenheimer, references to multiple Underwriters shall
be disregarded and the term Representative as used herein shall have the same meaning as Underwriter. The shares of common stock, par
value $0.01 per share, of the Company to be outstanding after giving effect to the sales contemplated hereby are hereinafter referred
to as the &ldquo;<B>Common Stock.</B>&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company has filed with the Securities and Exchange Commission (the
&ldquo;<B>Commission</B>&rdquo;) an automatic shelf registration statement on Form&nbsp;S-3 (File No.&nbsp;333-265488), including a base
prospectus dated June&nbsp;8, 2022 (the &ldquo;<B>Base Prospectus</B>&rdquo;), covering the offering and sale of certain securities (the
&ldquo;<B>Shelf Securities</B>&rdquo;), including the Shares, the Warrants and the Warrant Shares, which automatic shelf registration
statement became effective under Rule&nbsp;462(e)&nbsp;under the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;).
The registration statement as amended to the date of this Agreement, including the information (if any) deemed to be part of the registration
statement at the time it most recently became effective in connection with the offering of the Securities of effectiveness pursuant to
Rule&nbsp;430B under the Securities Act, is hereinafter referred to as the &ldquo;<B>Registration Statement</B>&rdquo;&#894; the related
prospectus covering the Shelf Securities, dated June&nbsp;8, 2022, in the form first used to confirm sales of the Securities (or in the
form first made available to the Underwriters by the Company to meet requests of purchasers pursuant to Rule&nbsp;173 under the Securities
Act), is hereinafter referred to as the &ldquo;<B>Base Prospectus.</B>&rdquo; The Base Prospectus, as supplemented by the prospectus supplement
specifically relating to the Securities in the form first used to confirm sales of the Securities (or in the form first made available
to the Underwriters by the Company to meet requests of purchasers pursuant to Rule&nbsp;173 under the Securities Act) is hereinafter referred
to as the &ldquo;<B><U>Prospectus</U></B>.&rdquo; For purposes of this Agreement, &ldquo;<B>free writing prospectus</B>&rdquo; has the
meaning set forth in Rule&nbsp;405 under the Securities Act, &ldquo;<B>Time of Sale Prospectus</B>&rdquo; means the Base Prospectus contained
in the Registration Statement at the time of its effectiveness together with the documents and pricing information set forth in Schedule
II hereto, and &ldquo;<B>broadly available road show</B>&rdquo; means a &ldquo;bona fide electronic road show&rdquo; as defined in Rule&nbsp;433(h)(5)&nbsp;under
the Securities Act that has been made available without restriction to any person. As used herein, the terms &ldquo;Registration Statement,&rdquo;
&ldquo;Time of Sale Prospectus&rdquo; and &ldquo;Prospectus&rdquo; shall include the documents, if any, incorporated by reference therein
as of the date hereof. The terms &ldquo;<B>supplement,</B>&rdquo; &ldquo;<B>amendment</B>&rdquo; and &ldquo;<B>amend</B>&rdquo; as used
herein with respect to the Registration Statement, the Time of Sale Prospectus or the Prospectus shall include all documents subsequently
filed by the Company with the Commission pursuant to the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;),
that are deemed to be incorporated by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Representations
and Warranties</I>. The Company represents and warrants to and agrees with each of the Underwriters that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company is a &ldquo;well-known seasoned issuer&rdquo; (as defined in Rule&nbsp;405) and meets the requirements for use of Form&nbsp;S-3
under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Registration Statement has become effective&#894; no stop order suspending the effectiveness of the Registration Statement is in effect,
and no proceedings for such purpose or pursuant to Section&nbsp;8A under the Securities Act are pending before or, to the Company&rsquo;s
knowledge, threatened by the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;(i)&nbsp;Each
document, if any, filed or to be filed pursuant to the Exchange Act and incorporated by reference in the Time of Sale Prospectus or the
Prospectus complied or will comply when so filed in all material respects with the Exchange Act and the applicable rules&nbsp;and regulations
of the Commission thereunder, (ii)&nbsp;the Registration Statement, when it became effective, did not contain and, as amended or supplemented,
if applicable, will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary to make the statements therein not misleading, (iii)&nbsp;the Registration Statement complied and the Prospectus, as amended
or supplemented, if applicable, will comply in all material respects with the Securities Act and the applicable rules&nbsp;and regulations
of the Commission thereunder, (iv)&nbsp;the Time of Sale Prospectus does not, and at the time of sale of the Shares and accompanying Warrants
in connection with the offering when the Prospectus is not yet available to prospective purchasers and at the Closing Date (as defined
in Section&nbsp;4), the Time of Sale Prospectus, as then amended or supplemented by the Company, if applicable, will not, contain any
untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading, (v)&nbsp;each broadly available road show, if any, when considered together with the Time
of Sale Prospectus, does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading and (vi)&nbsp;the Prospectus does not contain and,
as amended or supplemented, if applicable, will not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements therein, in the light of the circumstances under which they were made, not misleading, except that the representations
and warranties set forth in this paragraph do not apply to statements or omissions in the Registration Statement, the Time of Sale Prospectus
or the Prospectus based upon information relating to any Underwriter furnished to the Company in writing by such Underwriter through you
expressly for use therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company is not an &ldquo;ineligible issuer&rdquo; in connection with the offering pursuant to Rules&nbsp;164, 405 and 433 under the Securities
Act. Any free writing prospectus that the Company is required to file pursuant to Rule&nbsp;433(d)&nbsp;under the Securities Act has been,
or will be, filed with the Commission in accordance with the requirements of the Securities Act and the applicable rules&nbsp;and regulations
of the Commission thereunder. Each free writing prospectus that the Company has filed pursuant to Rule&nbsp;433(d)&nbsp;under the Securities
Act complies in all material respects with the requirements of the Securities Act and the applicable rules&nbsp;and regulations of the
Commission thereunder. Except for the free writing prospectuses, if any, identified in Schedule II hereto, and electronic road shows,
if any, each furnished to you before first use, the Company has not prepared, used or referred to, and will not, without your prior consent,
prepare, use or refer to, any free writing prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company has been duly incorporated, is validly existing as a corporation in good standing under the laws of the jurisdiction of its incorporation,
has the corporate power and authority to own or lease its property and to conduct its business as described in each of the Registration
Statement, the Time of Sale Prospectus and the Prospectus and is duly qualified to transact business and is in good standing (to the extent
the concept of good standing or an equivalent concept is applicable in such jurisdiction) in each jurisdiction in which the conduct of
its business or its ownership or leasing of property requires such qualification, except to the extent that the failure to be so qualified
or be in good standing would not have a material adverse effect on the Company and its subsidiaries, taken as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Each
subsidiary of the Company has been duly incorporated, is validly existing as a corporation in good standing (to the extent the concept
of good standing or an equivalent concept is applicable in such jurisdiction) under the laws of the jurisdiction of its incorporation,
has the corporate power and authority to own or lease its property and to conduct its business as described in each of the Registration
Statement, the Time of Sale Prospectus and the Prospectus and is duly qualified to transact business and is in good standing (to the extent
the concept of good standing or an equivalent concept is applicable in such jurisdiction) in each jurisdiction in which the conduct of
its business or its ownership or leasing of property requires such qualification, except to the extent that the failure to be so qualified
or be in good standing would not have a material adverse effect on the Company and its subsidiaries, taken as a whole&#894; all of the
issued shares of capital stock of each subsidiary of the Company have been duly and validly authorized and issued, are fully paid and
non-assessable and, except as described in the Registration Statement, the Time of Sale Prospectus and the Prospectus, are owned directly
or indirectly by the Company, free and clear of all liens, encumbrances, equities or claims. Each of the Company&rsquo;s subsidiaries
that is a &ldquo;significant subsidiary&rdquo; (as such term is defined in Rule&nbsp;1-02 of Regulation S-X promulgated under the Securities
Act) is set forth in Exhibit&nbsp;21.1 to the Company&rsquo;s Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company has the power and authority to enter this Agreement and the Warrants and to authorize, issue and sell the Shares and the Warrants
as contemplated by this Agreement. This Agreement has been duly authorized, executed and delivered by the Company and the Warrants </FONT>have
been duly authorized and, when executed and delivered by the Company in accordance with this Agreement, will constitute valid, legal and
binding obligations of the Company, enforceable against the Company in accordance with their terms, except as such enforceability may
be limited by bankruptcy, insolvency, reorganization or similar laws affecting the rights of creditors generally and subject to general
principles of equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
authorized capital stock of the Company conforms in all material respects as to legal matters to the description thereof contained in
each of the Registration Statement, the Time of Sale Prospectus and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
shares of Common Stock outstanding prior to the issuance of the Shares have been duly authorized and are validly issued, fully paid and
non-assessable and have been issued in compliance with all applicable securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Shares have been duly authorized and, when delivered to and paid for by the Underwriters in accordance with the terms of this Agreement,
will be validly issued, fully paid and non-assessable, and the issuance of the Shares will not be subject to any preemptive or similar
rights. </FONT>All necessary corporate action has been duly and validly taken by the Company to authorize the issuance and delivery of
the Warrant Shares by the Company. The Warrant Shares, when issued, paid for and delivered upon due exercise of the Warrants, will be
duly authorized and validly issued, fully paid and nonassessable, will be issued in compliance with all applicable securities laws, and
will be free of preemptive or similar rights. The Securities, when issued, will conform in all material respects to the descriptions thereof
set forth in the Registration Statement, the Time of Sale Prospectus and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
execution and delivery by the Company of, and the performance by the Company of its obligations under, this Agreement and the Warrants
will not contravene any provision of applicable law or the certificate of incorporation or by-laws of the Company or any agreement or
other instrument binding upon the Company or any of its subsidiaries that is material to the Company and its subsidiaries, taken as a
whole, or any material judgment, order or decree of any governmental body, agency or court having jurisdiction over the Company or any
subsidiary, and no consent, approval, authorization or order of, or qualification with, any governmental body or agency is required for
the performance by the Company of its obligations under this Agreement or the Warrants, except (i)&nbsp;such as have been obtained or
made under the Securities Act, (ii)&nbsp;such as may be required by the securities or Blue Sky laws of the various states in connection
with the offer and sale of the Securities, (iii)&nbsp;such as may be required by Nasdaq Stock Market, or (iv)&nbsp;such consents, approvals,
authorizations, filings or orders that will be obtained or completed on or prior to the Closing Date or the absence of which would not,
individually or in the aggregate, reasonably be expected to have a material adverse effect on the Company or its subsidiaries, taken as
a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;There
has not occurred any material adverse change, or any development involving a prospective material adverse change, in the condition, financial
or otherwise, or in the earnings, business or operations of the Company and its subsidiaries, taken as a whole, from that set forth in
the Time of Sale Prospectus provided to prospective purchasers of the Shares and accompanying Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(m)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To
the Company&rsquo;s knowledge, there are no legal or governmental proceedings pending or threatened to which the Company or any of its
subsidiaries is a party or to which any of the properties of the Company or any of its subsidiaries is subject, other than proceedings
accurately described in all material respects in each of the Registration Statement, the Time of Sale Prospectus and the Prospectus and
proceedings that would not have a material adverse effect on the Company and its subsidiaries, taken as a whole, or on the power or ability
of the Company to perform its obligations under this Agreement or to consummate the transactions contemplated by each of the Registration
Statement, the Time of Sale Prospectus and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(n)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;[Reserved].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(o)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To
the Company&rsquo;s knowledge, the Company and its subsidiaries (i)&nbsp;are in compliance with any and all applicable foreign, federal,
state and local laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances
or wastes, pollutants or contaminants (&ldquo;<B>Environmental Laws</B>&rdquo;), (ii)&nbsp;have received all permits, licenses or other
approvals required of them under applicable Environmental Laws to conduct their respective businesses and (iii)&nbsp;are in compliance
with all terms and conditions of any such permit, license or approval, except where such noncompliance with Environmental Laws, failure
to receive required permits, licenses or other approvals or failure to comply with the terms and conditions of such permits, licenses
or approvals would not, singly or in the aggregate, have a material adverse effect on the Company and its subsidiaries, taken as a whole.
The Company and its subsidiaries are not aware of any existing liabilities concerning hazardous or toxic substances or wastes, pollutants
or contaminants, that could reasonably be expected to have a material adverse effect on the capital expenditures, earnings or competitive
position of the Company and its subsidiaries. To the knowledge of the Company, no property which is or has been owned, leased, used, operated
or occupied by the Company or its subsidiaries has been designated as a Superfund site pursuant to the Comprehensive Environmental Response,
Compensation of Liability Act of 1980, as amended (42 U.S.C. Section&nbsp;9601, et. seq.), or otherwise designated as a contaminated sit
under applicable state or local law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(p)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;There
are no costs or liabilities associated with Environmental Laws (including, without limitation, any capital or operating expenditures required
for clean-up, closure of properties or compliance with Environmental Laws or any permit, license or approval, any related constraints
on operating activities and any potential liabilities to third parties) which would, singly or in the aggregate, have a material adverse
effect on the Company and its subsidiaries, taken as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(q)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company is not, and after giving effect to the offering and sale of the Shares and accompanying Warrants and the application of the proceeds
thereof as described in the Time of Sale Prospectus and Prospectus will not be, required to register as an &ldquo;investment company&rdquo;
as such term is defined in the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(r)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;(i)&nbsp;Neither
the Company nor any of its subsidiaries, nor any director, officer, or employee, nor, to the Company&rsquo;s knowledge, any agent, controlled
affiliate or representative of the Company or of any of its subsidiaries, has while acting on behalf of the Company or its subsidiaries
taken or will take any action in furtherance of an offer, payment, promise to pay, or authorization or approval of the payment or giving
of money, property, gifts or anything else of value, directly or indirectly, to any &ldquo;government official&rdquo; (including any officer
or employee of a government or government-owned or controlled entity or of a public international organization, or any person acting in
an official capacity for or on behalf of any of the foregoing, or any political party or party official or candidate for political office)
to influence official action or secure an improper advantage&#894; (ii)&nbsp;the Company and its subsidiaries and controlled affiliates
have conducted their businesses in compliance with the U.S. Foreign Corrupt Practices Act of 1977, the UK Bribery Act 2010, and any other
applicable anti-corruption laws (collectively, the &ldquo;<B>Anti-Corruption Laws</B>&rdquo;), and have instituted and maintained and
will continue to maintain policies and procedures reasonably designed to promote and achieve compliance with such laws and with the representation
and warranty contained herein&#894; and (iii)&nbsp;neither the Company nor its subsidiaries will use or lend, contribute or otherwise
make available, directly or indirectly, the proceeds of the offering in furtherance of an offer, payment, promise to pay, or authorization
of the payment or giving of money, or anything else of value, to any person in violation of any applicable Anti-Corruption Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(s)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
operations of the Company and its subsidiaries are and have been conducted at all times in material compliance with all applicable anti-money
laundering laws, rules&nbsp;and regulations, including the financial recordkeeping and reporting requirements contained therein, and including
the Bank Secrecy Act of 1970, applicable provisions of the USA PATRIOT Act of 2001, the Money Laundering Control Act of 1986, and the
Anti-Money Laundering Act of 2020 (collectively, the &ldquo;<B>Anti-Money Laundering Laws</B>&rdquo;), and no investigation, inquiry,
action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or
any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the best knowledge of the Company, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(t)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;(i)&nbsp;Neither
the Company nor any of its subsidiaries, nor any director, officer, or employee thereof, nor, to the Company&rsquo;s knowledge, any agent,
controlled affiliate or representative of the Company or any of its subsidiaries, is an individual or entity (&ldquo;<B>Person</B>&rdquo;)
that is, or is owned or controlled by a Person that is:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">(A)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
subject of any sanctions administered or enforced by the U.S. Department of Treasury&rsquo;s Office of Foreign Assets Control, the U.S.
Department of State, the United Nations Security Council, the European Union, His Majesty&rsquo;s Treasury, or other relevant sanctions
authority (collectively, &ldquo;<B>Sanctions</B>&rdquo;), nor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">(B)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;located,
organized or resident in a country or territory that is the subject of Sanctions (including, without limitation, the so-called Donetsk
People&rsquo;s Republic, the so-called Luhansk People&rsquo;s Republic or any other Covered Region of Ukraine identified pursuant to Executive
Order 14065, Crimea, Cuba,&nbsp;Iran, North Korea and Syria).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company will not, directly or indirectly, use the proceeds of the offering, or lend, contribute or otherwise make available such proceeds
to any subsidiary, joint venture partner or other Person:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">(A)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;to
fund or facilitate any activities or business of or with any Person or in any country or territory that, at the time of such funding or
facilitation, is the subject of Sanctions&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">(B)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;to
fund or facilitate any money laundering or terrorist financing activities&#894; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">(C)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;in
any other manner that will result in a violation of Sanctions by any Person (including any Person participating in the offering, whether
as underwriter, advisor, investor or otherwise).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;For
the past ten years, the Company and its subsidiaries have not knowingly engaged in, are not now knowingly engaged in, and will not engage
in, any dealings or transactions with any Person, or in any country or territory, that at the time of the dealing or transaction is or
was the subject of Sanctions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(u)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company and each of its subsidiaries have filed all federal, state, local and foreign tax returns required to be filed through the date
of this Agreement or have requested extensions thereof (except where the failure to file would not, individually or in the aggregate,
have a material adverse effect) and have paid all taxes required to be paid thereon (except for cases in which the failure to file or
pay would not have a material adverse effect, or, except as currently being contested in good faith and for which reserves required by
generally accepted accounting principles in the United States (&ldquo;<B>U.S. GAAP</B>&rdquo;) have been created in the financial statements
of the Company), and no tax deficiency has been determined adversely to the Company or any of its subsidiaries which has had (nor does
the Company nor any of its subsidiaries have any notice or knowledge of any tax deficiency which could reasonably be expected to be determined
adversely to the Company or its subsidiaries and which could reasonably be expected to have) a material adverse effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
financial statements included or incorporated by reference in each of the Registration Statement, the Time of Sale Prospectus and the
Prospectus, together with the related schedules and notes thereto, comply as to form in all material respects with the applicable accounting
requirements of the Securities Act and present fairly the consolidated financial position of the Company and its subsidiaries as of the
dates shown and its results of operations and cash flows for the periods shown, and such financial statements have been prepared in conformity
with U.S. GAAP applied on a consistent basis throughout the periods covered thereby, except for any normal year-end adjustments in the
Company&rsquo;s quarterly financial statements. The other financial information included in each of the Registration Statement, the Time
of Sale Prospectus and the Prospectus has been derived from the accounting records of the Company and its consolidated subsidiaries and
presents fairly in all material respects the information shown thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(w)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company and each of its subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that
(i)&nbsp;transactions are executed in accordance with management&rsquo;s general or specific authorizations&#894; (ii)&nbsp;transactions
are recorded as necessary to permit preparation of financial statements in conformity with U.S. GAAP and to maintain asset accountability&#894;
(iii)&nbsp;access to assets is permitted only in accordance with management&rsquo;s general or specific authorization&#894; and (iv)&nbsp;the
recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect
to any differences&#894; and (v)&nbsp;the interactive data in eXtensible Business Reporting Language included or incorporated by reference
in the Registration Statement is accurate. Except as previously disclosed in the Registration Statement, the Time of Sale Prospectus and
the Prospectus, since the end of the Company&rsquo;s most recent audited fiscal year, there has been (i)&nbsp;no material weakness in
the Company&rsquo;s internal control over financial reporting (whether or not remediated) and (ii)&nbsp;no change in the Company&rsquo;s
internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company&rsquo;s
internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(x)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement fairly
presents the information called for in all material respects and has been prepared in accordance with the Commission&rsquo;s rules&nbsp;and
guidelines applicable thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(y)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company and each of its subsidiaries holds, and is in compliance with, all franchises, grants, authorizations, licenses, permits, easements,
consents, certificates and orders (&ldquo;<B>Permits</B>&rdquo;) of any governmental or self-regulatory agency, authority or body required
for the conduct of its business, and all such Permits are in full force and effect, in each case except where the failure to hold, or
comply with, any of them is not reasonably likely to result in a material adverse effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(z)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company and its subsidiaries have legal and valid title to all personal property described in the Registration Statement, the Time of
Sale Prospectus or the Prospectus as being owned by them that is material to the business of the Company, in each case free and clear
of all liens, claims, security interests, other encumbrances or defects, except those that are not reasonably likely to result in a material
adverse effect. The real property held under lease by the Company and its subsidiaries is held by them under valid, subsisting and enforceable
leases with only such exceptions with respect to any particular lease as do not interfere in any material respect with the conduct of
the business of the Company and its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(aa)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company and each of its subsidiaries owns or possesses or has valid right to use all material patents, patent applications, trademark
service marks, trade names, trademark registrations, service mark registrations, copyrights, licenses, inventions, trade secrets and similar
rights (&ldquo;<B>Intellectual Property</B>&rdquo;) necessary for the conduct of the business of the Company and its subsidiaries as currently
carried on and as described in the Registration Statement, the Time of Sale Prospectus and the Prospectus. To the knowledge of the Company,
no action or use by the Company or any of its subsidiaries will involve or give rise to any infringement of, or license or similar fees
for, any Intellectual Property of others, except where such action, use, license or fee is not reasonably likely to result in a material
adverse effect. Neither the Company nor any of its subsidiaries has received any notice alleging any such infringement or fee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(bb)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company and each of its subsidiaries carries, or is covered by, insurance in such amounts and covering such risks as, in the Company&rsquo;s
reasonable judgment, is adequate for the conduct of its business and the value of its properties and as is customary for similarly sized
companies engaged in similar businesses in similar industries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(cc)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;No
labor dispute with employees of the Company or any of its subsidiaries exists or, to the knowledge of the Company, is imminent, that is
reasonably likely to result in a material adverse effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(dd)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;No
supplier, customer, distributor or sales agent of the Company has notified the Company that it intends to discontinue or decrease the
rate of business transacted with Company, except where such decrease is not reasonably likely to result in a material adverse effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ee)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Since
the respective dates as of which information is given (including by incorporation by reference) in the Registration Statement, the Time
of Sale Prospectus or the Prospectus, (a)&nbsp;neither the Company nor any of its subsidiaries has incurred any material liabilities or
obligations, direct or contingent, or entered into any material transactions other than in the ordinary course of business, (b)&nbsp;the
Company has not declared or paid any dividends or made any distribution of any kind with respect to its capital stock, (c)&nbsp;there
has not been any change in the capital stock of the Company or any of its subsidiaries (other than a change in the capital stock of the
Company due to the issuance of shares under the Company&rsquo;s at-the-market program and the issuance of shares of Common Stock upon
the exercise of outstanding options or warrants or the conversion of outstanding convertible notes or convertible debentures, or the issuance
of stock or restricted stock awards or the vesting of restricted stock units or restricted shares of common stock under the Company&rsquo;s
existing stock awards plan, or any new grants thereof in the ordinary course of business), (d)&nbsp;except as described in the Registration
Statement, the Time of Sale Prospectus or the Prospectus, there has not been any material change in the Company&rsquo;s long-term or short-term
debt, and (e)&nbsp;there has not been the occurrence of any material adverse effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ff)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Except
as set forth in the Registration Statement, the Time of Sale Prospectus and the Prospectus, there are no contracts, agreements or understandings
between the Company and any person granting such person the right (other than rights which have been waived in writing or otherwise satisfied)
to require the Company to file a registration statement under the Securities Act with respect to any securities of the Company owned or
to be owned by such person or to require the Company to include such securities in the securities registered pursuant to the Registration
Statement or in any securities being registered pursuant to any other registration statement filed by the Company under the Securities
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(gg)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
operations of the Company and its subsidiaries are being conducted in material compliance with applicable employment laws, the rules&nbsp;and
regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental
agency (collectively, the &ldquo;<B>Employee Benefit Laws</B>&rdquo;) and no action, suit or proceeding by or before any court or governmental
agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the Employee Benefit Laws
is pending or, to the knowledge of the Company, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(hh)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company had a reasonable basis for, and made in good faith, each &ldquo;forward-looking statement&rdquo; (within the meaning of Section&nbsp;27A
of the Securities Act or Section&nbsp;21E of the Exchange Act) contained or by reference in the Registration Statement, the Time of Sale
Prospectus or the Prospectus, in each case at the time such &ldquo;forward-looking statement&rdquo; was made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;All
statistical or market-related data included or incorporated by reference in the Registration Statement, the Time of Sale Prospectus or
the Prospectus are based on or derived from sources that the Company reasonably believes to be reliable and accurate, and the Company
has obtained the written consent to the use of such data from such sources, to the extent required, other than such consents the failure
of which to obtain is not reasonably likely to result in a material adverse effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(jj)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company has not taken, directly or indirectly, any action that is designed to or that has constituted or that would reasonably be expected
to cause or result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of
the Shares and accompanying Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(kk)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;There
are no securities or preferred stock of or guaranteed by the Company or any of its subsidiaries that are rated by a &ldquo;nationally
recognized statistical rating organization,&rdquo; as such term is defined in Section&nbsp;3(a)(62) of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ll)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;All
descriptions of the Company&rsquo;s franchise agreements, leases, contracts, or other agreements or documents contained in the Registration
Statement, the Time of Sale Prospectus and the Prospectus are accurate and complete descriptions of such documents in all material respects.
Except as described in the Registration Statement, the Time of Sale Prospectus and the Prospectus, no material franchise agreement, lease
or contract, or other material agreement has been suspended or terminated for convenience or default by the Company or any of the other
parties thereto, and neither the Company nor any of its subsidiaries has received notice of and the Company does not have knowledge of
any such pending or threatened suspension or termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(mm)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
exercise price of each option issued under the Company&rsquo;s stock option or other employee benefit plans has been no less than the
fair market value of a share of Common Stock as determined on the date of grant of such option. All grants of options were validly issued
and properly approved by the board of directors of the Company (or a duly authorized committee thereof) in material compliance with all
applicable laws and regulations and recorded in the Company&rsquo;s financial statements in accordance with U.S. GAAP and, to the Company&rsquo;s
knowledge, no such grants involved &ldquo;back dating,&rdquo; &ldquo;forward dating&rdquo; or similar practice with respect to the effective
date of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(nn)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;(i)&nbsp;The
Company and each of its subsidiaries have complied and are presently in compliance, in each case in all material respects, with all privacy
policies, contractual obligations and laws, statutes, judgments, orders, rules&nbsp;and regulations of any court or other governmental
or regulatory authority applicable to the Company and its subsidiaries, in each case, relating to the collection, use, transfer, processing,
import, export, storage, protection, disposal and disclosure by the Company or any of its subsidiaries of personal, personally identifiable,
household, sensitive, confidential or regulated data (&ldquo;<B>Data Security Obligations</B>,&rdquo; and such data, &ldquo;<B>Data</B>&rdquo;)&#894;
(ii)&nbsp;the Company and its subsidiaries have not received any notification of or complaint regarding and are unaware of any other facts
that, individually or in the aggregate, would reasonably indicate non-compliance with any Data Security Obligation in any material respect&#894;
and (iii)&nbsp;to the Company&rsquo;s knowledge, there is no pending or threatened action, suit or proceeding by or before any court or
governmental agency, authority or body alleging non-compliance by the Company or any of its subsidiaries with any Data Security Obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(oo)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company and each of its subsidiaries have taken all commercially reasonable measures necessary to protect Data and the information technology
systems used in connection with the operation of the Company&rsquo;s and its subsidiaries&rsquo; businesses. Without limiting the foregoing,
the Company and its subsidiaries have used commercially reasonable efforts to establish and maintain, and have established, maintained
and implemented, information technology, information security, cyber security and data protection controls, policies and procedures reasonably
designed to protect against and prevent breach, destruction, loss, unauthorized distribution, use, access, disablement or misappropriation,
or other compromise or misuse of or relating to any information technology system or Data used in connection with the operation of the
Company&rsquo;s and its subsidiaries&rsquo; businesses (&ldquo;<B>Breach</B>&rdquo;), except in each case to the extent that the failure
to do so would not reasonably be expected to have a material adverse effect on the Company and its subsidiaries, taken as a whole. Except
as disclosed in the Registration Statement, the Time of Sale Prospectus and the Prospectus, to the knowledge of the Company, there has
been no such Breach, and the Company and its subsidiaries have not been notified of and have no knowledge of any event or condition that
would reasonably be expected to result in, any such Breach.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Agreements
to Sell and Purchase</I>. The Company hereby agrees to sell to the several Underwriters, and each Underwriter, upon the basis of the representations
and warranties herein contained, but subject to the conditions hereinafter stated, agrees, severally and not jointly, to purchase from
the Company the respective number of (i)&nbsp;Shares, (ii)&nbsp;Pre-Funded Warrants and (iii)&nbsp;accompanying Common Warrants set forth
in Schedule I hereto opposite its name. The combined purchase price will be (x)&nbsp;$1.4558 for one Share and one Common Warrant and
(y)&nbsp;$1.4448 for </FONT>one Pre-Funded Warrant and one Common Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><I>Terms
of Public Offering</I>. The Company is advised by you that the Underwriters propose to make a public offering of their respective portions
of the Shares, Pre-Funded Warrants and accompanying Common Warrants as soon after the Registration Statement and this Agreement have become
effective as in the Underwriters judgment is advisable. The Company is further advised by you that the Shares, Pre-Funded Warrants and
accompanying Common Warrants are to be offered to the public initially at (x)&nbsp;a combined purchase price for one Share and one Common
Warrant of $1.51 and (y)&nbsp;a combined purchase price for one Pre-Funded Warrant and one Common Warrant of $1.509 (together, the &ldquo;<B>Public
Offering Price</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><I>Payment
and Delivery</I>. Payment for the Securities shall be made to the Company in Federal or other funds immediately available in New York
City against delivery of the Shares, Pre-Funded Warrants and accompanying Warrants for the respective accounts of the several Underwriters
at 10:00 a.m., New York City time, on March&nbsp;20, 2025, or at such other time on the same or such other date as shall be designated
in writing by you. The time and date of such payment are hereinafter referred to as the &ldquo;<B>Closing Date</B>.&rdquo; The Company
and the Representative shall instruct purchaser of the Pre-Funded Warrants to make payment for the Pre-Funded Warrants and accompanying
Common Warrants on the Closing Date to the Company by wire transfer in immediately available funds to the account specified by the Company
at a purchase price of $1.509 per Pre-Funded Warrant and accompanying Common Warrant, in lieu of payment by the Underwriters for such
Warrants, and the Company shall deliver the Warrants to such purchasers on such date in electronic form against such payment, in lieu
of the Company&rsquo;s obligation to deliver the Warrants to the Representative; <U>provided </U>that, the Underwriters shall withhold
$0.0641325 per Pre-Funded Warrant and accompanying Common Warrant with respect to such Warrants as an offset against the payment owed
by the Underwriters to the Company for such Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Shares and accompanying Warrants shall be registered in such names and in such denominations as you shall request in writing not later
than one full business day prior to the Closing Date. </FONT>The Shares shall be delivered by or on behalf of the Company to the Representative
through the facilities of the Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;) for the account of such Representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Conditions
to the Underwriters&rsquo; Obligations</I>. The obligations of the Company to sell the Shares and accompanying Warrants to the Underwriters
and the several obligations of the Underwriters to purchase and pay for the Shares and accompanying Warrants on the Closing Date are subject
to the following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Subsequent
to the execution and delivery of this Agreement and prior to the Closing Date, (i)&nbsp;no order suspending the effectiveness of the Registration
Statement shall be in effect, and no proceeding for such purpose or pursuant to Section&nbsp;8A under the Securities Act shall be pending
before or, to the Company&rsquo;s knowledge, threatened by the Commission and (ii)&nbsp;there shall not have occurred any change, or any
development involving a prospective change, in the condition, financial or otherwise, or in the earnings, business or operations of the
Company and its subsidiaries, taken as a whole, from that set forth in the Time of Sale Prospectus provided to the prospective purchasers
of the Securities that, in your judgment, is material and adverse and that makes it, in your judgment, impracticable to market the Securities
on the terms and in the manner contemplated in the Time of Sale Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Underwriters shall have received on the Closing Date a certificate, dated the Closing Date and signed by an executive officer of the Company,
to the effect set forth in Section&nbsp;5(a)&nbsp;and to the effect that the representations and warranties of the Company contained in
this Agreement are true and correct as of the Closing Date and that the Company has complied with all of the agreements and satisfied
all of the conditions on its part to be performed or satisfied hereunder on or before the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Underwriters shall have received on the Closing Date an opinion and negative assurance letter of Goodwin Procter LLP, outside counsel
for the Company, in form and substance satisfactory to you, dated the Closing Date. Such opinion and negative assurance letter shall be
rendered to the Underwriters at the request of the Company and shall so state therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Underwriters shall have received on the Closing Date an opinion and negative assurance letter of Milbank LLP, counsel for the Underwriters,
dated the Closing Date, in form and substance satisfactory to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Underwriters shall have received, on each of the date hereof and the Closing Date, a letter dated the date hereof or the Closing Date,
as the case may be, in form and substance satisfactory to the Underwriters, from Deloitte&nbsp;&amp; Touche LLP, independent public accountants,
containing statements and information of the type ordinarily included in accountants&rsquo; &ldquo;comfort letters&rdquo; to underwriters
with respect to the financial statements and certain financial information contained in the Registration Statement, the Time of Sale Prospectus
and the Prospectus&#894; provided that the letter delivered on the Closing Date shall use a &ldquo;cut-off date&rdquo; not earlier than
the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;[Reserved].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
&ldquo;lock-up&rdquo; agreements, each substantially in the form of <U>Exhibit&nbsp;A</U> hereto, between you and certain officers and
directors of the Company relating to sales and certain other dispositions of shares of Common Stock or certain other securities, delivered
to you on or before the date hereof, shall be in full force and effect on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
Company shall submit, prior to the Closing Date, a Notification Form: Listing of Additional Shares with the NASDAQ Capital Market with
respect to the Shares and Warrant Shares. The Company has taken no action to, or likely to have the effect of, delisting the Shares, nor
has the Company received any notification that the Nasdaq Capital Market is contemplating terminating such listing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Underwriters shall have received on the Closing Date certificates for the Warrants, registered in the names of the investors and in such
denominations as conveyed to the Company by the Representative on or after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Covenants
of the Company</I>. The Company covenants with each Underwriter as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To
furnish to you in New York City, without charge, prior to 10:00 a.m.&nbsp;New York City time on the business day next succeeding the date
of this Agreement and during the period mentioned in Section&nbsp;6(e)&nbsp;or 6(f)&nbsp;below, as many copies of the Time of Sale Prospectus,
the Prospectus, any documents incorporated by reference therein and any supplements and amendments thereto or to the Registration Statement
as you may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Before
amending or supplementing the Registration Statement, the Time of Sale Prospectus or the Prospectus, to furnish to you a copy of each
such proposed amendment or supplement and not to file any such proposed amendment or supplement to which you reasonably object, and to
file with the Commission within the applicable period specified in Rule&nbsp;424(b)&nbsp;under the Securities Act any prospectus required
to be filed pursuant to such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To
furnish to you a copy of each proposed free writing prospectus to be prepared by or on behalf of, used by, or referred to by the Company
and not to use or refer to any proposed free writing prospectus to which you reasonably object.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Without
the prior consent of Oppenheimer, not to take any action that would result in Oppenheimer or the Company being required to file with the
Commission pursuant to Rule&nbsp;433(d)&nbsp;under the Securities Act a free writing prospectus prepared by or on behalf of the Underwriters
that Oppenheimer otherwise would not have been required to file thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
the Time of Sale Prospectus is being used to solicit offers to buy the Shares and accompanying Warrants at a time when the Prospectus
is not yet available to prospective purchasers and any event shall occur or condition exist as a result of which it is necessary to amend
or supplement the Time of Sale Prospectus in order to make the statements therein, in the light of the circumstances, not misleading,
or if any event shall occur or condition exist as a result of which the Time of Sale Prospectus conflicts with the information contained
in the Registration Statement then on file, or if, in the opinion of counsel for the Underwriters, it is necessary to amend or supplement
the Time of Sale Prospectus to comply with applicable law, forthwith to prepare, file with the Commission and furnish, at its own expense,
to the Underwriters and to any dealer upon request, either amendments or supplements to the Time of Sale Prospectus so that the statements
in the Time of Sale Prospectus as so amended or supplemented will not, in the light of the circumstances when the Time of Sale Prospectus
is delivered to a prospective purchaser, be misleading or so that the Time of Sale Prospectus, as amended or supplemented, will no longer
conflict with the Registration Statement, or so that the Time of Sale Prospectus, as amended or supplemented, will comply with applicable
law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If,
during such period after the first date of the public offering of the Shares and accompanying Warrants as in the opinion of counsel for
the Underwriters the Prospectus (or in lieu thereof the notice referred to in Rule&nbsp;173(a)&nbsp;of the Securities Act) is required
by law to be delivered in connection with sales by an Underwriter or dealer, any event shall occur or condition exist as a result of which
it is necessary to amend or supplement the Prospectus in order to make the statements therein, in the light of the circumstances when
the Prospectus (or in lieu thereof the notice referred to in Rule&nbsp;173(a)&nbsp;of the Securities Act) is delivered to a purchaser,
not misleading, or if, in the opinion of counsel for the Underwriters, it is necessary to amend or supplement the Prospectus to comply
with applicable law, forthwith to prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to the dealers
(whose names and addresses you will furnish to the Company) to which Shares and accompanying Warrnats may have been sold by you on behalf
of the Underwriters and to any other dealers upon request, either amendments or supplements to the Prospectus so that the statements in
the Prospectus as so amended or supplemented will not, in the light of the circumstances when the Prospectus (or in lieu thereof the notice
referred to in Rule&nbsp;173(a)&nbsp;of the Securities Act) is delivered to a purchaser, be misleading or so that the Prospectus, as amended
or supplemented, will comply with applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To
endeavor to qualify the Securities for offer and sale under the securities or Blue Sky laws of such jurisdictions as you shall reasonably
request&#894; <I>provided </I>that in connection therewith the Company shall not be required to qualify as a foreign corporation or to
file a general consent to service of process in any jurisdiction or subject itself to taxation in any such jurisdiction in which it was
not otherwise subject to taxation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Whether
or not the transactions contemplated in this Agreement are consummated or this Agreement is terminated, to pay or cause to be paid all
expenses incident to the performance of its obligations under this Agreement, including: (i)&nbsp;the fees, disbursements and expenses
of the Company&rsquo;s counsel and the Company&rsquo;s accountants in connection with the registration and delivery of the Securities
under the Securities Act and all other fees or expenses in connection with the preparation and filing of the Registration Statement, the
Time of Sale Prospectus, the Prospectus, any free writing prospectus prepared by or on behalf of, used by, or referred to by the Company
and any amendments and supplements to any of the foregoing, including all printing costs associated therewith, and the delivering of copies
thereof to the Underwriters, (ii)&nbsp;all costs and expenses related to the transfer and delivery of the Securities to the Underwriters,
including any transfer or other taxes payable thereon, (iii)&nbsp;the cost of printing or producing any Blue Sky or legal investment memorandum
in connection with the offer and sale of the Securities under state securities laws and all expenses in connection with the qualification
of the Securities for offer and sale under state securities laws as provided in Section&nbsp;6(g)&nbsp;hereof, including filing fees and
the reasonable, documented fees and disbursements of counsel for the Underwriters in connection with such qualification and in connection
with the Blue Sky or legal investment memorandum&#894; <I>provided </I>that such fees and disbursements do not exceed $10,000, (iv)&nbsp;the
costs incurred in connection with the review and qualification of the offering of the Securities by the Financial Industry Regulatory
Authority, if any, (v)&nbsp;all costs and expenses incident to listing the Shares and the Warrant Shares on the Nasdaq Capital Market,
(vi)&nbsp;the costs and charges of any transfer agent, registrar or depositary, (vii)&nbsp;the costs and expenses of the Company relating
to investor presentations on any &ldquo;road show&rdquo; undertaken in connection with the marketing of the offering of the Securities,
including, without limitation, expenses associated with the preparation or dissemination of any electronic road show, and expenses associated
with the production of road show slides and graphics, (viii)&nbsp;the document production charges and expenses associated with printing
this Agreement and (ix)&nbsp;all other costs and expenses incident to the performance of the obligations of the Company hereunder for
which provision is not otherwise made in this Section. It is understood, however, that except as provided in this Section, Section&nbsp;8,
and the last paragraph of Section&nbsp;10, the Underwriters will pay all of their costs and expenses, including fees and disbursements
of their counsel, transfer taxes payable on resale of any of the Securities by them and any advertising expenses connected with any offers
they may make.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company also covenants with each of the Underwriters that, without the prior written consent of </FONT>Oppenheimer on behalf of the Underwriters,
it will not, and will not publicly disclose an intention to, during the period ending 45 days after the date of the Prospectus (the &ldquo;<B>Restricted
Period</B>&rdquo;), (1)&nbsp;offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract
to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares
of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock, or (2)&nbsp;enter into any swap or
other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Common Stock, whether
any such transaction described in clause (1)&nbsp;or (2)&nbsp;above is to be settled by delivery of Common Stock or such other securities,
in cash or otherwise or (3)&nbsp;file any registration statement with the Commission relating to the offering of any shares of Common
Stock or any securities convertible into or exercisable or exchangeable for Common Stock. The foregoing sentence shall not apply to (a)&nbsp;the
Securities to be sold hereunder, (b)&nbsp;the issuance by the Company of shares of Common Stock or such other securities upon the exercise
or vesting or settlement of any option, warrant, restricted stock unit or restricted shares of common stock outstanding on the date hereof
and described in the Registration Statement, the Time of Sale Prospectus and the Prospectus, or upon the conversion, redemption, retirement
or exchange of the 7.00% Convertible Senior Notes due 2026, the 3.75% Convertible Senior Notes due 2025, or the 6.00% Convertible Debenture
due 2026 outstanding on the date hereof and described in the Registration Statement, the Time of Sale Prospectus and the Prospectus, (c)&nbsp;the
issuance of shares of Common Stock, options to acquire Common Stock, restricted stock units, restricted shares of common stock or other
equity awards pursuant to the Company&rsquo;s stock option plans or other employee compensation plans, including the issuance of shares
of Common Stock to executive officers who elect to participate in the Company&rsquo;s executive compensation program, as such plans or
programs are in existence on the date hereof and described in the Registration Statement, the Time of Sale Prospectus and the Prospectus,
(d)&nbsp;the reacquisition or withholding of all or a portion of shares of Common Stock subject to a stock award to satisfy tax&nbsp;withholding&nbsp;obligations
of the Company pursuant to the Company&rsquo;s equity incentive plans or arrangements in existence on the date hereof and described in
the Registration Statement, the Time of Sale Prospectus and the Prospectus, (e)&nbsp;issuances of shares of Common Stock as matching contributions
under the Company&rsquo;s 401(k)&nbsp;plan, (f)&nbsp;the filing of a registration statement on Form&nbsp;S-8 relating to any employee
benefit plan or Form&nbsp;S-4 or amendments thereto, (g)&nbsp;the entry into an agreement providing for the issuance by the Company of
shares of Common Stock or any security convertible into or exercisable for shares of Common Stock in connection with the acquisition by
the Company or any of its subsidiaries of the securities, business, technology, property or other assets of another person or entity or
pursuant to an employee benefit plan assumed by the Company in connection with such acquisition, and the issuance of any such securities
pursuant to any such agreement, (h)&nbsp;the entry into any agreement providing for the issuance of shares of Common Stock or any security
convertible into or exercisable for shares of Common Stock in connection with joint ventures, commercial relationships or other strategic
transactions, and the issuance of any such securities pursuant to any such agreement, (i)&nbsp;the filing of any registration statement
or prospectus supplement pursuant to the Transaction Agreement, dated as of July&nbsp;20, 2017, by and between the Company and Wal-Mart
Stores,&nbsp;Inc., (j)&nbsp;the filing of any registration statement or prospectus supplement pursuant to each of the Transaction Agreement,
dated as of April&nbsp;4, 2017, by and between the Company and Amazon.com,&nbsp;Inc. and the Transaction Agreement, dated as of August&nbsp;24,
2022, by and between the Company and Amazon.com,&nbsp;Inc., (k)&nbsp;the amendment, modification, termination or unwind of any Base Call
Option Transaction or Additional Call Option Transaction, dated as of May&nbsp;13, 2020 and May&nbsp;13, 2020, respectively, between the
Company and each of Morgan Stanley&nbsp;&amp; Co. LLC and Wells Fargo Bank, National Association, (l)&nbsp;any issuance or sale of shares
pursuant to the At Market Issuance Sales Agreement, dated January&nbsp;17, 2024, between the Company and B. Riley Securities,&nbsp;Inc.,
as amended, and (m)&nbsp;the establishment of a trading plan pursuant to Rule&nbsp;10b5-1 under the Exchange Act, for the transfer of
shares of Common Stock, <I>provided </I>that (x)&nbsp;such plan does not provide for the transfer of Common Stock during the Restricted
Period and (y)&nbsp;to the extent a public announcement or filing under the Exchange Act, if any, is required of or voluntarily made by
the Company regarding the establishment of such plan, such announcement or filing shall include a statement to the effect that no transfer
of Common Stock may be made under such plan during the Restricted Period&#894; <I>provided </I>that in the case of clauses (g)&nbsp;and
(h), the aggregate number of shares of Common Stock that the Company may sell or issue or agree to sell or issue pursuant to clauses (g)&nbsp;and
(h)&nbsp;shall not exceed 10% of the total number of shares of the Common Stock issued and outstanding immediately following the completion
of the transactions contemplated by this Agreement&#894; and <I>provided</I>, <I>further</I>, that in the case of clauses (g)&nbsp;and
(h), each recipient of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock shall (A)&nbsp;execute
a lock-up agreement in the form of <U>Exhibit&nbsp;A</U> hereto or (B)&nbsp;enter into an agreement with the Company no less restrictive
than the form of lock-up agreement set forth in <U>Exhibit&nbsp;A</U> hereto with respect to transactions described in clauses (1)&nbsp;and
(2)&nbsp;in the preceding paragraph, in each case with respect to the remaining portion of the Restricted Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Covenants
of the Underwriters</I>. Each Underwriter, severally and not jointly, covenants with the Company not to take any action that would result
in the Company being required to file with the Commission under Rule&nbsp;433(d)&nbsp;a free writing prospectus prepared by or on behalf
of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the action of the Underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Indemnity
and Contribution</I>. (a)&nbsp;The Company agrees to indemnify and hold harmless each Underwriter, its directors, its officers and each
person, if any, who controls any Underwriter within the meaning of either Section&nbsp;15 of the Securities Act or Section&nbsp;20 of
the Exchange Act, and each affiliate of any Underwriter within the meaning of Rule&nbsp;405 under the Securities Act from and against
any and all losses, claims, damages and liabilities (including, without limitation, any legal or other expenses reasonably incurred in
connection with defending or investigating any such action or claim) that arise out of, or are based upon, any untrue statement or alleged
untrue statement of a material fact contained in the Registration Statement or any amendment thereof, the Time of Sale Prospectus or any
amendment or supplement thereto, any issuer free writing prospectus as defined in Rule&nbsp;433(h)&nbsp;under the Securities Act, any
Company information that the Company has filed, or is required to file, pursuant to Rule&nbsp;433(d)&nbsp;under the Securities Act, any
&ldquo;road show&rdquo; as defined in Rule&nbsp;433(h)&nbsp;under the Securities Act (a &ldquo;<B>road show</B>&rdquo;), or the Prospectus
or any amendment or supplement thereto, or arise out of, or are based upon, any omission or alleged omission to state therein a material
fact required to be stated therein or necessary to make the statements therein not misleading, except insofar as such losses, claims,
damages or liabilities or arise out of, or are based upon, any such untrue statement or omission or alleged untrue statement or omission
made in reliance upon and in conformity with any information relating to any Underwriter furnished to the Company in writing by such Underwriter
through you expressly for use therein, it being understood and agreed that the only such information furnished by the Underwriters through
you consists of the information described as such in paragraph (b)&nbsp;below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Each
Underwriter agrees, severally and not jointly, to indemnify and hold harmless the Company, its directors, its officers and each person,
if any, who controls the Company within the meaning of either Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange
Act to the same extent as the foregoing indemnity from the Company to such Underwriter, but only with reference to information relating
to such Underwriter furnished to the Company in writing by such Underwriter through you expressly for use in the Registration Statement,
the Time of Sale Prospectus, any issuer free writing prospectus, road show, or the Prospectus or any amendment or supplement thereto&#894;
it being understood and agreed upon that the only such information furnished by the Underwriters consists of the following information
in the Prospectus furnished on behalf of the Underwriters: the names and corresponding principal amounts set forth in the table of Underwriters
under the second paragraph of text under the caption &ldquo;Underwriting&rdquo; and the information contained under the captions &ldquo;Underwriting&mdash;Stabilization&rdquo;
concerning stabilizing transactions by the Underwriters, &ldquo;Underwriting&mdash;Passive Market Making&rdquo; concerning passive market
making transactions by the Underwriters and &ldquo;Underwriting&mdash;Electronic Prospectus&rdquo; concerning Prospectuses in electronic
format that may be made available on websites by the Underwriters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
case any proceeding (including any governmental investigation) shall be instituted involving any person in respect of which indemnity
may be sought pursuant to Section&nbsp;8(a)&nbsp;or 8(b), such person (the &ldquo;<B>indemnified party</B>&rdquo;) shall promptly notify
the person against whom such indemnity may be sought (the &ldquo;<B>indemnifying party</B>&rdquo;) in writing and the indemnifying party,
upon request of the indemnified party, shall retain counsel reasonably satisfactory to the indemnified party to represent the indemnified
party and any others the indemnifying party may designate in such proceeding and shall pay the reasonably incurred, documented fees and
disbursements of such counsel related to such proceeding. In any such proceeding, any indemnified party shall have the right to retain
its own counsel, but the fees and expenses of such counsel shall be at the expense of such indemnified party unless (i)&nbsp;the indemnifying
party and the indemnified party shall have mutually agreed in writing to the retention of such counsel or (ii)&nbsp;the named parties
to any such proceeding (including any impleaded parties) include both the indemnifying party and the indemnified party and representation
of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. It is understood
that the indemnifying party shall not, in respect of the legal expenses of any indemnified party in connection with any proceeding or
related proceedings in the same jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to any local
counsel) for all such indemnified parties and that all such fees and expenses shall be reimbursed as they are incurred. Such firm shall
be designated in writing by you, in the case of parties indemnified pursuant to Section&nbsp;8(a), and by the Company, in the case of
parties indemnified pursuant to Section&nbsp;8(b). The indemnifying party shall not be liable for any settlement of any proceeding effected
without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party
agrees to indemnify the indemnified party from and against any loss or liability by reason of such settlement or judgment. No indemnifying
party shall, without the prior written consent of the indemnified party, effect any settlement of any pending or threatened proceeding
in respect of which any indemnified party is or could have been a party and indemnity could have been sought hereunder by such indemnified
party, unless such settlement includes an unconditional release of such indemnified party from all liability on claims that are the subject
matter of such proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To
the extent the indemnification provided for in Section&nbsp;8(a)&nbsp;or 8(b)&nbsp;is unavailable to an indemnified party or insufficient
in respect of any losses, claims, damages or liabilities referred to therein, then each indemnifying party under such paragraph, in lieu
of indemnifying such indemnified party thereunder, shall contribute to the amount paid or payable by such indemnified party as a result
of such losses, claims, damages or liabilities (i)&nbsp;in such proportion as is appropriate to reflect the relative benefits received
by the Company on the one hand and the Underwriters on the other hand from the offering of the Shares and accompanying Warrants or (ii)&nbsp;if
the allocation provided by clause 8(d)(i)&nbsp;above is not permitted by applicable law, in such proportion as is appropriate to reflect
not only the relative benefits referred to in clause 8(d)(i)&nbsp;above but also the relative fault of the Company on the one hand and
of the Underwriters on the other hand in connection with the statements or omissions that resulted in such losses, claims, damages or
liabilities, as well as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and
the Underwriters on the other hand in connection with the offering of the Shares and accompanying Warrants shall be deemed to be in the
same respective proportions as the net proceeds from the offering of the Shares and accompanying Warrants (before deducting expenses)
received by the Company and the total underwriting discounts and commissions received by the Underwriters, in each case as set forth in
the table on the cover of the Prospectus, bear to the aggregate Public Offering Price of the Shares and accompanying Warrants. The relative
fault of the Company on the one hand and of the Underwriters on the other hand shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates
to information supplied by the Company or by the Underwriters and the parties&rsquo; relative intent, knowledge, access to information
and opportunity to correct or prevent such statement or omission. The Underwriters&rsquo; respective obligations to contribute pursuant
to this Section&nbsp;8 are several in proportion to the respective number of Shares and accompanying Warrants they have purchased hereunder,
and not joint.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company and the Underwriters agree that it would not be just or equitable if contribution pursuant to this Section&nbsp;8 were determined
by <I>pro rata </I>allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation
that does not take account of the equitable considerations referred to in Section&nbsp;8(d). The amount paid or payable by an indemnified
party as a result of the losses, claims, damages and liabilities referred to in Section&nbsp;8(d)&nbsp;shall be deemed to include, subject
to the limitations set forth above, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating
or defending any such action or claim. Notwithstanding the provisions of this Section&nbsp;8, no Underwriter shall be required to contribute
any amount in excess of the amount by which the total price at which the Shares and accompanying Warrants underwritten by it and distributed
to the public were offered to the public exceeds the amount of any damages that such Underwriter has otherwise been required to pay by
reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within
the meaning of Section&nbsp;11(f)&nbsp;of the Securities Act) shall be entitled to contribution from any person who was not guilty of
such fraudulent misrepresentation. The remedies provided for in this Section&nbsp;8 are not exclusive and shall not limit any rights or
remedies which may otherwise be available to any indemnified party at law or in equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
indemnity and contribution provisions contained in this Section&nbsp;8 and the representations, warranties and other statements of the
Company contained in this Agreement shall remain operative and in full force and effect regardless of (i)&nbsp;any termination of this
Agreement, (ii)&nbsp;any investigation made by or on behalf of any Underwriter, any person controlling any Underwriter or any affiliate
of any Underwriter or by or on behalf of the Company, its officers or directors or any person controlling the Company and (iii)&nbsp;acceptance
of and payment for any of the Shares and accompanying Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Termination</I>.
Oppenheimer may terminate this Agreement by notice given by you to the Company, if after the execution and delivery of this Agreement
and prior to or on the Closing Date, (i)&nbsp;trading generally shall have been suspended or materially limited on, or by, as the case
may be, any of the New York Stock Exchange, the NYSE American, the Nasdaq Capital Market, the Chicago Board of Options Exchange, the Chicago
Mercantile Exchange or the Chicago Board of Trade, (ii)&nbsp;trading of any securities of the Company shall have been suspended on any
exchange or in any over-the-counter market, (iii)&nbsp;a material disruption in securities settlement, payment or clearance services in
the United States shall have occurred, (iv)&nbsp;any moratorium on commercial banking activities shall have been declared by Federal or
New York State authorities or (v)&nbsp;there shall have occurred any outbreak or escalation of hostilities, or any change in financial
markets or any calamity or crisis that, in your judgment, is material and adverse and which, singly or together with any other event specified
in this clause (v), makes it, in your judgment, impracticable or inadvisable to proceed with the offer, sale or delivery of the Shares
and accompanying Warrants on the terms and in the manner contemplated in the Time of Sale Prospectus or the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Effectiveness&#894;
Defaulting Underwriters</I>. This Agreement shall become effective upon the execution and delivery hereof by the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If, on the Closing Date, any one or more of the
Underwriters shall fail or refuse to purchase Shares and accompanying Warrants that it has or they have agreed to purchase hereunder on
such date, and the aggregate number of Shares and accompanying Warrants which such defaulting Underwriter or Underwriters agreed but failed
or refused to purchase is not more than one-tenth of the aggregate number of the Shares and accompanying Warrants to be purchased on such
date, the other Underwriters shall be obligated severally in the proportions that the number of Shares and accompanying Warrants set forth
opposite their respective names in Schedule I bears to the aggregate number of Shares and accompanying Warrants set forth opposite the
names of all such non-defaulting Underwriters, or in such other proportions as you may specify, to purchase the Shares and accompanying
Warrants which such defaulting Underwriter or Underwriters agreed but failed or refused to purchase on such date&#894; <I>provided </I>that
in no event shall the number of Shares and accompanying Warrants that any Underwriter has agreed to purchase pursuant to this Agreement
be increased pursuant to this Section&nbsp;10 by an amount in excess of one-ninth of such number of Shares and accompanying Warrants without
the written consent of such Underwriter. If, on the Closing Date, any Underwriter or Underwriters shall fail or refuse to purchase Shares
and accompanying Warrants and the aggregate number of Shares and accompanying Warrants with respect to which such default occurs is more
than one-tenth of the aggregate number of Shares and accompanying Warrants to be purchased on such date, and arrangements satisfactory
to you and the Company for the purchase of such Shares and accompanying Warrants are not made within 36 hours after such default, this
Agreement shall terminate without liability on the part of any non-defaulting Underwriter or the Company. In any such case either you
or the Company shall have the right to postpone the Closing Date, but in no event for longer than seven days, in order that the required
changes, if any, in the Registration Statement, in the Time of Sale Prospectus, in the Prospectus or in any other documents or arrangements
may be effected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If this Agreement shall be terminated (i)&nbsp;by
Oppenheimer pursuant to Section&nbsp;9(ii), or (ii)&nbsp;by any of the Underwriters because of any failure or refusal on the part of the
Company to comply with the terms or to fulfill any of the conditions of this Agreement, or if for any reason the Company shall be unable
to perform its obligations under this Agreement, the Company will reimburse the Underwriters or such Underwriters as have so terminated
this Agreement with respect to themselves, severally, for all out-of-pocket expenses (including the fees and disbursements of their counsel)
reasonably incurred by such Underwriters in connection with this Agreement or the offering contemplated hereunder. If this Agreement is
terminated pursuant to Section&nbsp;10 by reason of the default of one or more Underwriters, the Company shall not be obligated to reimburse
any defaulting Underwriter on account of those expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Entire
Agreement</I>. (a)&nbsp;This Agreement, together with any contemporaneous written agreements and any prior written agreements (to the
extent not superseded by this Agreement) that relate to the offering of the Securities, represents the entire agreement between the Company
and the Underwriters with respect to the preparation of the Time of Sale Prospectus, the Prospectus, the conduct of the offering, and
the purchase and sale of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company acknowledges that in connection with the offering of the Shares and accompanying Warrants: (i)&nbsp;the Underwriters have acted
at arm&rsquo;s length, are not agents of, and owe no fiduciary duties to, the Company or any other person, (ii)&nbsp;the Underwriters
owe the Company only those duties and obligations set forth in this Agreement and prior written agreements (to the extent not superseded
by this Agreement) if any, (iii)&nbsp;the Underwriters may have interests that differ from those of the Company. The Company waives to
the full extent permitted by applicable law any claims it may have against the Underwriters arising from an alleged breach of fiduciary
duty in connection with the offering of the Securities, and (iv)&nbsp;none of the activities of the Underwriters in connection with the
transactions contemplated herein constitutes a recommendation, investment advice, or solicitation of any action by the Underwriters with
respect to any entity or natural person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">13.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Counterparts</I>.
This Agreement may be signed in two or more counterparts, each of which shall be an original, with the same effect as if the signatures
thereto and hereto were upon the same instrument. Counterparts may be delivered via electronic mail (including any electronic signature
complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act or other applicable law, e.g., www.docusign.com)
or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and
effective for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">14.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Applicable
Law</I>. This Agreement, and any claim, controversy or dispute arising under or related to this Agreement, shall be governed by and construed
in accordance with the internal laws of the State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">15.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Headings</I>.
The headings of the sections of this Agreement have been inserted for convenience of reference only and shall not be deemed a part of
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">16.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Notices</I>.
All communications hereunder shall be in writing and effective only upon receipt and if to the Underwriters shall be delivered, mailed
or sent to you in care of Oppenheimer&nbsp;&amp; Co. Inc., 85 Broad Street, New York, New York 10004, Attention: Equity Capital Markets,
with a copy to Oppenheimer&nbsp;&amp; Co. Inc., 85 Broad Street, New York, New York 10004 Attention: General Counsel&#894; and if to the
Company shall be delivered, mailed or sent to Plug Power Inc., 968 Albany Shaker Road, Latham, New York 12110 (Attn: [***]), with a copy
to Goodwin Procter LLP, New York Times Building, 620 Eighth Ave, New York, NY 10018 (Attn: Audrey S. Leigh).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">17.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Recognition
of the U.S. Special Resolution Regimes</I>. (a)&nbsp;In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding
under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under
this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this
Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under
a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to
be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement
were governed by the laws of the United States or a state of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For purposes of this Section&nbsp;16, the following
terms shall have the following meaning:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<I>BHC Act Affiliate</I>&rdquo; has the
meaning assigned to the term &ldquo;affiliate&rdquo; in, and shall be interpreted in accordance with, 12 U.S.C. &sect; 1841(k)&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<I>Covered Entity</I>&rdquo; means any of
the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;a
&ldquo;covered entity&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 252.82(b)&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;a
&ldquo;covered bank&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 47.3(b)&#894; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;a
&ldquo;covered FSI&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 382.2(b)&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<I>Default Right</I>&rdquo; has the meaning
assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &sect;&sect; 252.81, 47.2 or 382.1, as applicable&#894;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<I>U.S. Special Resolution Regime</I>&rdquo;
means each of (i)&nbsp;the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii)&nbsp;Title II of the Dodd-Frank
Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;Follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">Very truly yours,</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">PLUG POWER INC.</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ Paul B. Middleton</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 42%">Paul B. Middleton</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Chief Financial Officer and Executive Vice President</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>[Signature Page to Underwriting
Agreement (Company)]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accepted as of the date hereof</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Oppenheimer&nbsp;&amp; Co. Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acting on behalf of itself and the several</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Underwriters named in Schedule I hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By: <FONT STYLE="text-transform: uppercase">Oppenheimer&nbsp;&amp;
Co. Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ Peter Bennett</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 32%">Peter Bennett</TD>
    <TD STYLE="font-size: 10pt; width: 60%">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Head of Equity Capital Markets</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>[Signature Page to Underwriting
Agreement (Company)]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>SCHEDULE I</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font-size: 10pt; font-weight: bold">Underwriter</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">Number of<BR>
 Shares to be<BR>
 Purchased</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">Number of<BR>
 Pre-Funded<BR>
 Warrants to<BR>
 Be <BR>
Purchased</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold">Number of<BR>
 Accompanying<BR>
 Warrants for <BR>
the Shares and<BR>
 Pre-Funded<BR>
 Warrants<BR>
 Purchased</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 58%; text-align: left">Oppenheimer&nbsp;&amp; Co. Inc.</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: #231f20">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: #231f20; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; color: #231f20; text-align: right">39,525,000</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: #231f20; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: #231f20">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: #231f20; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; color: #231f20; text-align: right">118,090,895</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: #231f20; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; color: #231f20">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: #231f20; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; color: #231f20; text-align: right">157,615,895</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; color: #231f20; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Roth Capital Partners, LLC</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,720,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">11,114,437</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">14,834,437</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Craig-Hallum Capital Group LLC</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,627,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,862,566</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">6,490,066</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">H.C. Wainwright&nbsp;&amp; Co. LLC</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,627,500</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,862,566</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">6,490,066</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1pt; padding-left: 0.125in; font: bold 10pt Times New Roman, Times, Serif">Total:</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">46,500,000</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">138,930,464</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">185,430,464</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> I-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>SCHEDULE II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Time of Sale Prospectus</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">-</TD><TD>Free writing prospectus filed by the Company under Rule&nbsp;433(d)&nbsp;of the Securities Act on March&nbsp;19, 2025.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">-</TD><TD>Pricing Information Conveyed Orally by the Underwriters:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD>Number of Shares: 46,500,000</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD>Number of Pre-Funded Warrants: 138,930,464</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD>Number of Common Warrants: 185,430,464</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD>The public offering price per share for one Share and one Common Warrant is $1.51 per share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD>The public offering price per share for one Pre-funded Warrant and one Common Warrant is $1.509 per Pre-funded Warrant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD>Pre-funded Warrant exercise price: $0.001 per share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD>Common Warrant exercise price: $2.00 per share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD>Underwriting discount for each Share and Common Warrant: $0.0641750</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD>Underwriting discount for each Pre-Funded Warrant and Common Warrant: $0.0641325</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT&nbsp;A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;OF LOCK-UP LETTER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">March&nbsp;&#8239;&#8239;&#8239;&#8239;&#8239;, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Oppenheimer&nbsp;&amp; Co. Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">c/o Oppenheimer&nbsp;&amp; Co. Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">85 Broad Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">New York, New York 10004</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left">Re:</TD><TD STYLE="text-align: justify">Plug Power Inc.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The undersigned understands that you, as representative
of the several Underwriters (as defined below), propose to enter into an Underwriting Agreement (the &ldquo;<B>Underwriting Agreement</B>&rdquo;)
with Plug Power Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), providing for the public offering (the &ldquo;<B>Offering</B>&rdquo;)
by the several Underwriters (the &ldquo;<B>Underwriters</B>&rdquo;), of shares (the &ldquo;<B>Shares</B>&rdquo;) of (i)&nbsp;common stock,
par value $0.01 per share, of the Company (the &ldquo;<B>Common Stock</B>&rdquo;), (ii)&nbsp;warrants to purchase 185,430,464 shares of
Common Stock of the Company at an exercise price of $2.00 per share (the (&ldquo;<B>Common Warrants</B>,&rdquo;) and (iii)&nbsp;pre-funded
warrants to purchase 138,930,464 shares of Common Stock at an exercise price of $0.001 per share (the &ldquo;<B>Pre-funded Warrants</B>&rdquo;
and, together with the Common Warrants, the &ldquo;<B>Warrants</B>&rdquo;). Capitalized terms used herein and not otherwise defined shall
have the meanings set forth in the Underwriting Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">To induce the Underwriters that may participate
in the Offering to continue their efforts in connection with the Offering, the undersigned hereby agrees that, without the prior written
consent of Oppenheimer&nbsp;&amp; Co. Inc. on behalf of the Underwriters, it will not, and will not publicly disclose an intention to,
during the period commencing on the date hereof and ending 45 days after the date of the prospectus (the &ldquo;<B>Restricted Period</B>&rdquo;)
relating to the Offering (the &ldquo;<B>Prospectus</B>&rdquo;), (1)&nbsp;offer, pledge, sell, contract to sell, sell any option or contract
to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose
of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock,
or (2)&nbsp;enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences
of ownership of the Common Stock, whether any such transaction described in clause 1 or 2 above is to be settled by delivery of Common
Stock or such other securities, in cash or otherwise. The foregoing sentence shall not apply to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;transactions
relating to shares of Common Stock or other securities acquired in open market transactions after the completion of the Offering&#894;
<I>provided </I>that no filing under Section&nbsp;16(a)&nbsp;of the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange
Act</B>&rdquo;) shall be required or shall be voluntarily made in connection with subsequent sales of Common Stock or other securities
acquired in such open market transactions&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;transfers
of shares of Common Stock or any security convertible into Common Stock as a bona fide gift&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;distributions
of shares of Common Stock or any security convertible into Common Stock to limited partners, members, owners or shareholders of the undersigned&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;transfers
or other dispositions by will, other testamentary document or intestate succession upon the death of the undersigned, or by operation
of law, such as pursuant to a qualified domestic order or in connection with a divorce settlement, <I>provided </I>that any filing under
Section&nbsp;16(a)&nbsp;of the Exchange Act required to be made during the Restricted Period in connection with any such transfer or disposition
shall indicate by footnote disclosure or otherwise the nature of the transfer or disposition&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
receipt by the undersigned from the Company of shares of Common Stock upon the grant or exercise of options, warrants, Common Stock (restricted
or unrestricted), restricted stock units, restricted shares of common stock or other equity awards pursuant to any employee benefit plans
or arrangements described in the Prospectus, <I>provided </I>that any shares of Common Stock received pursuant to this clause (e), other
than shares of Common Stock received pursuant to the Company&rsquo;s executive compensation program, shall be subject to the restrictions
on transferability contained in this agreement, <I>provided further </I>that any filing under Section&nbsp;16(a)&nbsp;of the Exchange
Act required to be made during the Restricted Period in connection with such transaction shall indicate by footnote disclosure or otherwise
(i)&nbsp;the nature of the transaction and (ii)&nbsp;that any shares of Common Stock received pursuant to this clause (e)&nbsp;are subject
to the restrictions on transferability contained in this agreement&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;dispositions
or transfers of shares of Common Stock by the undersigned solely (i)&nbsp;in connection with the &ldquo;net&rdquo; or &ldquo;cashless&rdquo;
exercise of options or other rights to acquire shares of Common Stock granted pursuant to an equity incentive plan, employee compensation
plan or other arrangement described in the Prospectus, or (ii)&nbsp;in satisfaction of tax withholding obligations in connection with
any such exercise or the vesting of restricted stock, <I>provided </I>that any shares of Common Stock received upon any such exercise
or vesting contemplated by this clause (f)&nbsp;shall be subject to the restrictions on transferability contained in this agreement, <I>provided
further </I>that any filing under Section&nbsp;16(a)&nbsp;of the Exchange Act required to be made during the Restricted Period in connection
with any such transfer or disposition shall indicate by footnote disclosure or otherwise (i)&nbsp;the nature of the transfer or disposition
and (ii)&nbsp;any shares of Common Stock received upon any such exercise or vesting contemplated by this clause (f)&nbsp;are subject to
the restrictions on transferability contained in this agreement&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;transfers
of shares of Common Stock or any security convertible into Common Stock to the undersigned&rsquo;s affiliates or to any investment fund
or other entity controlled by the undersigned&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;transfer
of shares of Common Stock or any security convertible into Common Stock to any immediate family member of the undersigned or a trust,
partnership, limited liability company or other entity for the direct or indirect benefit of the undersigned or the immediate family of
the undersigned. For purposes of this clause (h), &ldquo;immediate family member&rdquo; shall mean any relationship by blood, marriage,
domestic partnership or adoption, not more remote than first cousin&#894;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
establishment of a trading plan pursuant to Rule&nbsp;10b5-1 under the Exchange Act for the transfer of shares of Common Stock&#894; <I>provided
</I>that (i)&nbsp;such plan does not provide for the transfer of Common Stock during the Restricted Period and (ii)&nbsp;to the extent
a public announcement or filing under the Exchange Act, if any, is required of or voluntarily made by or on behalf of the undersigned
or the Company regarding the establishment of such plan, such announcement or filing shall include a statement to the effect that no transfer
of Common Stock may be made under such plan during the Restricted Period&#894; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;sales,
transfers or other dispositions pursuant to a trading plan pursuant to Rule&nbsp;10b5-1 under the Exchange Act for the transfer of shares
of Common Stock that has been entered into by the undersigned prior to the date hereof of which Oppenheimer&nbsp;&amp; Co. Inc. has received
notice, <I>provided </I>that any filing made under Section&nbsp;16(a)&nbsp;of the Exchange Act includes a footnote that expressly states
that the sale was made pursuant to an existing 10b5-1 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>provided
</I></FONT>that in the case of any transfer or distribution pursuant to clauses (b), (c), (d), (g)&nbsp;or (h), each donee, transferee,
heir, beneficiary or distributee shall sign and deliver a lock-up letter substantially in the form of this letter, <I>provided further
</I>that in the case of any transfer or distribution pursuant to clauses (b), (c), (g), or (h), no filing under Section&nbsp;16(a)&nbsp;of
the Exchange Act by the undersigned, reporting a reduction in beneficial ownership of shares of Common Stock, shall be required or shall
be voluntarily made during the Restricted Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, the undersigned agrees that, without
the prior written consent of Oppenheimer&nbsp;&amp; Co. Inc. on behalf of the Underwriters, it will not, during the Restricted Period,
make any demand for or exercise any right with respect to, the registration of any shares of Common Stock or any security convertible
into or exercisable or exchangeable for Common Stock. The undersigned also agrees and consents to the entry of stop transfer instructions
with the Company&rsquo;s transfer agent and registrar against the transfer of the undersigned&rsquo;s shares of Common Stock except in
compliance with the foregoing restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The undersigned understands that the Company and
the Underwriters are relying upon this agreement in proceeding toward consummation of the Offering. The undersigned further understands
that this agreement is irrevocable and shall be binding upon the undersigned&rsquo;s heirs, legal representatives, successors and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This letter shall automatically terminate upon
the earliest to occur, if any, of (a)&nbsp;the date the Company advises Oppenheimer&nbsp;&amp; Co. Inc., in writing, prior to the execution
of the Underwriting Agreement, that it has determined not to proceed with the Offering, (b)&nbsp;the date of the termination of the Underwriting
Agreement (without regard to any provisions thereof that survive termination) if prior to the sale of any Shares pursuant to the Underwriting
Agreement, or (c)&nbsp;March&nbsp;31, 2025 if, and only if, the Underwriting Agreement has not been executed by such date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The undersigned acknowledges and agrees that the
Underwriters have not provided any recommendation or investment advice nor have the Underwriters solicited any action from the undersigned
with respect to the Offering of the Shares and the undersigned has consulted his or her own legal, accounting, financial, regulatory and
tax advisors to the extent deemed appropriate. The undersigned further acknowledges and agrees that, although the Underwriters may provide
certain Regulation Best Interest and Form&nbsp;CRS disclosures or other related documentation to you in connection with the Offering,
the Underwriters are not making a recommendation to you to participate in the Offering or sell any Shares at the price determined in the
Offering, and nothing set forth in such disclosures or documentation is intended to suggest that any Underwriter is making such a recommendation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This agreement shall be governed by and construed
in accordance with the laws of the State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Very truly yours,</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Name:</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD></TR>
  </TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Exhibit&nbsp;B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form&nbsp;of Common Warrant</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Exhibit&nbsp;C</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form&nbsp;of Pre-Funded Warrant</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>tm259816d1_ex4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;OF WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Plug
Power Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>Warrant
To Purchase Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Warrant No.: _________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Number of Shares of Common Stock:_____________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date of Issuance: March&nbsp;[20], 2025 (&ldquo;<B>Issuance Date</B>&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Plug Power Inc., a company
organized under the laws of State of Delaware (the &ldquo;<B>Company</B>&rdquo;), hereby certifies that, for good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged<FONT STYLE="text-transform: uppercase">,
[HOLDER]</FONT>, the registered holder hereof or its permitted assigns (the &ldquo;<B>Holder</B>&rdquo;), is entitled, subject to
the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, at any time or
times on or after six (6)&nbsp;months after the date hereof (the &ldquo;<B>Initial Exercisability Date</B>&rdquo;), but not after
11:59 p.m., New York time, on the Expiration Date, (as defined below), ______________ (_____________)<SUP></SUP> fully paid
non-assessable shares of Common Stock (as defined below), subject to adjustment as provided herein (the &ldquo;<B>Warrant
Shares</B>&rdquo;). Except as otherwise defined herein, capitalized terms in this Warrant to Purchase Common Stock (including any
Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, this &ldquo;<B>Warrant</B>&rdquo;), shall have
the meanings set forth in Section&nbsp;10. This Warrant is one of the Warrants to purchase Common Stock (the
&ldquo;<B>Warrants</B>&rdquo;) issued pursuant to (i)&nbsp;that certain Underwriting Agreement, dated as of March 19, 2025 (the
&ldquo;<B>Subscription Date</B>&rdquo;) by and between the Company and Oppenheimer&nbsp;&amp; Co. Inc., as representative of the
several underwriters named therein, (ii)&nbsp;the Company&rsquo;s Registration Statement on Form&nbsp;S-3 (File No.&nbsp;333-265488)
(the &ldquo;<B>Registration Statement</B>&rdquo;) and (iii)&nbsp;the Company&rsquo;s prospectus supplement dated as of
March 19, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>EXERCISE
OF WARRANT.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Mechanics
of Exercise</U>. Subject to the terms and conditions hereof (including, without limitation, the limitations set forth in Section&nbsp;1(e)),
this Warrant may be exercised by the Holder at any time or times on or after the Initial Exercisability Date, in whole or in part, by
delivery (whether via electronic mail or otherwise) of a written notice, in the form attached hereto as <U>Exhibit&nbsp;A</U> (the &ldquo;<B>Exercise
Notice</B>&rdquo;), of the Holder&rsquo;s election to exercise this Warrant. Within one (1)&nbsp;Trading Day following the delivery of
the Exercise Notice, the Holder shall make payment to the Company of an amount equal to the Exercise Price in effect on the date of such
exercise multiplied by the number of Warrant Shares as to which this Warrant is being exercised (the &ldquo;<B>Aggregate Exercise Price</B>&rdquo;)
in cash by wire transfer of immediately available funds or, if the provisions of Section&nbsp;1(d)&nbsp;are applicable, by notifying the
Company pursuant to the Exercise Notice that this Warrant is being exercised pursuant to a Cashless Exercise (as defined in Section&nbsp;1(d)).
Execution and delivery of the Exercise Notice with respect to less than all of the Warrant Shares shall have the same effect as cancellation
of the original Warrant and issuance of a new Warrant evidencing the right to purchase the remaining number of Warrant Shares and the
Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares
available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company
for cancellation within five (5)&nbsp;Trading Days of the date on which the final Exercise Notice has been delivered to the Company. On
or before the first (1</FONT><SUP>st</SUP>) Trading Day following the date on which the Holder has delivered the applicable Exercise Notice,
the Company shall transmit by electronic mail an acknowledgment of confirmation of receipt of the Exercise Notice, in the form attached
to the Exercise Notice, to the Holder and the Company&rsquo;s transfer agent (the &ldquo;<B>Transfer Agent</B>&rdquo;). So long as the
Holder delivers the Aggregate Exercise Price (or notice of a Cashless Exercise, if applicable) on or prior to the first (1<SUP>st</SUP>)
Trading Day following the date on which the Exercise Notice has been delivered to the Company, then on or prior to the number of Trading
Days comprising the Standard Settlement Period following the date on which the Exercise Notice has been delivered to the Company, or,
if the Holder does not deliver the Aggregate Exercise Price (or notice of a Cashless Exercise, if applicable) on or prior to the first
(1<SUP>st</SUP>) Trading Day following the date on which the Exercise Notice has been delivered to the Company, then on or prior to the
first (1<SUP>st</SUP>) Trading Day following the date on which the Aggregate Exercise Price (or notice of a Cashless Exercise, if applicable)
is delivered (such earlier date, or if later, the earliest day on which the Company is required to deliver Warrant Shares pursuant to
this Section&nbsp;1(a), the &ldquo;<B>Share Delivery Date</B>&rdquo;), the Company shall (X)&nbsp;provided that the Transfer Agent is
participating in The Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;) Fast Automated Securities Transfer Program, credit such aggregate
number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the Holder&rsquo;s or its designee&rsquo;s balance
account with DTC through its Deposit / Withdrawal At Custodian system, or (Y)&nbsp;if the Transfer Agent is not participating in the DTC
Fast Automated Securities Transfer Program, issue and dispatch by overnight courier to the address as specified in the Exercise Notice,
a certificate or evidence of a credit book entry of shares, registered in the name of the Holder or its designee, for the number of Warrant
Shares to which the Holder is entitled pursuant to such exercise. The Company shall be responsible for all fees and expenses of the Transfer
Agent and all fees and expenses with respect to the issuance of Warrant Shares via DTC, if any, including without limitation for same
day processing. On the Share Delivery Date, the Holder shall be deemed for all corporate purposes to have become the holder of record
and beneficial owner of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date such Warrant
Shares are credited to the Holder&rsquo;s DTC account or the date of delivery of the certificates evidencing such Warrant Shares, as the
case may be. If this Warrant is physically delivered to the Company in connection with any exercise pursuant to this Section&nbsp;1(a)&nbsp;and
the number of Warrant Shares represented by this Warrant submitted for exercise is greater than the number of Warrant Shares being acquired
upon an exercise, then the Company shall as soon as practicable and in no event later than three (3)&nbsp;Trading Days after any exercise
and at its own expense, issue and deliver to the Holder (or its designee) a new Warrant (in accordance with Section&nbsp;7(b)) representing
the right to purchase the number of Warrant Shares issuable immediately prior to such exercise under this Warrant, less the number of
Warrant Shares with respect to which this Warrant is exercised. No fractional Warrant Shares are to be issued upon the exercise of this
Warrant, but rather the number of Warrant Shares to be issued shall be rounded down to the nearest whole number. Issuance of Warrant Shares
shall be made without charge to the Holder for any issue or transfer tax or any incidental expense in respect of the issuance of such
Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the
Holder or in such name or names as may be directed by the Holder; provided, however, that, in the event that Warrant Shares are to be
issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment
Form&nbsp;attached hereto as <U>Exhibit&nbsp;B</U> duly executed by the Holder and the Company may require, as a condition thereto, the
payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. Subject to the foregoing, the Holder shall be responsible
for all other tax liability that may arise as a result of holding or transferring this Warrant or receiving Warrant Shares upon exercise
hereof, including any United States withholding taxes imposed on any dividends or deemed dividends, and the Company shall be entitled
to withhold such tax liability from shares of Common Stock, sales proceeds subsequently paid or credited, or other amounts payable or
distributable to the relevant Holder as required by applicable law. The Company will not close its stockholder books or records in any
matter that prevents the timely exercise of this Warrant, pursuant to the terms hereof. The Company&rsquo;s obligations to issue and deliver
Warrant Shares in accordance with the terms and subject to the conditions hereof are absolute and unconditional, irrespective of any action
or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment
against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination; <U>provided</U>,
<U>however</U>, that the Company shall not be required to deliver Warrant Shares with respect to an exercise prior to the Holder&rsquo;s
delivery of the Aggregate Exercise Price (or notice of a Cashless Exercise) with respect to such exercise. <B>The Holder and any assignee,
by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a
portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than
the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exercise
Price</U>. For purposes of this Warrant, &ldquo;<B>Exercise Price</B>&rdquo; means $2.00 per share, subject to adjustment as provided
herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Company&rsquo;s
Failure to Timely Deliver Securities</U>. If either (I)&nbsp;the Company shall fail for any reason or for no reason to issue or credit,
as the case may be, to the Holder on or prior to the applicable Share Delivery Date, </FONT>if (x)&nbsp;the Transfer Agent is not participating
in the DTC Fast Automated Securities Transfer Program, a certificate or evidence of a book-entry credit for the number of shares of Common
Stock to which the Holder is entitled and register such Common Stock on the Company&rsquo;s share register or (y)&nbsp;the Transfer Agent
is participating in the DTC Fast Automated Securities Transfer Program, to credit the Holder&rsquo;s balance account with DTC, for such
number of shares of Common Stock to which the Holder is entitled upon the Holder&rsquo;s exercise of this Warrant or (II)&nbsp;a registration
statement (which may be the Registration Statement) covering the issuance or resale of the Warrant Shares that are the subject of the
Exercise Notice (the &ldquo;<B>Exercise Notice Warrant Shares</B>&rdquo;) is not available for the issuance or resale, as applicable,
of such Exercise Notice Warrant Shares and (x)&nbsp;the Company fails to promptly, but in no event later than one (1)&nbsp;Business Day
after such registration statement becomes unavailable, to so notify the Holder and (y)&nbsp;the Company is unable to deliver the Exercise
Notice Warrant Shares electronically without any restrictive legend by crediting such aggregate number of Exercise Notice Warrant Shares
to the Holder&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit / Withdrawal At Custodian system (the event
described in the immediately foregoing clause (II)&nbsp;is hereinafter referred as a &ldquo;<B>Notice Failure</B>&rdquo; and together
with the event described in clause (I)&nbsp;above, an &ldquo;<B>Exercise Failure</B>&rdquo;), then, in addition to all other remedies
available to the Holder, if on or prior to the applicable Share Delivery Date either (I)&nbsp;if the Transfer Agent is not participating
in the DTC Fast Automated Securities Transfer Program, the Company shall fail to issue and deliver a certificate or evidence of a book-entry
credit to the Holder and register such shares of Common Stock on the Company&rsquo;s share register or, if the Transfer Agent is participating
in the DTC Fast Automated Securities Transfer Program, credit the Holder&rsquo;s balance account with DTC for the number of shares of
Common Stock to which the Holder is entitled upon the Holder&rsquo;s exercise hereunder or pursuant to the Company&rsquo;s obligation
pursuant to clause (ii)&nbsp;below or (II)&nbsp;if a Notice Failure occurs, and, in each case, if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such
exercise (a &ldquo;<B>Buy-In</B>&rdquo;), then the Company shall, within five (5)&nbsp;Trading Days after the Holder&rsquo;s request,
(A)&nbsp;pay in cash to the Holder the amount, if any, by which (x)&nbsp;the Holder&rsquo;s total purchase price (including reasonable
and customary brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y)&nbsp;the amount obtained by multiplying
(1)&nbsp;the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue
times and (2)&nbsp;the price at which the sell order giving rise to such purchase obligation was executed, and (B)&nbsp;at the option
of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored
(in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have
been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases
Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock
with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A)&nbsp;of the immediately preceding sentence
the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable
to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit
a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree
of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock
upon exercise of the Warrant as required pursuant to the terms hereof. The Company&rsquo;s current transfer agent participates in the
DTC Fast Automated Securities Transfer Program (&ldquo;<B>FAST</B>&rdquo;). In the event that the Company changes transfer agents while
this Warrant is outstanding, the Company shall select a transfer agent that participates in FAST. While this Warrant is outstanding, the
Company shall cause its transfer agent to participate in FAST with respect to this Warrant. In addition to the foregoing rights, (i)&nbsp;if
the Company fails to deliver the applicable number of Warrant Shares upon an exercise pursuant to Section&nbsp;1 by the applicable Share
Delivery Date, then the Holder shall have the right to rescind such exercise in whole or in part and retain and/or have the Company return,
as the case may be, any portion of this Warrant that has not been exercised pursuant to such Exercise Notice; provided that the rescission
of an exercise shall not affect the Company&rsquo;s obligation to make any payments that have accrued prior to the date of such notice
pursuant to this Section&nbsp;1(c)&nbsp;or otherwise, and (ii)&nbsp;if a registration statement (which may be the Registration Statement)
covering the issuance or resale of the Warrant Shares that are subject to an Exercise Notice is not available for the issuance or resale,
as applicable, of such Exercise Notice Warrant Shares and the Holder has submitted an Exercise Notice prior to receiving notice of the
non-availability of such registration statement and the Company has not already delivered the Warrant Shares underlying such Exercise
Notice electronically without any restrictive legend by crediting such aggregate number of Warrant Shares to which the Holder is entitled
pursuant to such exercise to the Holder&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit / Withdrawal At Custodian
system, the Holder shall have the option, by delivery of notice to the Company, to (x)&nbsp;rescind such Exercise Notice in whole or in
part and retain or have returned, as the case may be, any portion of this Warrant that has not been exercised pursuant to such Exercise
Notice; provided that the rescission of an Exercise Notice shall not affect the Company&rsquo;s obligation to make any payments that have
accrued prior to the date of such notice pursuant to this Section&nbsp;1(c)&nbsp;or otherwise, and/or (y)&nbsp;switch some or all of such
Exercise Notice from a cash exercise to a Cashless Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Cashless
Exercise</U>. If at the time of exercise hereof, there is no effective registration statement, or the prospectus contained therein is
not available for the issuance or resale of the Warrant Shares to or by the Holder, then this Warrant may also be exercised, in whole
or in part, at such time by means of a &ldquo;cashless exercise&rdquo; (a &ldquo;<B>Cashless Exercise</B>&rdquo;) in which the Holder
shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing (A-B) * (X)&nbsp;by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in">A= as applicable,
(i)&nbsp;the VWAP (as defined herein) on the Trading Day immediately preceding the date of the applicable Exercise Notice if such Exercise
Notice is (1)&nbsp;both executed and delivered pursuant to Section&nbsp;1(a)&nbsp;hereof on a day that is not a Trading Day or (2)&nbsp;both
executed and delivered pursuant to Section&nbsp;1(a)&nbsp;hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo;
(as defined in Rule&nbsp;600(b)(88) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii)&nbsp;at
the option of the Holder, either (y)&nbsp;the VWAP on the Trading Day immediately preceding the date of the applicable Exercise Notice
or (z)&nbsp;the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg as of the time of the Holder&rsquo;s
execution of the applicable Exercise Notice if such Exercise Notice is executed during &ldquo;regular trading hours&rdquo; on a Trading
Day and is delivered within two (2)&nbsp;hours thereafter (including until two (2)&nbsp;hours after the close of &ldquo;regular trading
hours&rdquo; on a Trading Day) pursuant to Section&nbsp;1(a)&nbsp;hereof or (iii)&nbsp;the VWAP on the date of the applicable Exercise
Notice if the date of such Exercise Notice is a Trading Day and such Exercise Notice is both executed and delivered pursuant to Section&nbsp;1(a)&nbsp;hereof
after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in">B= the Exercise
Price of this Warrant, as adjusted hereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in">X= the number
of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were
by means of a cash exercise rather than a cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the Company acknowledges and agrees that in accordance with Section&nbsp;3(a)(9)&nbsp;of
the Securities Act of 1933, as amended, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised.
The Company agrees not to take any position contrary to this Section&nbsp;1(d).<FONT STYLE="background-color: white">&nbsp;</FONT></FONT>Without
limiting the rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise,&rdquo; and to receive the cash payments contemplated
pursuant to Sections 1(c)&nbsp;and 3(b), in no event will the Company be required to net cash settle a Warrant exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Beneficial
Ownership</U>. Notwithstanding anything to the contrary contained herein, the Company shall not effect the exercise of any portion of
this Warrant, and the Holder shall not have the right to exercise any portion of this Warrant, pursuant to the terms and conditions of
this Warrant and any such exercise shall be null and void and treated as if never made, to the extent that after giving effect to such
exercise, the Holder together with the other Attribution Parties collectively would beneficially own in excess of the Maximum Percentage
(as defined below). For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by the Holder
and the other Attribution Parties shall include the number of shares of Common Stock held by the Holder and all other Attribution Parties
plus the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which the determination of such sentence
is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (A)&nbsp;exercise of the remaining,
unexercised portion of this Warrant beneficially owned by the Holder or any of the other Attribution Parties and (B)&nbsp;exercise or
conversion of the unexercised or unconverted portion of any other securities of the Company (including, without limitation, any convertible
notes or convertible preferred stock or warrants, including the other Warrants) beneficially owned by the Holder or any other Attribution
Party subject to a limitation on conversion or exercise analogous to the limitation contained in this Section&nbsp;1(e). For purposes
of this Section&nbsp;1(e), beneficial ownership shall be calculated in accordance with Section&nbsp;13(d)&nbsp;of the Securities Exchange
Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;), it being acknowledged by the Holder that the Company is not representing
to the Holder that such calculation is in compliance with Section&nbsp;13(d)&nbsp;of the Exchange Act and the Holder is solely responsible
for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section&nbsp;1(e)&nbsp;applies,
the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission
of a Exercise Notice shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other
securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable,
in each case subject to the Maximum Percentage, and the Company shall have no obligation to verify or confirm the accuracy of such determination.
In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section&nbsp;13(d)&nbsp;of
the Exchange Act and the rules&nbsp;and regulations promulgated thereunder. For purposes of this Warrant, in determining the number of
outstanding shares of Common Stock the Holder may acquire upon the exercise of this Warrant without exceeding the Maximum Percentage,
the Holder may rely on the number of outstanding shares of Common Stock as reflected in (x)&nbsp;the Company&rsquo;s most recent Annual
Report on Form&nbsp;10-K, Quarterly Report on Form&nbsp;10-Q or other public filing with the Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;),
as the case may be, (y)&nbsp;a more recent public announcement by the Company or (z)&nbsp;any other written notice by the Company or the
Transfer Agent setting forth the number of shares of Common Stock outstanding (the &ldquo;<B>Reported Outstanding Share Number</B>&rdquo;).
If the Company receives an Exercise Notice from the Holder at a time when the actual number of outstanding shares of Common Stock is less
than the Reported Outstanding Share Number, the Company shall (i)&nbsp;notify the Holder in writing of the number of shares of Common
Stock then outstanding and, to the extent that such Exercise Notice would otherwise cause the Holder&rsquo;s beneficial ownership, as
determined pursuant to this Section&nbsp;1(e), to exceed the Maximum Percentage, the Holder must notify the Company of a reduced number
of Warrant Shares to be purchased pursuant to such Exercise Notice (the number of shares by which such purchase is reduced, the &ldquo;<B>Reduction
Shares</B>&rdquo;) and (ii)&nbsp;as soon as reasonably practicable, the Company shall return to the Holder any exercise price paid by
the Holder for the Reduction Shares. For any reason at any time, upon the written or oral request of the Holder, the Company shall within
one (1)&nbsp;Business Day confirm orally and in writing or by electronic mail to the Holder the number of shares of Common Stock then
outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or
exercise of securities of the Company, including this Warrant, by the Holder and any other Attribution Party since the date as of which
the Reported Outstanding Share Number was reported. In the event that the issuance of Common Stock to the Holder upon exercise of this
Warrant results in the Holder and the other Attribution Parties being deemed to beneficially own, in the aggregate, more than the Maximum
Percentage of the number of outstanding shares of Common Stock (as determined under Section&nbsp;13(d)&nbsp;of the Exchange Act), the
number of shares so issued by which the Holder&rsquo;s and the other Attribution Parties&rsquo; aggregate beneficial ownership exceeds
the Maximum Percentage (the &ldquo;<B>Excess Shares</B>&rdquo;) shall be deemed null and void and shall be cancelled ab initio, and the
Holder shall not have the power to vote or to transfer the Excess Shares. As soon as reasonably practicable after the issuance of the
Excess Shares has been deemed null and void, the Company shall return to the Holder the Exercise Price paid by the Holder for the Excess
Shares. The Maximum Percentage shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect
to the issuance of shares of Common Stock issuable upon exercise of this Warrant (the &ldquo;<B>Maximum Percentage</B>&rdquo;). Upon delivery
of a written notice to the Company, the Holder may from time to time increase or decrease the Maximum Percentage to any other percentage
not in excess of 9.99% as specified in such notice; provided that (i)&nbsp;any such increase in the Maximum Percentage will not be effective
until the sixty-first (61<SUP>st</SUP>) day after such notice is delivered to the Company and (ii)&nbsp;any such increase or decrease
will apply only to the Holder and the other Attribution Parties and not to any other holder of Warrants that is not an Attribution Party
of the Holder. For purposes of clarity, the shares of Common Stock issuable pursuant to the terms of this Warrant in excess of the Maximum
Percentage shall not be deemed to be beneficially owned by the Holder for any purpose including for purposes of Section&nbsp;13(d)&nbsp;or
Rule&nbsp;16a-1(a)(1)&nbsp;of the Exchange Act. No prior inability to exercise this Warrant pursuant to this paragraph shall have any
effect on the applicability of the provisions of this paragraph with respect to any subsequent determination of exercisability. The provisions
of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section&nbsp;1(e)&nbsp;to
the extent necessary to correct this paragraph or any portion of this paragraph which may be defective or inconsistent with the intended
beneficial ownership limitation contained in this Section&nbsp;1(e)&nbsp;or to make changes or supplements necessary or desirable to properly
give effect to such limitation. The limitation contained in this paragraph may not be waived and shall apply to a successor holder of
this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>ADJUSTMENT
OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES</U>. The Exercise Price and the number of Warrant Shares shall be adjusted from time to
time as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Voluntary
Adjustment By Company</U>. Subject to the rules&nbsp;and regulations of the Trading Market, the Company may at any time during the term
of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the Board of Directors
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Adjustment
Upon Stock Dividends and Splits</U>. If the Company at any time while this Warrant it outstanding: (i)&nbsp;pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for the avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of
this Warrant), (ii)&nbsp;subdivides outstanding shares of Common Stock into a greater number of shares, (iii)&nbsp;combines (including
by way of reverse stock split) outstanding shares of Common Stock into smaller number of shares, or (iv)&nbsp;issues by reclassification
of shares of the Common Stock any shares of capital stock of the Company, then, in each case, the Exercise Price shall be multiplied by
a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately
before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event,
and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the Exercise Price of this
Warrant shall remain unchanged. Any adjustment under this Section&nbsp;2(b)&nbsp;shall become effective immediately after the record date
for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or reclassification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>RIGHTS
UPON DISTRIBUTION OF ASSETS</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or
otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) other than dividends or distributions
subject to Section&nbsp;2(b)&nbsp;above (a &quot;<B>Distribution</B>&quot;), or other than a reclassification to which Section&nbsp;4(b)&nbsp;applies,
then at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations or restrictions on exercise of this Warrant, including without
limitation, the Maximum Percentage) immediately before the date on which a record is taken for such Distribution, or, if no such record
is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution
(<U>provided</U>, <U>however</U>, that to the extent that the Holder's right to participate in any such Distribution would result in the
Holder and the other Attribution Parties exceeding the Maximum Percentage, then the Holder shall not be entitled to participate in such
Distribution to such extent (and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of such Distribution
(and beneficial ownership) to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder
</FONT>until such time or times as its right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum
Percentage, at which time or times the Holder shall be granted such Distribution (and any Distributions declared or made on such initial
Distribution or on any subsequent Distribution held similarly in abeyance) to the same extent as if there had been no such limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>PURCHASE
RIGHTS; FUNDAMENTAL TRANSACTIONS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Purchase
Rights</U>. If at any time after the Subscription Date and on or prior to the Expiration Date, the Company grants, issues or sells any
Options, Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata to the record holders of
any class of Common Stock (the &ldquo;<B>Purchase Rights</B>&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable
to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares
of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations or restrictions on exercise of this
Warrant, including without limitation, the Maximum Percentage) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Common Stock are to be determined
for the grant, issuance or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that to the extent that the Holder&rsquo;s right
to participate in any such Purchase Right would result in the Holder and the other Attribution Parties exceeding the Maximum Percentage,
then the Holder shall not be entitled to participate in such Purchase Right to such extent (and shall not be entitled to beneficial ownership
of such Common Stock as a result of such Purchase Right (and beneficial ownership) to such extent) and such Purchase Right to such extent
shall be held in abeyance for the benefit of the Holder </FONT>until such time or times as its right thereto would not result in the Holder
and the other Attribution Parties exceeding the Maximum Percentage, at which time or times the Holder shall be granted such right (and
any Purchase Right granted, issued or sold on such initial Purchase Right or on any subsequent Purchase Right to be held similarly in
abeyance) to the same extent as if there had been no such limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Fundamental Transaction.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
at any time while this Warrant is outstanding, (i)&nbsp;the Company, directly or indirectly, in one or more related transactions effects
any merger or consolidation of the Company with or into another Person (other than a reincorporation in a different state), (ii)&nbsp;the
Company (and all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer,
conveyance or other disposition of all or substantially all of the Company&rsquo;s (including its Subsidiaries, taken as a whole) assets
in one or a series of related transactions (which shall not include a license or other agreement granting rights to intellectual property),
(iii)&nbsp;any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed
pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property
and has been accepted by the holders of greater than 50% of the outstanding voting power of the common and preferred equity of the Company,
(iv)&nbsp;the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
of shares of Common Stock or any compulsory share exchange pursuant to which the shares of Common Stock are effectively converted into
or exchanged for other securities, cash or property, or (v)&nbsp;the Company, directly or indirectly, in one more related transactions
consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization,
spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires greater
than 50% of the outstanding voting power of the common and preferred equity of the Company (the &ldquo;<B>Fundamental Transaction</B>&rdquo;),
then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have
been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without
regard to any limitation in Section&nbsp;4(c)&nbsp;on the exercise of this Warrant), the number of shares of Common Stock of the successor
or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<B>Alternate
Consideration</B>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock
for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section&nbsp;4(c)&nbsp;on
the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted
to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock
in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable
manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given
any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same
choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding
anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity shall, at the Holder&rsquo;s
option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later,
the date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the
Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on
the date of the consummation of such Fundamental Transaction; provided, however, that, if the Fundamental Transaction is not within the
Company&rsquo;s control, including not approved by the Company&rsquo;s Board of Directors, Holder shall only be entitled to receive from
the Company or any Successor Entity, as of the date of consummation of such Fundamental Transaction, the same type or form of consideration
(and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to
the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the form
of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative
forms of consideration in connection with the Fundamental Transaction; provided, further, that if holders of Common Stock of the Company
are not offered or paid any consideration in such Fundamental Transaction, such holders of Common Stock will be deemed to have received
common stock of the Successor Entity (which Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction.
The payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within
the later of (i)&nbsp;five Business Days of the Holder&rsquo;s election and (ii)&nbsp;the date of consummation of the Fundamental Transaction.
The Company shall cause any Successor Entity in a Fundamental Transaction in which the Company is not the survivor to assume in writing
all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this
Section&nbsp;4(b)&nbsp;pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the
Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder
in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance
to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity)
equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on
the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder
to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental
Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the
purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and
which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor
Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this
Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and
may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the other
Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Calculations</U>.
All calculations under Sections 2, 3 and 4 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For
purposes of Sections 2, 3 and 4, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be
the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>NONCIRCUMVENTION</U>.
The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation or Bylaws, or through
any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issuance or sale of securities, or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all
times in good faith carry out all of the provisions of this Warrant and take all action as may be required to protect the rights of the
Holder. Without limiting the generality of the foregoing, the Company (i)&nbsp;shall not increase the par value of any shares of Common
Stock receivable upon the exercise of this Warrant above the Exercise Price then in effect, (ii)&nbsp;shall take all such actions as may
be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock
upon the exercise of this Warrant, and (iii)&nbsp;shall, so long as any of the Warrants are outstanding, take all action necessary to
reserve and keep available out of its authorized and unissued shares of Common Stock, solely for the purpose of effecting the exercise
of the Warrants, the number of shares of Common Stock as shall from time to time be necessary to effect the exercise of the Warrants then
outstanding (without regard to any limitations on exercise).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;[RESERVED]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>REISSUANCE
OF WARRANTS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Transfer
of Warrant</U>. Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder are transferable, in
whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so
assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three Trading Days of the date on which the Holder delivers an assignment form to the Company
assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase
of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section&nbsp;7(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant and shall be identical with
this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<B>Warrant
Register</B>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>NOTICES</U>.
Whenever notice is required to be given under this Warrant, including, without limitation, an Exercise Notice, unless otherwise provided
herein, such notice shall be given in writing, (i)&nbsp;if delivered (a)&nbsp;from within the domestic United States, by first-class registered
or certified airmail, or nationally recognized overnight express courier, postage prepaid or electronic mail or (b)&nbsp;from outside
the United States, by International Federal Express or electronic mail, and (ii)&nbsp;will be deemed given (A)&nbsp;if delivered by first-class
registered or certified mail domestic, three (3)&nbsp;Business Days after so mailed, (B)&nbsp;if delivered by nationally recognized overnight
carrier, one (1)&nbsp;Business Day after so mailed, (C)&nbsp;if delivered by International Federal Express, two (2)&nbsp;Business Days
after so mailed and (D)&nbsp;at the time of transmission, if delivered by electronic mail to each of the email addresses specified in
this Section&nbsp;8 prior to 5:00 p.m.&nbsp;(New York time) on a Trading Day, and (E)&nbsp;the next Trading Day after the date of transmission,
if delivered by electronic mail to each of the email addresses specified in this Section&nbsp;8 on a day that is not a Trading Day or
later than 5:00 p.m.&nbsp;(New York time) on any Trading Day:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
to the Company, to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Plug Power&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">125 Vista Boulevard</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Slingerlands, New York, 12159</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attention: General Counsel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Telephone: (518)&nbsp;782-7700</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Email: [***]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(ii)&nbsp;if to the Holder, at such address
or other contact information delivered by the Holder to the Company or as is on the books and records of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company will give written notice to the Holder
(i)&nbsp;immediately upon any adjustment of the Exercise Price, setting forth in reasonable detail, and certifying, the calculation of
such adjustment and (ii)&nbsp;at least fifteen (15) days prior to the date on which the Company closes its books or takes a record (A)&nbsp;with
respect to any dividend or distribution upon the shares of Common Stock, (B)&nbsp;with respect to any grants, issuances or sales of any
Options, Convertible Securities or rights to purchase stock, warrants, securities or other property to holders of shares of Common Stock
or (C)&nbsp;for determining rights to vote with respect to any Fundamental Transaction, dissolution or liquidation; <U>provided</U> in
each case that such information shall be made known to the public prior to or in conjunction with such notice being provided to the Holder.
It is expressly understood and agreed that the time of exercise specified by the Holder in each Exercise Notice shall be definitive and
may not be disputed or challenged by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>MISCELLANEOUS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section&nbsp;1(a), except as expressly set
forth in Sections 2, 3 and 4. Without limiting the rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section&nbsp;1(d), or to receive cash payments contemplated by Sections 1(a)&nbsp;and 1(c)&nbsp;herein, in no event will the Company
be required to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Authorized
Shares</U>. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued
Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of this Warrant. The Company
further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing
the necessary Warrant Shares upon the exercise of this Warrant. The Company will take all such reasonable action as may be necessary to
assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements
of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon
the exercise of this Warrant will, upon exercise hereunder and payment for such Warrant Shares in accordance herewith, be duly authorized,
validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue
thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except and to the extent as
waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of
incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any
other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times
in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to
protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company
will (i)&nbsp;not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii)&nbsp;take all such action as may be necessary or appropriate in order that the Company may validly
and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii)&nbsp;use commercially reasonable
efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may
be, necessary to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Before taking any action which
would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company
shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or
bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and construed
and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof.
The Company and, by accepting this Warrant, the Holder each agrees that all legal proceedings concerning the interpretations, enforcement
and defense of the transactions contemplated by this Warrant (whether brought against the Company or the Holder or their respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. The Company and, by accepting this Warrant, the Holder each hereby irrevocably submits to the exclusive
jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute
hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and
agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court,
that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. The Company and, by accepting this Warrant,
the Holder each hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or
proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to it at the address
in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and
notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law. If the Company or the Holder shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing
party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo; fees and other costs
and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. <B>EACH OF THE COMPANY AND EACH
HOLDER HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY&nbsp;HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE
HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS WARRANT OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant or the Underwriting Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which
results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs
and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the
Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Warrant
Agent</U>. [The Company][Broadridge Corporate Issuer Solutions,&nbsp;Inc.] shall initially serve as warrant agent under this Warrant.
Upon ten (10)&nbsp;days&rsquo; notice to the Holder, the Company may appoint a new warrant agent. Any corporation into which the Company
or any new warrant agent may be merged or any corporation resulting from any consolidation to which the Company or any new warrant agent
shall be a party or any corporation to which the Company or any new warrant agent transfers substantially all of its corporate trust or
shareholders services business shall be a successor warrant agent under this Warrant without any further act. Any such successor warrant
agent shall promptly cause notice of its succession as warrant agent to be mailed (by first class mail, postage prepaid) to the Holder
at the Holder&rsquo;s last address as shown on the Warrant Register.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder of this Warrant, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(m)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Headings</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>CERTAIN
DEFINITIONS</U>. For purposes of this Warrant, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Affiliate</B>&rdquo;
means, with respect to any Person, any other Person that directly or indirectly controls, is controlled by, or is under common control
with, such Person, as such terms are used in and construed under Rule&nbsp;405 under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Attribution
Parties</B>&rdquo; means, collectively, the following Persons and entities: (i)&nbsp;any investment vehicle, including, any funds, feeder
funds or managed accounts, currently, or from time to time after the Subscription Date, directly or indirectly managed or advised by the
Holder&rsquo;s investment manager or any of its Affiliates or principals, (ii)&nbsp;any direct or indirect Affiliates of the Holder or
any of the foregoing, (iii)&nbsp;any Person acting or who could be deemed to be acting as a Group together with the Holder or any of the
foregoing and (iv)&nbsp;any other Persons whose beneficial ownership of the Company&rsquo;s Common Stock would or could be aggregated
with the Holder&rsquo;s and the other Attribution Parties for purposes of Section&nbsp;13(d)&nbsp;of the Exchange Act. For clarity, the
purpose of the foregoing is to subject collectively the Holder and all other Attribution Parties to the Maximum Percentage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Bid
Price</B>&rdquo; means, for any security as of the particular time of determination, the bid price for such security on the Principal
Market as reported by Bloomberg as of such time of determination, or, if the Principal Market is not the principal securities exchange
or trading market for such security, the bid price of such security on the principal securities exchange or trading market where such
security is listed or traded as reported by Bloomberg as of such time of determination, or if the foregoing does not apply, the bid price
of such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg as of such
time of determination, or, if no bid price is reported for such security by Bloomberg as of such time of determination, the average of
the bid prices of any market makers for such security as reported on the Pink Open Market as of such time of determination. If the Bid
Price cannot be calculated for a security as of the particular time of determination on any of the foregoing bases, the Bid Price of such
security as of such time of determination shall be the fair market value of such securities as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company. All such determinations shall be appropriately adjusted for any stock dividend,
stock split, stock combination or other similar transaction during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Black
Scholes Value</B>&rdquo; means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo;
function on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting
(A)&nbsp;a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public
announcement of the applicable Fundamental Transaction and the Expiration Date, (B)&nbsp;an expected volatility equal to the 30-day volatility
obtained from the HVT function on Bloomberg (determined utilizing a 365-day annualization factor) as of the Trading Day immediately following
the public announcement of the applicable Fundamental Transaction, (C)&nbsp;the underlying price per share used in such calculation shall
be the greater of (i)&nbsp;the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration,
if any, being offered in such Fundamental Transaction and (ii)&nbsp;the highest VWAP during the period beginning on the Trading Day immediately
preceding the public announcement of the applicable Fundamental Transaction (or the consummation of the applicable Fundamental Transaction,
if earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant to Section&nbsp;4(b)&nbsp;and (D)&nbsp;a remaining option
time equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Expiration Date and
(E)&nbsp;a zero cost of borrow.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Bloomberg</B>&rdquo;
means Bloomberg Financial Markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Business
Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required
by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any
other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so
long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Change
of Control</B>&rdquo; means any Fundamental Transaction other than (i)&nbsp;any reorganization, recapitalization or reclassification of
the Common Stock in which holders of the Company&rsquo;s voting power immediately prior to such reorganization, recapitalization or reclassification
continue after such reorganization, recapitalization or reclassification to hold publicly traded securities and, directly or indirectly,
are, in all material respect, the holders of the voting power of the surviving entity (or entities with the authority or voting power
to elect the members of the board of directors (or their equivalent if other than a corporation) of such entity or entities) after such
reorganization, recapitalization or reclassification, (ii)&nbsp;pursuant to a migratory merger effected solely for the purpose of changing
the jurisdiction of incorporation of the Company or (iii)&nbsp;a merger in connection with a bona fide acquisition by the Company of any
Person in which (x)&nbsp;the gross consideration paid, directly or indirectly, by the Company in such acquisition is not greater than
50% of the Company&rsquo;s market capitalization as calculated on the date of the consummation of such merger and (y)&nbsp;such merger
does not contemplate a change to the identity of a majority of the board of directors of the Company. Notwithstanding anything herein
to the contrary, any transaction or series of transaction that, directly or indirectly, results in the Company or the Successor Entity
not having Common Stock or common stock, as applicable, registered under the Exchange Act and listed on an Eligible Market shall be deemed
a Change of Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Common
Stock</B>&rdquo; means (i)&nbsp;the Company&rsquo;s Common Stock, par value $0.01 per share, and (ii)&nbsp;any capital stock into which
such Common Stock shall have been changed or any capital stock resulting from a reclassification of such Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Convertible
Securities</B>&rdquo; means any stock or securities (other than Options) directly or indirectly convertible into or exercisable or exchangeable
for shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Eligible
Market</B>&rdquo; means The NASDAQ Capital Market, the NYSE American LLC, The NASDAQ Global Select Market, The NASDAQ Global Market or
The New York Stock Exchange,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Expiration
Date</B>&rdquo; means the date that is the third anniversary after the date hereof or, if such date falls on a day other than a Business
Day or on which trading does not take place on the Principal Market (a &ldquo;<B>Holiday</B>&rdquo;), the next day that is not a Holiday.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Group</B>&rdquo;
means a &ldquo;group&rdquo; as that term is used in Section&nbsp;13(d)&nbsp;of the Exchange Act and as defined in Rule&nbsp;13d-5 thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(m)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Options</B>&rdquo;
means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(n)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Parent
Entity</B>&rdquo; of a Person means an entity that, directly or indirectly, controls the applicable Person, including such entity whose
common stock or equivalent equity security is quoted or listed on an Eligible Market (or, if so elected by the Holder, any other market,
exchange or quotation system), or, if there is more than one such Person or such entity, the Person or such entity designated by the Holder
or in the absence of such designation, such Person or entity with the largest public market capitalization as of the date of consummation
of the Fundamental Transaction or Change of Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(o)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Person</B>&rdquo;
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity and a government or any department or agency thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(p)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Principal
Market</B>&rdquo; means The NASDAQ Capital Market (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(q)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Required
Holders</B>&rdquo; means the holders of the Warrants representing at least a majority of the shares of Common Stock underlying the Warrants
then outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(r)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>&ldquo;Standard
Settlement Period&rdquo;</B> means the standard settlement period, expressed in a number of Trading Days, for the Company&rsquo;s primary
trading market or quotation system with respect to the Common Stock that is in effect on the date of receipt of an applicable Exercise
Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(s)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Successor
Entity</B>&rdquo; means one or more Person or Persons (or, if so elected by the Holder, the Company or Parent Entity) formed by, resulting
from or surviving any Fundamental Transaction or Change of Control or one or more Person or Persons (or, if so elected by the Holder,
the Company or the Parent Entity) with which such Fundamental Transaction or Change of Control shall have been entered into.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(t)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Trading
Day</B>&rdquo; means any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal
trading market for the Common Stock, then on the principal securities exchange or securities market on which the Common Stock is then
traded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(u)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Trading
Market</B>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock
Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Transaction
Documents</B>&rdquo; means any agreement entered into by and between the Company and the Holder, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(w)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>VWAP</B>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a)&nbsp;if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m.&nbsp;(New York City time) to 4:02 p.m.&nbsp;(New York City time)), (b)&nbsp;if OTCQB or OTCQX is not a Trading Market, the volume
weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)&nbsp;if
the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The
Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per
share of the Common Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;Follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF,</B></FONT> the Company has caused this Warrant to purchase Common Stock to be duly executed as of the Issuance Date set
out above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase">Plug Power Inc.</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%">&nbsp;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Name:</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT>[<I>Signature
Page&nbsp;to Warrant</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>EXHIBIT&nbsp;A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXERCISE NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TO BE EXECUTED BY THE REGISTERED HOLDER TO
EXERCISE THIS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WARRANT TO PURCHASE COMMON STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Plug
Power Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned holder hereby
exercises the right to purchase _________________ shares of Common Stock (&ldquo;<B>Warrant Shares</B>&rdquo;) of <FONT STYLE="text-transform: uppercase">Plug
Power Inc.</FONT>, a corporation organized under the laws of the State of Delaware (the &ldquo;<B>Company</B>&rdquo;), evidenced by the
attached Warrant to Purchase Common Stock (the &ldquo;<B>Warrant</B>&rdquo;). Capitalized terms used herein and not otherwise defined
shall have the respective meanings set forth in the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. Form&nbsp;of Exercise Price.
The Holder intends that payment of the Exercise Price shall be made as:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">____________</TD><TD STYLE="padding-left: 5.4pt; text-align: justify">a &ldquo;<U>Cash Exercise&rdquo;</U> with respect to _________________ Warrant Shares; and/or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">____________</TD><TD STYLE="padding-left: 5.4pt; text-align: justify">a <U>&ldquo;Cashless Exercise&rdquo;</U> with respect to _______________ Warrant Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to Section&nbsp;1(d)&nbsp;the Holder
[is][is not] exercising its option to have the VWAP determined by reference to [the VWAP on the Trading Day immediately preceding the
date of the applicable Exercise Notice] or [the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg
as of the time of the Holder&rsquo;s execution of the applicable Exercise Notice if such Exercise Notice is executed during &ldquo;regular
trading hours&rdquo; on a Trading Day and is delivered within two (2)&nbsp;hours thereafter (including until two (2)&nbsp;hours after
the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section&nbsp;1(d)&nbsp;of the [Warrant]].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. Payment of Exercise Price.
In the event that the holder has elected a Cash Exercise with respect to some or all of the Warrant Shares to be issued pursuant hereto,
the holder shall pay the Aggregate Exercise Price in the sum of $___________________ to the Company in accordance with the terms of the
Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. Delivery of Warrant Shares.
The Company shall deliver to the holder __________ Warrant Shares in accordance with the terms of the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: _______________ __, ______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 70%">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Name of Registered Holder</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 27%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 70%">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Name:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ACKNOWLEDGMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company hereby acknowledges
this Exercise Notice and hereby directs Broadridge Corporate Issuer Solutions,&nbsp;Inc. to issue the above indicated number of shares
of Common Stock on or prior to the applicable Share Delivery Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase">Plug Power Inc.</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%">&nbsp;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Name:</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT&nbsp;B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>(To assign the foregoing Warrant, execute this
form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR VALUE RECEIVED, the foregoing Warrant and
all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.5in">(Please Print)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.5in">(Please Print)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Phone Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dated: __________________________________ __,
______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Holder&rsquo;s Signature:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Holder&rsquo;s Address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>4
<FILENAME>tm259816d1_ex4-2.htm
<DESCRIPTION>EXHIBIT 4.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;OF PRE-FUNDED WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Plug
Power Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>Pre-Funded
Warrant To Purchase Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Warrant No.: ________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Number of Shares of Common Stock:_____________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date of Issuance: March&nbsp;[20], 2025 (&ldquo;<B>Issuance Date</B>&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Plug Power Inc., a company organized
under the laws of State of Delaware (the &ldquo;<B>Company</B>&rdquo;), hereby certifies that, for good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged<FONT STYLE="text-transform: uppercase">, [HOLDER]</FONT>, the registered holder
hereof or its permitted assigns (the &ldquo;<B>Holder</B>&rdquo;), is entitled, subject to the terms set forth below, to purchase from
the Company, at the Exercise Price (as defined below) then in effect, at any time or times on or after the date hereof (the &ldquo;<B>Initial
Exercisability Date</B>&rdquo;), but not after 11:59 p.m., New York time, on the Expiration Date, (as defined below), ______________ (_____________)<SUP></SUP>
fully paid non-assessable shares of Common Stock (as defined below), subject to adjustment as provided herein (the &ldquo;<B>Warrant Shares</B>&rdquo;).
Except as otherwise defined herein, capitalized terms in this Warrant to Purchase Common Stock (including any Warrants to Purchase Common
Stock issued in exchange, transfer or replacement hereof, this &ldquo;<B>Warrant</B>&rdquo;), shall have the meanings set forth in Section&nbsp;10.
This Warrant is one of the Warrants to purchase Common Stock (the &ldquo;<B>Warrants</B>&rdquo;) issued pursuant to (i)&nbsp;that certain
Underwriting Agreement, dated as of March 19, 2025 (the &ldquo;<B>Subscription Date</B>&rdquo;) by and between the Company and
Oppenheimer&nbsp;&amp; Co. Inc., as representative of the several underwriters named therein, (ii)&nbsp;the Company&rsquo;s Registration
Statement on Form&nbsp;S-3 (File No.&nbsp;333-265488) (the &ldquo;<B>Registration Statement</B>&rdquo;) and (iii)&nbsp;the Company&rsquo;s
prospectus supplement dated as of March 19, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>EXERCISE
OF WARRANT.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Mechanics
of Exercise</U>. Subject to the terms and conditions hereof (including, without limitation, the limitations set forth in Section&nbsp;1(e)),
this Warrant may be exercised by the Holder at any time or times on or after the Initial Exercisability Date, in whole or in part, by
delivery (whether via electronic mail or otherwise) of a written notice, in the form attached hereto as <U>Exhibit&nbsp;A</U> (the &ldquo;<B>Exercise
Notice</B>&rdquo;), of the Holder&rsquo;s election to exercise this Warrant. Within one (1)&nbsp;Trading Day following the delivery of
the Exercise Notice, the Holder shall make payment to the Company of an amount equal to the Exercise Price in effect on the date of such
exercise multiplied by the number of Warrant Shares as to which this Warrant is being exercised (the &ldquo;<B>Aggregate Exercise Price</B>&rdquo;)
in cash by wire transfer of immediately available funds or, if the provisions of Section&nbsp;1(d)&nbsp;are applicable, by notifying the
Company pursuant to the Exercise Notice that this Warrant is being exercised pursuant to a Cashless Exercise (as defined in Section&nbsp;1(d)).
Execution and delivery of the Exercise Notice with respect to less than all of the Warrant Shares shall have the same effect as cancellation
of the original Warrant and issuance of a new Warrant evidencing the right to purchase the remaining number of Warrant Shares and the
Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares
available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company
for cancellation within five (5)&nbsp;Trading Days of the date on which the final Exercise Notice has been delivered to the Company. On
or before the first (1</FONT><SUP>st</SUP>) Trading Day following the date on which the Holder has delivered the applicable Exercise Notice,
the Company shall transmit by electronic mail an acknowledgment of confirmation of receipt of the Exercise Notice, in the form attached
to the Exercise Notice, to the Holder and the Company&rsquo;s transfer agent (the &ldquo;<B>Transfer Agent</B>&rdquo;). So long as the
Holder delivers the Aggregate Exercise Price (or notice of a Cashless Exercise, if applicable) on or prior to the first (1<SUP>st</SUP>)
Trading Day following the date on which the Exercise Notice has been delivered to the Company, then on or prior to the number of Trading
Days comprising the Standard Settlement Period following the date on which the Exercise Notice has been delivered to the Company, or,
if the Holder does not deliver the Aggregate Exercise Price (or notice of a Cashless Exercise, if applicable) on or prior to the first
(1<SUP>st</SUP>) Trading Day following the date on which the Exercise Notice has been delivered to the Company, then on or prior to the
first (1<SUP>st</SUP>) Trading Day following the date on which the Aggregate Exercise Price (or notice of a Cashless Exercise, if applicable)
is delivered (such earlier date, or if later, the earliest day on which the Company is required to deliver Warrant Shares pursuant to
this Section&nbsp;1(a), the &ldquo;<B>Share Delivery Date</B>&rdquo;), the Company shall (X)&nbsp;provided that the Transfer Agent is
participating in The Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;) Fast Automated Securities Transfer Program, credit such aggregate
number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the Holder&rsquo;s or its designee&rsquo;s balance
account with DTC through its Deposit / Withdrawal At Custodian system, or (Y)&nbsp;if the Transfer Agent is not participating in the DTC
Fast Automated Securities Transfer Program, issue and dispatch by overnight courier to the address as specified in the Exercise Notice,
a certificate or evidence of a credit book entry of shares, registered in the name of the Holder or its designee, for the number of Warrant
Shares to which the Holder is entitled pursuant to such exercise. The Company shall be responsible for all fees and expenses of the Transfer
Agent and all fees and expenses with respect to the issuance of Warrant Shares via DTC, if any, including without limitation for same
day processing. On the Share Delivery Date, the Holder shall be deemed for all corporate purposes to have become the holder of record
and beneficial owner of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date such Warrant
Shares are credited to the Holder&rsquo;s DTC account or the date of delivery of the certificates evidencing such Warrant Shares, as the
case may be. If this Warrant is physically delivered to the Company in connection with any exercise pursuant to this Section&nbsp;1(a)&nbsp;and
the number of Warrant Shares represented by this Warrant submitted for exercise is greater than the number of Warrant Shares being acquired
upon an exercise, then the Company shall as soon as practicable and in no event later than three (3)&nbsp;Trading Days after any exercise
and at its own expense, issue and deliver to the Holder (or its designee) a new Warrant (in accordance with Section&nbsp;7(b)) representing
the right to purchase the number of Warrant Shares issuable immediately prior to such exercise under this Warrant, less the number of
Warrant Shares with respect to which this Warrant is exercised. No fractional Warrant Shares are to be issued upon the exercise of this
Warrant, but rather the number of Warrant Shares to be issued shall be rounded down to the nearest whole number. Issuance of Warrant Shares
shall be made without charge to the Holder for any issue or transfer tax or any incidental expense in respect of the issuance of such
Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the
Holder or in such name or names as may be directed by the Holder; provided, however, that, in the event that Warrant Shares are to be
issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment
Form&nbsp;attached hereto as <U>Exhibit&nbsp;B</U> duly executed by the Holder and the Company may require, as a condition thereto, the
payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. Subject to the foregoing, the Holder shall be responsible
for all other tax liability that may arise as a result of holding or transferring this Warrant or receiving Warrant Shares upon exercise
hereof, including any United States withholding taxes imposed on any dividends or deemed dividends, and the Company shall be entitled
to withhold such tax liability from shares of Common Stock, sales proceeds subsequently paid or credited, or other amounts payable or
distributable to the relevant Holder as required by applicable law. The Company will not close its stockholder books or records in any
matter that prevents the timely exercise of this Warrant, pursuant to the terms hereof. The Company&rsquo;s obligations to issue and deliver
Warrant Shares in accordance with the terms and subject to the conditions hereof are absolute and unconditional, irrespective of any action
or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment
against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination; <U>provided</U>,
<U>however</U>, that the Company shall not be required to deliver Warrant Shares with respect to an exercise prior to the Holder&rsquo;s
delivery of the Aggregate Exercise Price (or notice of a Cashless Exercise) with respect to such exercise. <B>The Holder and any assignee,
by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a
portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than
the amount stated on the face hereof.</B> Notwithstanding the foregoing, with respect to any Exercise Notice(s)&nbsp;delivered on or prior
to 9:00 a.m.&nbsp;(New York City time) on the Trading Day immediately prior to the Initial Exercisability Date, the Company agrees to
deliver the Warrant Shares subject to such notice(s)&nbsp;by 4:00 p.m.&nbsp;(New York City time) on the Initial Exercisability Date and
the Initial Exercisability Date shall be the Share Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise
Price (other than in the case of a cashless exercise) is received by such Share Delivery Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exercise
Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.001 per Warrant Share, was pre-funded
to the Company on or prior to the Initial Exercisability Date and, consequently, no additional consideration (other than the nominal exercise
price of $0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The
Holder shall not be entitled to the return or refund of all, or any portion, of such pre-funded aggregate exercise price under any circumstance
or for any reason whatsoever, including in the event this Warrant is not exercised in whole or in part. The remaining unpaid exercise
price per share of Common Stock under this Warrant shall be $0.001, subject to adjustment hereunder (the &ldquo;<B>Exercise Price</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Company&rsquo;s
Failure to Timely Deliver Securities</U>. If either (I)&nbsp;the Company shall fail for any reason or for no reason to issue or credit,
as the case may be, to the Holder on or prior to the applicable Share Delivery Date, </FONT>if (x)&nbsp;the Transfer Agent is not participating
in the DTC Fast Automated Securities Transfer Program, a certificate or evidence of a book-entry credit for the number of shares of Common
Stock to which the Holder is entitled and register such Common Stock on the Company&rsquo;s share register or (y)&nbsp;the Transfer Agent
is participating in the DTC Fast Automated Securities Transfer Program, to credit the Holder&rsquo;s balance account with DTC, for such
number of shares of Common Stock to which the Holder is entitled upon the Holder&rsquo;s exercise of this Warrant or (II)&nbsp;a registration
statement (which may be the Registration Statement) covering the issuance or resale of the Warrant Shares that are the subject of the
Exercise Notice (the &ldquo;<B>Exercise Notice Warrant Shares</B>&rdquo;) is not available for the issuance or resale, as applicable,
of such Exercise Notice Warrant Shares and (x)&nbsp;the Company fails to promptly, but in no event later than one (1)&nbsp;Business Day
after such registration statement becomes unavailable, to so notify the Holder and (y)&nbsp;the Company is unable to deliver the Exercise
Notice Warrant Shares electronically without any restrictive legend by crediting such aggregate number of Exercise Notice Warrant Shares
to the Holder&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit / Withdrawal At Custodian system (the event
described in the immediately foregoing clause (II)&nbsp;is hereinafter referred as a &ldquo;<B>Notice Failure</B>&rdquo; and together
with the event described in clause (I)&nbsp;above, an &ldquo;<B>Exercise Failure</B>&rdquo;), then, in addition to all other remedies
available to the Holder, if on or prior to the applicable Share Delivery Date either (I)&nbsp;if the Transfer Agent is not participating
in the DTC Fast Automated Securities Transfer Program, the Company shall fail to issue and deliver a certificate or evidence of a book-entry
credit to the Holder and register such shares of Common Stock on the Company&rsquo;s share register or, if the Transfer Agent is participating
in the DTC Fast Automated Securities Transfer Program, credit the Holder&rsquo;s balance account with DTC for the number of shares of
Common Stock to which the Holder is entitled upon the Holder&rsquo;s exercise hereunder or pursuant to the Company&rsquo;s obligation
pursuant to clause (ii)&nbsp;below or (II)&nbsp;if a Notice Failure occurs, and, in each case, if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such
exercise (a &ldquo;<B>Buy-In</B>&rdquo;), then the Company shall, within five (5)&nbsp;Trading Days after the Holder&rsquo;s request,
(A)&nbsp;pay in cash to the Holder the amount, if any, by which (x)&nbsp;the Holder&rsquo;s total purchase price (including reasonable
and customary brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y)&nbsp;the amount obtained by multiplying
(1)&nbsp;the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue
times and (2)&nbsp;the price at which the sell order giving rise to such purchase obligation was executed, and (B)&nbsp;at the option
of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored
(in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have
been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases
Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock
with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A)&nbsp;of the immediately preceding sentence
the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable
to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit
a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree
of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock
upon exercise of the Warrant as required pursuant to the terms hereof. The Company&rsquo;s current transfer agent participates in the
DTC Fast Automated Securities Transfer Program (&ldquo;<B>FAST</B>&rdquo;). In the event that the Company changes transfer agents while
this Warrant is outstanding, the Company shall select a transfer agent that participates in FAST. While this Warrant is outstanding, the
Company shall cause its transfer agent to participate in FAST with respect to this Warrant. In addition to the foregoing rights, (i)&nbsp;if
the Company fails to deliver the applicable number of Warrant Shares upon an exercise pursuant to Section&nbsp;1 by the applicable Share
Delivery Date, then the Holder shall have the right to rescind such exercise in whole or in part and retain and/or have the Company return,
as the case may be, any portion of this Warrant that has not been exercised pursuant to such Exercise Notice; provided that the rescission
of an exercise shall not affect the Company&rsquo;s obligation to make any payments that have accrued prior to the date of such notice
pursuant to this Section&nbsp;1(c)&nbsp;or otherwise, and (ii)&nbsp;if a registration statement (which may be the Registration Statement)
covering the issuance or resale of the Warrant Shares that are subject to an Exercise Notice is not available for the issuance or resale,
as applicable, of such Exercise Notice Warrant Shares and the Holder has submitted an Exercise Notice prior to receiving notice of the
non-availability of such registration statement and the Company has not already delivered the Warrant Shares underlying such Exercise
Notice electronically without any restrictive legend by crediting such aggregate number of Warrant Shares to which the Holder is entitled
pursuant to such exercise to the Holder&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit / Withdrawal At Custodian
system, the Holder shall have the option, by delivery of notice to the Company, to (x)&nbsp;rescind such Exercise Notice in whole or in
part and retain or have returned, as the case may be, any portion of this Warrant that has not been exercised pursuant to such Exercise
Notice; provided that the rescission of an Exercise Notice shall not affect the Company&rsquo;s obligation to make any payments that have
accrued prior to the date of such notice pursuant to this Section&nbsp;1(c)&nbsp;or otherwise, and/or (y)&nbsp;switch some or all of such
Exercise Notice from a cash exercise to a Cashless Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Cashless
Exercise</U>. If at the time of exercise hereof, there is no effective registration statement, or the prospectus contained therein is
not available for the issuance or resale of the Warrant Shares to or by the Holder, then this Warrant may also be exercised, in whole
or in part, at such time by means of a &ldquo;cashless exercise&rdquo; (a &ldquo;<B>Cashless Exercise</B>&rdquo;) in which the Holder
shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing (A-B) * (X)&nbsp;by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in">A= as applicable,
(i)&nbsp;the VWAP (as defined herein) on the Trading Day immediately preceding the date of the applicable Exercise Notice if such Exercise
Notice is (1)&nbsp;both executed and delivered pursuant to Section&nbsp;1(a)&nbsp;hereof on a day that is not a Trading Day or (2)&nbsp;both
executed and delivered pursuant to Section&nbsp;1(a)&nbsp;hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo;
(as defined in Rule&nbsp;600(b)(88) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii)&nbsp;at
the option of the Holder, either (y)&nbsp;the VWAP on the Trading Day immediately preceding the date of the applicable Exercise Notice
or (z)&nbsp;the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg as of the time of the Holder&rsquo;s
execution of the applicable Exercise Notice if such Exercise Notice is executed during &ldquo;regular trading hours&rdquo; on a Trading
Day and is delivered within two (2)&nbsp;hours thereafter (including until two (2)&nbsp;hours after the close of &ldquo;regular trading
hours&rdquo; on a Trading Day) pursuant to Section&nbsp;1(a)&nbsp;hereof or (iii)&nbsp;the VWAP on the date of the applicable Exercise
Notice if the date of such Exercise Notice is a Trading Day and such Exercise Notice is both executed and delivered pursuant to Section&nbsp;1(a)&nbsp;hereof
after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in">B= the Exercise
Price of this Warrant, as adjusted hereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in">X= the number
of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were
by means of a cash exercise rather than a cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the Company acknowledges and agrees that in accordance with Section&nbsp;3(a)(9)&nbsp;of
the Securities Act of 1933, as amended, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised.
The Company agrees not to take any position contrary to this Section&nbsp;1(d).<FONT STYLE="background-color: white">&nbsp;</FONT></FONT>Without
limiting the rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise,&rdquo; and to receive the cash payments contemplated
pursuant to Sections 1(c)&nbsp;and 3(b), in no event will the Company be required to net cash settle a Warrant exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Beneficial
Ownership</U>. Notwithstanding anything to the contrary contained herein, the Company shall not effect the exercise of any portion of
this Warrant, and the Holder shall not have the right to exercise any portion of this Warrant, pursuant to the terms and conditions of
this Warrant and any such exercise shall be null and void and treated as if never made, to the extent that after giving effect to such
exercise, the Holder together with the other Attribution Parties collectively would beneficially own in excess of the Maximum Percentage
(as defined below). For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by the Holder
and the other Attribution Parties shall include the number of shares of Common Stock held by the Holder and all other Attribution Parties
plus the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which the determination of such sentence
is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (A)&nbsp;exercise of the remaining,
unexercised portion of this Warrant beneficially owned by the Holder or any of the other Attribution Parties and (B)&nbsp;exercise or
conversion of the unexercised or unconverted portion of any other securities of the Company (including, without limitation, any convertible
notes or convertible preferred stock or warrants, including the other Warrants) beneficially owned by the Holder or any other Attribution
Party subject to a limitation on conversion or exercise analogous to the limitation contained in this Section&nbsp;1(e). For purposes
of this Section&nbsp;1(e), beneficial ownership shall be calculated in accordance with Section&nbsp;13(d)&nbsp;of the Securities Exchange
Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;), it being acknowledged by the Holder that the Company is not representing
to the Holder that such calculation is in compliance with Section&nbsp;13(d)&nbsp;of the Exchange Act and the Holder is solely responsible
for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section&nbsp;1(e)&nbsp;applies,
the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission
of a Exercise Notice shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other
securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable,
in each case subject to the Maximum Percentage, and the Company shall have no obligation to verify or confirm the accuracy of such determination.
In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section&nbsp;13(d)&nbsp;of
the Exchange Act and the rules&nbsp;and regulations promulgated thereunder. For purposes of this Warrant, in determining the number of
outstanding shares of Common Stock the Holder may acquire upon the exercise of this Warrant without exceeding the Maximum Percentage,
the Holder may rely on the number of outstanding shares of Common Stock as reflected in (x)&nbsp;the Company&rsquo;s most recent Annual
Report on Form&nbsp;10-K, Quarterly Report on Form&nbsp;10-Q or other public filing with the Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;),
as the case may be, (y)&nbsp;a more recent public announcement by the Company or (z)&nbsp;any other written notice by the Company or the
Transfer Agent setting forth the number of shares of Common Stock outstanding (the &ldquo;<B>Reported Outstanding Share Number</B>&rdquo;).
If the Company receives an Exercise Notice from the Holder at a time when the actual number of outstanding shares of Common Stock is less
than the Reported Outstanding Share Number, the Company shall (i)&nbsp;notify the Holder in writing of the number of shares of Common
Stock then outstanding and, to the extent that such Exercise Notice would otherwise cause the Holder&rsquo;s beneficial ownership, as
determined pursuant to this Section&nbsp;1(e), to exceed the Maximum Percentage, the Holder must notify the Company of a reduced number
of Warrant Shares to be purchased pursuant to such Exercise Notice (the number of shares by which such purchase is reduced, the &ldquo;<B>Reduction
Shares</B>&rdquo;) and (ii)&nbsp;as soon as reasonably practicable, the Company shall return to the Holder any exercise price paid by
the Holder for the Reduction Shares. For any reason at any time, upon the written or oral request of the Holder, the Company shall within
one (1)&nbsp;Business Day confirm orally and in writing or by electronic mail to the Holder the number of shares of Common Stock then
outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or
exercise of securities of the Company, including this Warrant, by the Holder and any other Attribution Party since the date as of which
the Reported Outstanding Share Number was reported. In the event that the issuance of Common Stock to the Holder upon exercise of this
Warrant results in the Holder and the other Attribution Parties being deemed to beneficially own, in the aggregate, more than the Maximum
Percentage of the number of outstanding shares of Common Stock (as determined under Section&nbsp;13(d)&nbsp;of the Exchange Act), the
number of shares so issued by which the Holder&rsquo;s and the other Attribution Parties&rsquo; aggregate beneficial ownership exceeds
the Maximum Percentage (the &ldquo;<B>Excess Shares</B>&rdquo;) shall be deemed null and void and shall be cancelled ab initio, and the
Holder shall not have the power to vote or to transfer the Excess Shares. As soon as reasonably practicable after the issuance of the
Excess Shares has been deemed null and void, the Company shall return to the Holder the Exercise Price paid by the Holder for the Excess
Shares. The Maximum Percentage shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect
to the issuance of shares of Common Stock issuable upon exercise of this Warrant (the &ldquo;<B>Maximum Percentage</B>&rdquo;). Upon delivery
of a written notice to the Company, the Holder may from time to time increase or decrease the Maximum Percentage to any other percentage
not in excess of 9.99% as specified in such notice; provided that (i)&nbsp;any such increase in the Maximum Percentage will not be effective
until the sixty-first (61<SUP>st</SUP>) day after such notice is delivered to the Company and (ii)&nbsp;any such increase or decrease
will apply only to the Holder and the other Attribution Parties and not to any other holder of Warrants that is not an Attribution Party
of the Holder. For purposes of clarity, the shares of Common Stock issuable pursuant to the terms of this Warrant in excess of the Maximum
Percentage shall not be deemed to be beneficially owned by the Holder for any purpose including for purposes of Section&nbsp;13(d)&nbsp;or
Rule&nbsp;16a-1(a)(1)&nbsp;of the Exchange Act. No prior inability to exercise this Warrant pursuant to this paragraph shall have any
effect on the applicability of the provisions of this paragraph with respect to any subsequent determination of exercisability. The provisions
of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section&nbsp;1(e)&nbsp;to
the extent necessary to correct this paragraph or any portion of this paragraph which may be defective or inconsistent with the intended
beneficial ownership limitation contained in this Section&nbsp;1(e)&nbsp;or to make changes or supplements necessary or desirable to properly
give effect to such limitation. The limitation contained in this paragraph may not be waived and shall apply to a successor holder of
this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>ADJUSTMENT
OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES</U>. The Exercise Price and the number of Warrant Shares shall be adjusted from time to
time as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Voluntary
Adjustment By Company</U>. Subject to the rules&nbsp;and regulations of the Trading Market, the Company may at any time during the term
of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the Board of Directors
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Adjustment
Upon Stock Dividends and Splits</U>. If the Company at any time while this Warrant it outstanding: (i)&nbsp;pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for the avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of
this Warrant), (ii)&nbsp;subdivides outstanding shares of Common Stock into a greater number of shares, (iii)&nbsp;combines (including
by way of reverse stock split) outstanding shares of Common Stock into smaller number of shares, or (iv)&nbsp;issues by reclassification
of shares of the Common Stock any shares of capital stock of the Company, then, in each case, the Exercise Price shall be multiplied by
a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately
before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event,
and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the Exercise Price of this
Warrant shall remain unchanged. Any adjustment under this Section&nbsp;2(b)&nbsp;shall become effective immediately after the record date
for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or reclassification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>RIGHTS
UPON DISTRIBUTION OF ASSETS</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or
otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) other than dividends or distributions
subject to Section&nbsp;2(b)&nbsp;above (a &quot;<B>Distribution</B>&quot;), or other than a reclassification to which Section&nbsp;4(b)&nbsp;applies,
then at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations or restrictions on exercise of this Warrant, including without
limitation, the Maximum Percentage) immediately before the date on which a record is taken for such Distribution, or, if no such record
is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution
(<U>provided</U>, <U>however</U>, that to the extent that the Holder's right to participate in any such Distribution would result in the
Holder and the other Attribution Parties exceeding the Maximum Percentage, then the Holder shall not be entitled to participate in such
Distribution to such extent (and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of such Distribution
(and beneficial ownership) to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder
</FONT>until such time or times as its right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum
Percentage, at which time or times the Holder shall be granted such Distribution (and any Distributions declared or made on such initial
Distribution or on any subsequent Distribution held similarly in abeyance) to the same extent as if there had been no such limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>PURCHASE
RIGHTS; FUNDAMENTAL TRANSACTIONS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Purchase
Rights</U>. If at any time after the Subscription Date and on or prior to the Expiration Date, the Company grants, issues or sells any
Options, Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata to the record holders of
any class of Common Stock (the &ldquo;<B>Purchase Rights</B>&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable
to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares
of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations or restrictions on exercise of this
Warrant, including without limitation, the Maximum Percentage) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Common Stock are to be determined
for the grant, issuance or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that to the extent that the Holder&rsquo;s right
to participate in any such Purchase Right would result in the Holder and the other Attribution Parties exceeding the Maximum Percentage,
then the Holder shall not be entitled to participate in such Purchase Right to such extent (and shall not be entitled to beneficial ownership
of such Common Stock as a result of such Purchase Right (and beneficial ownership) to such extent) and such Purchase Right to such extent
shall be held in abeyance for the benefit of the Holder </FONT>until such time or times as its right thereto would not result in the Holder
and the other Attribution Parties exceeding the Maximum Percentage, at which time or times the Holder shall be granted such right (and
any Purchase Right granted, issued or sold on such initial Purchase Right or on any subsequent Purchase Right to be held similarly in
abeyance) to the same extent as if there had been no such limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Fundamental Transaction.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
at any time while this Warrant is outstanding, (i)&nbsp;the Company, directly or indirectly, in one or more related transactions effects
any merger or consolidation of the Company with or into another Person (other than a reincorporation in a different state), (ii)&nbsp;the
Company (and all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer,
conveyance or other disposition of all or substantially all of the Company&rsquo;s (including its Subsidiaries, taken as a whole) assets
in one or a series of related transactions (which shall not include a license or other agreement granting rights to intellectual property),
(iii)&nbsp;any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed
pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property
and has been accepted by the holders of greater than 50% of the outstanding voting power of the common and preferred equity of the Company,
(iv)&nbsp;the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
of shares of Common Stock or any compulsory share exchange pursuant to which the shares of Common Stock are effectively converted into
or exchanged for other securities, cash or property, or (v)&nbsp;the Company, directly or indirectly, in one more related transactions
consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization,
spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires greater
than 50% of the outstanding voting power of the common and preferred equity of the Company (the &ldquo;<B>Fundamental Transaction</B>&rdquo;),
then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have
been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without
regard to any limitation in Section&nbsp;4(c)&nbsp;on the exercise of this Warrant), the number of shares of Common Stock of the successor
or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<B>Alternate
Consideration</B>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock
for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section&nbsp;4(c)&nbsp;on
the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted
to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock
in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable
manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given
any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same
choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company
shall cause any Successor Entity in a Fundamental Transaction in which the Company is not the survivor to assume in writing all of the
obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section&nbsp;4(b)&nbsp;pursuant
to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay)
prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable
for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common
Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior
to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock
(but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such
shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic
value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in
form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and
be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction
Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power
of the Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the
same effect as if such Successor Entity had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Calculations</U>.
All calculations under Sections 2, 3 and 4 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For
purposes of Sections 2, 3 and 4, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be
the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>NONCIRCUMVENTION</U>.
The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation or Bylaws, or through
any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issuance or sale of securities, or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all
times in good faith carry out all of the provisions of this Warrant and take all action as may be required to protect the rights of the
Holder. Without limiting the generality of the foregoing, the Company (i)&nbsp;shall not increase the par value of any shares of Common
Stock receivable upon the exercise of this Warrant above the Exercise Price then in effect, (ii)&nbsp;shall take all such actions as may
be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock
upon the exercise of this Warrant, and (iii)&nbsp;shall, so long as any of the Warrants are outstanding, take all action necessary to
reserve and keep available out of its authorized and unissued shares of Common Stock, solely for the purpose of effecting the exercise
of the Warrants, the number of shares of Common Stock as shall from time to time be necessary to effect the exercise of the Warrants then
outstanding (without regard to any limitations on exercise).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;[RESERVED]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>REISSUANCE
OF WARRANTS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Transfer
of Warrant</U>. Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder are transferable, in
whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so
assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three Trading Days of the date on which the Holder delivers an assignment form to the Company
assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase
of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section&nbsp;7(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant and shall be identical with
this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<B>Warrant
Register</B>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>NOTICES</U>.
Whenever notice is required to be given under this Warrant, including, without limitation, an Exercise Notice, unless otherwise provided
herein, such notice shall be given in writing, (i)&nbsp;if delivered (a)&nbsp;from within the domestic United States, by first-class registered
or certified airmail, or nationally recognized overnight express courier, postage prepaid or electronic mail or (b)&nbsp;from outside
the United States, by International Federal Express or electronic mail, and (ii)&nbsp;will be deemed given (A)&nbsp;if delivered by first-class
registered or certified mail domestic, three (3)&nbsp;Business Days after so mailed, (B)&nbsp;if delivered by nationally recognized overnight
carrier, one (1)&nbsp;Business Day after so mailed, (C)&nbsp;if delivered by International Federal Express, two (2)&nbsp;Business Days
after so mailed and (D)&nbsp;at the time of transmission, if delivered by electronic mail to each of the email addresses specified in
this Section&nbsp;8 prior to 5:00 p.m.&nbsp;(New York time) on a Trading Day, and (E)&nbsp;the next Trading Day after the date of transmission,
if delivered by electronic mail to each of the email addresses specified in this Section&nbsp;8 on a day that is not a Trading Day or
later than 5:00 p.m.&nbsp;(New York time) on any Trading Day:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
to the Company, to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Plug Power&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">125 Vista Boulevard</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Slingerlands, New York, 12159</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attention: General Counsel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Telephone: (518)&nbsp;782-7700</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Email: [***]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">(ii)&nbsp;if to the Holder, at such address
or other contact information delivered by the Holder to the Company or as is on the books and records of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company will give written notice to the Holder
(i)&nbsp;immediately upon any adjustment of the Exercise Price, setting forth in reasonable detail, and certifying, the calculation of
such adjustment and (ii)&nbsp;at least fifteen (15) days prior to the date on which the Company closes its books or takes a record (A)&nbsp;with
respect to any dividend or distribution upon the shares of Common Stock, (B)&nbsp;with respect to any grants, issuances or sales of any
Options, Convertible Securities or rights to purchase stock, warrants, securities or other property to holders of shares of Common Stock
or (C)&nbsp;for determining rights to vote with respect to any Fundamental Transaction, dissolution or liquidation; <U>provided</U> in
each case that such information shall be made known to the public prior to or in conjunction with such notice being provided to the Holder.
It is expressly understood and agreed that the time of exercise specified by the Holder in each Exercise Notice shall be definitive and
may not be disputed or challenged by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>MISCELLANEOUS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section&nbsp;1(a), except as expressly set
forth in Sections 2, 3 and 4. Without limiting the rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section&nbsp;1(d), or to receive cash payments contemplated by Sections 1(a)&nbsp;and 1(c)&nbsp;herein, in no event will the Company
be required to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Authorized
Shares</U>. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued
Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of this Warrant. The Company
further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing
the necessary Warrant Shares upon the exercise of this Warrant. The Company will take all such reasonable action as may be necessary to
assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements
of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon
the exercise of this Warrant will, upon exercise hereunder and payment for such Warrant Shares in accordance herewith, be duly authorized,
validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue
thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except and to the extent as
waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of
incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any
other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times
in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to
protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company
will (i)&nbsp;not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii)&nbsp;take all such action as may be necessary or appropriate in order that the Company may validly
and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii)&nbsp;use commercially reasonable
efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may
be, necessary to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Before taking any action which
would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company
shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or
bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and construed
and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof.
The Company and, by accepting this Warrant, the Holder each agrees that all legal proceedings concerning the interpretations, enforcement
and defense of the transactions contemplated by this Warrant (whether brought against the Company or the Holder or their respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. The Company and, by accepting this Warrant, the Holder each hereby irrevocably submits to the exclusive
jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute
hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and
agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court,
that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. The Company and, by accepting this Warrant,
the Holder each hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or
proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to it at the address
in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and
notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law. If the Company or the Holder shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing
party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo; fees and other costs
and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. <B>EACH OF THE COMPANY AND EACH
HOLDER HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY&nbsp;HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE
HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS WARRANT OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant or the Underwriting Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which
results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs
and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the
Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Warrant
Agent</U>. [The Company][Broadridge Corporate Issuer Solutions,&nbsp;Inc.] shall initially serve as warrant agent under this Warrant.
Upon ten (10)&nbsp;days&rsquo; notice to the Holder, the Company may appoint a new warrant agent. Any corporation into which the Company
or any new warrant agent may be merged or any corporation resulting from any consolidation to which the Company or any new warrant agent
shall be a party or any corporation to which the Company or any new warrant agent transfers substantially all of its corporate trust or
shareholders services business shall be a successor warrant agent under this Warrant without any further act. Any such successor warrant
agent shall promptly cause notice of its succession as warrant agent to be mailed (by first class mail, postage prepaid) to the Holder
at the Holder&rsquo;s last address as shown on the Warrant Register.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder of this Warrant, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(m)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Headings</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>CERTAIN
DEFINITIONS</U>. For purposes of this Warrant, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Affiliate</B>&rdquo;
means, with respect to any Person, any other Person that directly or indirectly controls, is controlled by, or is under common control
with, such Person, as such terms are used in and construed under Rule&nbsp;405 under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Attribution
Parties</B>&rdquo; means, collectively, the following Persons and entities: (i)&nbsp;any investment vehicle, including, any funds, feeder
funds or managed accounts, currently, or from time to time after the Subscription Date, directly or indirectly managed or advised by the
Holder&rsquo;s investment manager or any of its Affiliates or principals, (ii)&nbsp;any direct or indirect Affiliates of the Holder or
any of the foregoing, (iii)&nbsp;any Person acting or who could be deemed to be acting as a Group together with the Holder or any of the
foregoing and (iv)&nbsp;any other Persons whose beneficial ownership of the Company&rsquo;s Common Stock would or could be aggregated
with the Holder&rsquo;s and the other Attribution Parties for purposes of Section&nbsp;13(d)&nbsp;of the Exchange Act. For clarity, the
purpose of the foregoing is to subject collectively the Holder and all other Attribution Parties to the Maximum Percentage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Bid
Price</B>&rdquo; means, for any security as of the particular time of determination, the bid price for such security on the Principal
Market as reported by Bloomberg as of such time of determination, or, if the Principal Market is not the principal securities exchange
or trading market for such security, the bid price of such security on the principal securities exchange or trading market where such
security is listed or traded as reported by Bloomberg as of such time of determination, or if the foregoing does not apply, the bid price
of such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg as of such
time of determination, or, if no bid price is reported for such security by Bloomberg as of such time of determination, the average of
the bid prices of any market makers for such security as reported on the Pink Open Market as of such time of determination. If the Bid
Price cannot be calculated for a security as of the particular time of determination on any of the foregoing bases, the Bid Price of such
security as of such time of determination shall be the fair market value of such securities as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company. All such determinations shall be appropriately adjusted for any stock dividend,
stock split, stock combination or other similar transaction during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Bloomberg</B>&rdquo;
means Bloomberg Financial Markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Business
Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required
by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any
other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so
long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Change
of Control</B>&rdquo; means any Fundamental Transaction other than (i)&nbsp;any reorganization, recapitalization or reclassification of
the Common Stock in which holders of the Company&rsquo;s voting power immediately prior to such reorganization, recapitalization or reclassification
continue after such reorganization, recapitalization or reclassification to hold publicly traded securities and, directly or indirectly,
are, in all material respect, the holders of the voting power of the surviving entity (or entities with the authority or voting power
to elect the members of the board of directors (or their equivalent if other than a corporation) of such entity or entities) after such
reorganization, recapitalization or reclassification, (ii)&nbsp;pursuant to a migratory merger effected solely for the purpose of changing
the jurisdiction of incorporation of the Company or (iii)&nbsp;a merger in connection with a bona fide acquisition by the Company of any
Person in which (x)&nbsp;the gross consideration paid, directly or indirectly, by the Company in such acquisition is not greater than
50% of the Company&rsquo;s market capitalization as calculated on the date of the consummation of such merger and (y)&nbsp;such merger
does not contemplate a change to the identity of a majority of the board of directors of the Company. Notwithstanding anything herein
to the contrary, any transaction or series of transaction that, directly or indirectly, results in the Company or the Successor Entity
not having Common Stock or common stock, as applicable, registered under the Exchange Act and listed on an Eligible Market shall be deemed
a Change of Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Common
Stock</B>&rdquo; means (i)&nbsp;the Company&rsquo;s Common Stock, par value $0.01 per share, and (ii)&nbsp;any capital stock into which
such Common Stock shall have been changed or any capital stock resulting from a reclassification of such Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Convertible
Securities</B>&rdquo; means any stock or securities (other than Options) directly or indirectly convertible into or exercisable or exchangeable
for shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Eligible
Market</B>&rdquo; means The NASDAQ Capital Market, the NYSE American LLC, The NASDAQ Global Select Market, The NASDAQ Global Market or
The New York Stock Exchange,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="background-color: white">&ldquo;<B>Expiration
Date</B>&rdquo; means the date that is the third anniversary after the date hereof or, if such date falls on a day other than a Business
Day or on which trading does not take place on the Principal Market (a &ldquo;<B>Holiday</B>&rdquo;), the next day that is not a Holiday.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Group</B>&rdquo;
means a &ldquo;group&rdquo; as that term is used in Section&nbsp;13(d)&nbsp;of the Exchange Act and as defined in Rule&nbsp;13d-5 thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Options</B>&rdquo;
means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(m)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Parent
Entity</B>&rdquo; of a Person means an entity that, directly or indirectly, controls the applicable Person, including such entity whose
common stock or equivalent equity security is quoted or listed on an Eligible Market (or, if so elected by the Holder, any other market,
exchange or quotation system), or, if there is more than one such Person or such entity, the Person or such entity designated by the Holder
or in the absence of such designation, such Person or entity with the largest public market capitalization as of the date of consummation
of the Fundamental Transaction or Change of Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(n)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Person</B>&rdquo;
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity and a government or any department or agency thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(o)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Principal
Market</B>&rdquo; means The NASDAQ Capital Market (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(p)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Required
Holders</B>&rdquo; means the holders of the Warrants representing at least a majority of the shares of Common Stock underlying the Warrants
then outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(q)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<B>&ldquo;Standard
Settlement Period&rdquo;</B> means the standard settlement period, expressed in a number of Trading Days, for the Company&rsquo;s primary
trading market or quotation system with respect to the Common Stock that is in effect on the date of receipt of an applicable Exercise
Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(r)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Successor
Entity</B>&rdquo; means one or more Person or Persons (or, if so elected by the Holder, the Company or Parent Entity) formed by, resulting
from or surviving any Fundamental Transaction or Change of Control or one or more Person or Persons (or, if so elected by the Holder,
the Company or the Parent Entity) with which such Fundamental Transaction or Change of Control shall have been entered into.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(s)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Trading
Day</B>&rdquo; means any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal
trading market for the Common Stock, then on the principal securities exchange or securities market on which the Common Stock is then
traded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(t)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Trading
Market</B>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock
Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(u)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>Transaction
Documents</B>&rdquo; means any agreement entered into by and between the Company and the Holder, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&ldquo;<B>VWAP</B>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a)&nbsp;if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m.&nbsp;(New York City time) to 4:02 p.m.&nbsp;(New York City time)), (b)&nbsp;if OTCQB or OTCQX is not a Trading Market, the volume
weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)&nbsp;if
the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The
Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per
share of the Common Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;Follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> - <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF,</B></FONT> the Company has caused this Warrant to purchase Common Stock to be duly executed as of the Issuance Date set
out above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase">Plug Power Inc.</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%">&nbsp;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Name:</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;<FONT>[<I>Signature
Page&nbsp;to Warrant</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>EXHIBIT&nbsp;A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXERCISE NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TO BE EXECUTED BY THE REGISTERED HOLDER TO
EXERCISE THIS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WARRANT TO PURCHASE COMMON STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Plug
Power Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned holder hereby
exercises the right to purchase _________________ shares of Common Stock (&ldquo;<B>Warrant Shares</B>&rdquo;) of <FONT STYLE="text-transform: uppercase">Plug
Power Inc.</FONT>, a corporation organized under the laws of the State of Delaware (the &ldquo;<B>Company</B>&rdquo;), evidenced by the
attached Warrant to Purchase Common Stock (the &ldquo;<B>Warrant</B>&rdquo;). Capitalized terms used herein and not otherwise defined
shall have the respective meanings set forth in the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. Form&nbsp;of Exercise Price.
The Holder intends that payment of the Exercise Price shall be made as:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">____________</TD><TD STYLE="padding-left: 5.4pt; text-align: justify">a &ldquo;<U>Cash Exercise&rdquo;</U> with respect to _________________ Warrant Shares; and/or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">____________</TD><TD STYLE="padding-left: 5.4pt; text-align: justify">a <U>&ldquo;Cashless Exercise&rdquo;</U> with respect to _______________ Warrant Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to Section&nbsp;1(d)&nbsp;the Holder
[is][is not] exercising its option to have the VWAP determined by reference to [the VWAP on the Trading Day immediately preceding the
date of the applicable Exercise Notice] or [the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg
as of the time of the Holder&rsquo;s execution of the applicable Exercise Notice if such Exercise Notice is executed during &ldquo;regular
trading hours&rdquo; on a Trading Day and is delivered within two (2)&nbsp;hours thereafter (including until two (2)&nbsp;hours after
the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section&nbsp;1(d)&nbsp;of the [Warrant]].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. Payment of Exercise Price.
In the event that the holder has elected a Cash Exercise with respect to some or all of the Warrant Shares to be issued pursuant hereto,
the holder shall pay the Aggregate Exercise Price in the sum of $___________________ to the Company in accordance with the terms of the
Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. Delivery of Warrant Shares.
The Company shall deliver to the holder __________ Warrant Shares in accordance with the terms of the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: _______________ __, ______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 70%">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-align: left">Name of Registered Holder</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 27%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 70%">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Name:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ACKNOWLEDGMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company hereby acknowledges
this Exercise Notice and hereby directs Broadridge Corporate Issuer Solutions,&nbsp;Inc. to issue the above indicated number of shares
of Common Stock on or prior to the applicable Share Delivery Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase">Plug Power Inc.</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%">&nbsp;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Name:</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT&nbsp;B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>(To assign the foregoing Warrant, execute this
form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR VALUE RECEIVED, the foregoing Warrant and
all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.5in">(Please Print)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.5in">(Please Print)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Phone Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dated: __________________________________ __,
______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Holder&rsquo;s Signature:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Holder&rsquo;s Address:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>5
<FILENAME>tm259816d1_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>Exhibit 5.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 8pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 8pt; vertical-align: bottom">
    <TD STYLE="text-align: left; font-size: 8pt; width: 80%; vertical-align: top"><FONT STYLE="font-size: 8pt"><IMG SRC="tm259816d1_ex5-1img001.jpg" ALT=""></FONT></TD>
    <TD STYLE="font: 8pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-size: 8pt">Goodwin Procter <FONT STYLE="font-variant: small-caps">llp</FONT><BR>
    The New York Times Building<BR> 620 Eighth Avenue<BR> New York, NY 10018<BR> <BR> goodwinlaw.com<BR> +1 212 813 8800</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March 19, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Plug Power Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">125 Vista Boulevard</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Slingerlands, New York 12159</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">Re:</TD><TD STYLE="text-align: left"><U>Securities Registered under Registration Statement on Form
S-3</U></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have acted as counsel to you in connection with your filing of
a Registration Statement on Form S-3 (File No. 333-265488) (as amended or supplemented, the &ldquo;Registration Statement&rdquo;)
filed on June 8, 2022 with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) pursuant to the Securities Act of
1933, as amended (the &ldquo;Securities Act&rdquo;), relating to the issuance and/or sale from time to time of, among other
securities, common stock, par value $0.01 per share (the &ldquo;Common Stock&rdquo;), and warrants to purchase shares of Common
Stock, of Plug Power Inc., a Delaware corporation (the &ldquo;Company&rdquo;). The Registration Statement became effective upon
filing with the Commission on June 8, 2022. Reference is made to our opinion letter dated June 8, 2022 and included as Exhibit 5.1
to the Registration Statement. We are delivering this supplemental opinion letter in connection with the prospectus supplement (the
&ldquo;Prospectus Supplement&rdquo;) filed on March 19, 2025 by the Company with the Commission pursuant to Rule 424 under the
Securities Act. The Prospectus Supplement relates to the offering by the Company of (i) 46,500,000 shares (the &ldquo;Shares&rdquo;)
of the Company&rsquo;s Common Stock, (ii) 138,930,464 pre-funded warrants to purchase Common Stock (the &ldquo;Pre-Funded
Warrants&rdquo;), (iii) warrants to purchase 185,430,464 shares of Common Stock (the &ldquo;Warrants&rdquo;), and (iv) shares
issuable upon the exercise of the Pre-Funded Warrants and Warrants (such shares, the &ldquo;Warrant Shares&rdquo; and, together with
the Shares, Pre-Funded Warrants and Warrants, the &ldquo;Securities&rdquo;), covered by the Registration Statement. The Shares,
Pre-Funded Warrants and Warrants are being sold to the several underwriters named in, and pursuant to, an underwriting agreement,
dated March 19, 2025 (the &ldquo;Underwriting Agreement&rdquo;), by and between the Company and Oppenheimer &amp; Co. Inc., as
representative of the several underwriters named in Schedule I thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have reviewed such documents and made such examination of law as
we have deemed appropriate to give the opinions set forth below. We have relied, without independent verification, on certificates of
public officials and, as to matters of fact material to the opinions set forth below, on certificates of officers of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For purposes of the opinion set forth in numbered paragraph 3 below,
we have assumed that before the Warrant Shares are issued, the Company does not issue shares of Common Stock or reduce the total number
of shares of Common Stock the Company is authorized to issue under its amended and restated certificate of incorporation, as amended (the
&ldquo;Certificate of Incorporation), such that the number of unissued shares of Common Stock authorized under the Certificate of Incorporation
is less than the number of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The opinions set forth below are limited to the Delaware General Corporation
Law and, with respect to numbered paragraph 2, the law of the State of New York. Based on the foregoing, we are of the opinion that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD>The
Shares have been duly authorized and, when delivered and paid for in accordance with the terms of the Underwriting Agreement, will be
validly issued, fully paid and non-assessable.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD>The
Warrants have been duly authorized by the Company and, when the Warrants are executed by the Company and delivered and paid for in accordance
with the terms of the Underwriting Agreement, will constitute valid and binding obligations of the Company.</TD></TR></TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD>The
Warrant Shares have been duly authorized by the Company and, when issued, delivered and paid for upon exercise of the Warrants in accordance
with the terms of the Warrants, will be validly issued, fully paid and non-assessable.&nbsp;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The opinions expressed above are subject to bankruptcy, insolvency,
fraudulent transfer, reorganization, moratorium and other similar laws of general application affecting the rights and remedies of creditors
and to general principles of equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This opinion letter and the opinions it contains shall be interpreted
in accordance with the Core Opinion Principles as published in 74 <I>Business Lawyer</I> 815 (Summer 2019).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This opinion letter is being furnished to you for submission to the
Commission as an exhibit to the Company&rsquo;s Current Report on Form 8-K, dated March 19, 2025 (the &ldquo;Current Report&rdquo;), which
is incorporated by reference in the Registration Statement. We hereby consent to the filing of this opinion letter as an exhibit to the
Current Report and its incorporation by reference and the reference to our firm in that report. In giving our consent, we do not admit
that we are in the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules and regulations
thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif">Very truly yours,</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">/s/ Goodwin Procter LLP</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">GOODWIN PROCTER LLP</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>plug-20250319.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWayGubOdzZR++YkxtmB8bUkqTy0h6G8kpysx7yGmQe8K -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:plug="http://plugpoweinc/20250319" elementFormDefault="qualified" targetNamespace="http://plugpoweinc/20250319">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://plugpoweinc/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="plug-20250319_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="plug-20250319_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>plug-20250319_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>plug-20250319_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://plugpoweinc/role/Cover" xlink:href="plug-20250319.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://plugpoweinc/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tm259816d1_ex5-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm259816d1_ex5-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  [ ,@# 2(  A$! Q$!_\0
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M>E)L/.&SC@X7VS_?],'Z'GOC['VU3^FO\CXKDEY?>:N1ZC\Q1D>H_,5E!<G
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MK>0>9IFHP^'=*U;X;:3X*TW584ENM!L?$GCFY\1:SILEMJTFA:1%-Y==_P#
M'_@MO\:/!7QZT#]FW_@I]^RTW[)GB_Q[=:<G@;XDZ0_B32? 4PU&]BTRUD\2
MZ1XHOO$D=MX:;5);2SE\<^'_ !YK6D:=?WB:?K]GH,:C4Y_KK_@A);?#:#_@
MF1^SM-\/VT'[5J3^/;OXC'3'M#<WGQ3;QQK=MXB_MXVLCNVN6FGV^BVWF7S/
M=1Z.NC+&R0A(F^._^#F^T^$<_P"Q)X#O/%TNC)\4[;XN6L'PJN+FX3_A(?\
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M90=T,]O$SE9(Q)E6(^*=9U[_ ()^_P#!/B74-1L-/\.Z3\0=9>XO!I/A]_\
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MQ-\%Z/XPT6.9;F.TU7[2CPW(58Q+!<V=Q;S0%U1!*D6P2$ L^%5:ZOPI\/\
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ME]F/H?\ OH?_ !-'V8^A_P"^A_\ $U=HHT[+[E_D'/+O^"*7V8^A_P"^A_\
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*14P@H*RO\R3_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Mar. 19, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 19,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-34392<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Plug Power Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001093691<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">22-3672377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">125 Vista Boulevard<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Slingerlands<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">12159<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">518<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">782-7700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PLUG<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( /VD<UI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( /VD<UJ^_:(A[P   "L"   1
M9&]C4')O<',O8V]R92YX;6S-DL]JPS ,AU]E^)[(2>B@)O5EI:<-!BML[&9L
MM36+_V!K)'W[)5F;,K8'V-'2SY\^@5H=A0X)GU.(F,ABOAM<Y[/0<<-.1%$
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M@2";_-;;I/;=X Q\U*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F
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M    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0
M   ( /VD<UJ^_:(A[P   "L"   1              "  <,   !D;V-0<F]P
M<R]C;W)E+GAM;%!+ 0(4 Q0    ( /VD<UJ97)PC$ 8  )PG   3
M      "  >$!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ _:1S
M6H %'>)%!   ?!   !@              ("!(@@  'AL+W=O<FMS:&5E=',O
M<VAE970Q+GAM;%!+ 0(4 Q0    ( /VD<UJ?H!OPL0(  .(,   -
M      "  9T,  !X;"]S='EL97,N>&UL4$L! A0#%     @ _:1S6I>*NQS
M    $P(   L              ( !>0\  %]R96QS+RYR96QS4$L! A0#%
M  @ _:1S6JK$(A8S 0  (@(   \              ( !8A   'AL+W=O<FMB
M;V]K+GAM;%!+ 0(4 Q0    ( /VD<UHD'INBK0   /@!   :
M  "  <(1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (
M /VD<UIED'F2&0$  ,\#   3              "  :<2  !;0V]N=&5N=%]4
?>7!E<UTN>&UL4$L%!@     )  D /@(  /$3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm259816d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://plugpoweinc/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>plug-20250319.xsd</File>
    <File>plug-20250319_lab.xml</File>
    <File>plug-20250319_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm259816d1_8k.htm">tm259816d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm259816d1_8k.htm": {
   "nsprefix": "plug",
   "nsuri": "http://plugpoweinc/20250319",
   "dts": {
    "schema": {
     "local": [
      "plug-20250319.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "plug-20250319_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "plug-20250319_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm259816d1_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://plugpoweinc/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-19",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm259816d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-03-19",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm259816d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://plugpoweinc/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001104659-25-025700-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-25-025700-xbrl.zip
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M3,Z@PAA\%;PSR/'MA0$-T&XR=$0$A-X F] -AR(2%:$?4!F,&M&>SL^R0Q9
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M- VBIJ;O-#5UZRXX1(NXPZRHK8HPPPK9UW?GQXOF07[[1=-:X%';'SK>F 9
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MBR/P$_5N69!ECY^JE"*2CGW;0"\>/,LYT7D"$KK<DNF(\5U_F<2@Z1- )H0
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MAG_C4"O;$FQ_U"Q^A-%\MATB;^F9Q_#^T.7'SO<<F +@0!8_C6!R'8Q5S67
M, >Y] PCV.Q#/>^A/\IOBGL3PP42T7;ZX.M8%(-+=/9\X>AAKB@P@S#@MHQ+
MN"4E/"$VJ+NECX?Y5ZF^+[DN-"?(*0FO\AA^R L:SADWD'&&<:=55> #9HX!
MA- *1/1MF,A@)#J_C>Z=X&P',Z]RYR<OI(C<3C&@F+Z40^.,$^J93HAY(A1S
M7@P';\[Q_*IR<<](ICUQK EW%C%J1\H1S_1OA="&MDPI"F\3$Q"</$2G43$Q
M*_A2H\AUES&USK<2PT@*)OCT$8J#F!QLFL2)#P$H#PCL((T6247<*>'A^BQS
M46HJ7E:5\'47+"3*EX*<@]6[$9*>"BL&H!HQ?\/]9EX6*LO$& [H,9&.DNF9
MN)"TC+%$RS$_D)"L BG 6#Y+Z)I8=E:G $USV0*AL<Z,7DGA1A<5PQ1,$@U#
MS!DMY<BD<)T##.10\%$D7[YT<I9"HOSR91&B1,%P42'L=;'4ERYS\IS5%/=]
M893$\2.<(X$7<>^-Q BNZ)XB9*^;M5@=VT;4I4VCHM;QSA9IZ_ +*HBH$APP
MG>&M1J2A<OB:L?M=+%F<R8Q5C'$<F.9FU"8FF_HR6$S4O.X;M8JU5BP5\;U]
M/T+3$PBRZ#3M=_*@&<N>6*L0&P9$\L]+W$*#9>K0%5-[1&P5YVG-.Z3PM7I+
MT2[6G6I=K9+#>+M[PME+Q&K^*]Z]6FIO&'*G?0+:ISO>_G)GVO%PWH-/M=^7
M/I6S;_^ZYN.\DA;BQ*ZXMNV^P]$2BXL,9N*@P#V79*ZXRIWZLQV^SS^'S$FX
MRI6+,! EXJM1@['6VME6-PWUFLW4BEH=!>.8S?" 8@46A+FKW2BCL,[UJ%4U
M7@9]V G3!U]J^FH6790GRMN,5$:#PE.9W)/*;G+'-\^RZ[R:)=.#.>X1]/IK
M7=8D$\WG9H_F*Y")9U_T86Y^])_,==IS<YWV"KCNF1=]6)AV_[DY;U4WKH .
MK>>6_E:QRLM#RFL!^W11+,BI#]S%0BL3*&_U]SS[B?E :_R<C-!U;)Y<R&<$
MLI%*YR0*3V]^*AY9G]=?;^9%:OD47B.18(E\KPP>J66\'@\.\0$-*/^^*[*!
M"2C#2&;.^K8%9"-?WYT?$T-^5VJ":$E,1G>>K.-8\<M]\?&]NZP:_ZP-58U_
M[(:J%_G6[8O^^Y/.Y=5Y[WF_%';M=75>5D]^H;>H%/ <L<A_KG9YCZR*I*\E
M@<A\+LH3ADA1BUR]W,Z+E1ZLYH@](@,VHM8P2MOS:%\VP+@^Q//O?#@:!B/'
M S$SGFROP?)6@U>=\N1._-*5B&+H5OWNA&%TM>%*K9I;Z\Z.+GTO=&&R<*7%
M/Y&#D9YC?0C KS#?S:31<MV-]4WY;KY[5^HY8Q,':9NX3N+7_!H8K] BGTS#
ML%B WU3Z#(1?WP(B^_L3+X$GZ'=)=V2R8:+V=<J_6\F[TW=\?=6O^QW"9F+;
M_3%^8\H_P"MLKNP5/I&/EJ%S:@E!!._,F.V1_@'_Y;J^_>Z:GW,17UV"8/!N
M[./L\+O1.[JY[7P^']0ZP]EW[?1J_M4]Z\]^?+OQ/YL?-[]^/3KZ:&CGFM[P
M;VO>\8EY1=\Y@U'#/IWTNJ<SU_TCO#U]OWWTH=_\%JA7<[-WQ7I?WNOU#Y/Y
MP6!P>#8-MH]H\$W[HM=J6YWO!_,#^];J'EWLL,TC+0@L<]SK-3YL?YWZ'V<'
M)_7QY^ZH5>]/;/=]ZX=[?-+;]+KN9[>I'USY/6K_^^#J]L/AEP^CT/WZM?&E
M&[CNIZ[=^W8P[ _^A%!-.SSU;/^\T6V,F?G'P=7E_."/RW[M?=BBQN?:)^O;
M%VNTQ2;^Y[/MQK\[G<_=W@]=8*0V<(PY_AP%8ZO]_U!+ P04    " #]I'-:
MISJ[D_1Q  #NI0( %    '1M,C4Y.#$V9#%?97@Q+3$N:'1M[7WI<]O&EN]W
M5>E_P/.[DY*G($6K[3@>5\E;HAG']K.=>^?6U'P "9!"# (,%BF\?_T[6W>?
MQD)2MNA(L::F;BP2;/1R^NSG=Y[\_/&7UT^WMY[\_/+T!?PWP/][\O'LX^N7
M3Y]\S_^%;[^7KY\\>_OBG\&'C_]\_?(_[DV*O'X<'.S/Z^!C.DNJX$UR&;PO
M9E$>\@=A\"$IT\D]^"'\])WY79W\4>]&63K-'P=E.CVO?PQF43E-X<_]>T^?
M/'OZ\H_S=)36P<'>P9/OG\$\WK5&4(]_EX^J^8_=1]:=G'HW/+K_8Z!G-T[R
M.BEI3N]>__I3\.[M/UZ^#\[>/-_KG]=GOO1KK>+5VS<?]<B[DVB69HO'J\:F
M9ZOT7PE/14:ORRBO)D4Y>QPT\WE2CJ,JH:TZ?A">[.^'^_O[VUL?SJ,2ABXF
M >\83@&?>?[VEU_>OH')O'W^7V'P[O1]\/?3U[^^#/ZVO[=_$+R#7?[P\^G[
ME[=^FY?OU#^B$KZJJ^VMN@C>->7X'+X)#AZ=A,='^^'Q@^/ [=_S8C8K\N!#
M78P_Z;W\Z^[.Z9L7W\9"WY7)[J3)XR3>WC(D$7@4<?0H_.$O2Q'/GO[ZYL7+
M]_]X?_;Q[,U/P>E/[U^^_.7EFX\W^_+?<W/[/[N[P:LTR>+'P;MHFOP(S__>
M)/D8^66PNRMB]<F+L[_[ FRW+N;PR.'<2L#=45'7!1#( _QL5)1Q4MK/GF71
M^%-P "^OBBR-80+>&KH<VMMH^PIZZ7[/.^&S>T\#7-63[V&N/=,>E4GT:7>4
M !'#F^:T5CWJ@YY1<7EZJFH3]9EXKU0;^CWN*&_B3:0"?Z=)F[GW])<([BV_
MZ."',#C</SRYR73\%IA1?I[ (R6/_5TTF_\([&4O.,O'>]?XIM,J*),YL"^@
MR*A.+Q)D8_5Y$E3)15)&68!,L+PL4Z#7ZAK?FT>S) Y2X)7C\R1NLB0X"\Z3
M,JF+FWLN0EDI[ C^?G_O),WO/1U_7P1?Z[SZ9_#H)'A6%E$,<J=,DGK#;\/?
M_K,H/X6!^1>,O+]_?'//[=[3UU&<PN-1'@<_P5JR9);DCV_RA-]ES31X5UPF
M)1%0&$3!BR2++D'1",9%.2]*N*R@:>S@5?TNBW]OBA]1AR]F\RA?H)C^KJ0/
M[X?;6_.RF!=50@I,6E5-0AM1)5F&G^C+_JNZ[,'P%6V_]E>/1ZAW@YU2!I?G
MQ6S@AFQOF2L2[+CAU+-JM "&\E_[WF-<^L6PS" :UVD^#:(V@PN#G?0^ST&;
M1955XE)0]<:LR%6HR(4@5LO@(LI@X]@8 DTQH.?;&\&:H+\%.ZEYW:52).=]
MI@7/87NKI4D&40TG%B1_@(*:PD_F93HF/OVWP[W]_>'9R!A&?_4V""D 9F:F
M-K?Z;G"I+:!YG[Y;]>J[P[.$/5NV:4[7[IOJ]A9,-80MFR;P,Z"FM#XG.FBM
M+FP11]^JKU-P7K_N>DV^@'M//YXGFIZ]0R)QGBWP9N!^6=L&SP4O=YI'$[C&
M<&<F25G"D0 1P!52>RL_$:MGS]Q.>*E\%'HCT_GI3XRYM/X;/R3C!I@+<'!Y
MV9[85?Q2^RWR*OP9675X_6'5EREPN5&"^CF8<C"NO?Q%+A.FNX!_1>,Q\T_<
M'9^\O"N+SWJ+0=;DKCE^C33]RJ-I/0+<\,X07SR)/=H-V-EY,B9%+IH5#1ZM
M*'3F<-S4E&F+;V]=*'P;;)QY81R,%D$2C<_;"J(G,W E55(CWX=K6LQ![L 7
M^'Q:DD"!Z?0(E&_I8AKR[]EQ0ZPDI%%"@^")ZB1;!*.FMM^Z$[%,D0@_Q:.&
M.T12#T:GPP(VP+^2*Y/.0*BG-"CP"'K!*#,* 1THO(W=(@E_U<QABCBC",QG
M)K(N=7_!>D _^:P%J94$G[&0;XCBX&;.+!NPAV,WLFI&50T?I;1E50IO GU'
M-,-713D3MC:Q_":JZPBO,/+I)[^:X  _]NS)][\^-=>:J,6\'B8R0#L;FLIS
M/14K,@J>!U@V";)4_)K85@YB)XY3E!IMKI:E59W$+<Y5$*'6YZ#S*(4U9#F&
MKB;BH+,FJ],Y_, ;D!:\O04KCM.J3*91B?MA!"5N6. KM[B\!F\(2TS9L?/H
M(F%>#)PUF"51+AJO>AF?@=,&.IKM]E:O:AL:@A&;0L1!T=1X0C&]B.3V-+W
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M+5D<41V'^QKH%CY+)^F8=% Z.SJGHKVAUW$4P>!)D#[T58\"+\']H8/H5\]
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MB[0L<G-9SZ-_165<2)5Y\0=B_3$*+15A8K%#5-5X8O,BRYHZDJ(TBA+-4,&
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M\!F&[O96G]:^EJ$[..F47"LN@9&FRD:6"AR_(\5(LW.+V\ ):U709ZUA2\V
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M<&N$A&1D:&TS^?#[.LEU1I^4:WD);<L2X$(*CCG7/4'5R%\2I,P6MCL+1NA
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MI$E:\+GNF+_F=()48%#IR5.'6LI9<XU3"$H%V_T59=K,*'SM(,U&44YYVVB
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M-E-<3-C2F602G&;+[K<176^;61FN@IT1IA>.\7\P!H$F*1]TR8HR%8K&19X
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M=1VEW/Z]4DYO))N; Q3KCJR>Q4N09*!$\/0F*-WPE:PN!VIIU-1*\=D5"N8
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MX>W#$B3E^%ET"#R&-P/L#5CB(R]I27^%WT0/OZ14?:1\(#!B[R:KRBAQDH2
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MN$CP9^=6XHGR:OSX/DX2Q>!ED1?$2C:\'/7@Z3 +"-X\1L? 9),C6VVGL=K
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MD^)7?JJK"LG%_@T+L9W)MCIL;"2.X52U>BJ$E^UV7;#)Z*KEODUO0'J-[VS
M4M7P=>%*8-,;MM1DR&L0!COW#$UP.M M#,I-*9)JD'15:'#2\*86GGWC5LF3
MCA.QU44@M=5,(4V.W6+/XXUNX7RAS=1T\3K>"&HL11HYG!<J]<:&:&G&93S7
M<VJ$CC9$P; 62'(&(YCWU\YN*QK>Q'Z=%!R7K&O&^G'>Y?:=::YN;2Y>7S9
M.%W\ZX")\PQ4S'"%8LL)F6W]>NO[[_]KE7(ALVQ7X;R^>$T&9]PL'O;W'_+:
M!J357)I?%/D&7Z;%(F*X![INHV[$-TQ8=T1=4:I+D?$B921<6R[_[K@)8F&*
MC>"X^9%&O7C ]W0083L3I[0BK ,Q:J,)F9B)I7G7? RR\7EBTZ;1DZRMYZKT
M7;U\*%V/O@G;'F$"IP/^D9M<K,[.#X%NTYBJLX=83(X79#XG4S!;M@#,W.RC
MED0$N^NVR8?M&^[FH.9-J1A 'S3M[7$6 Q$)L=Q$T.W!L);\G];@D"=S/#Q@
MS\]THY]:G8RR#$=]F :+ZY1'H)O8G->=;^*'F$QG-+<6<47]$SCE-LT-4'I'
M;].FL6"0>EW?$ %M^\U%->O0%/81WU^!_-L*)&T!R)L>.N/IHB&8J]H!K(\]
MG/$Y*7=53;53I+[.I%&YPOS/P%9/G%HHUCGPYE,5(*G !<RE7G;EA'5X<KE-
ME['X\@1I2_)PQD59<I38F[-22.#Q<[;-K4"=)%IU0<>+Z\2,(HVL$=O'B!EA
MC+:J$>_CH&8!3K5J6M).^(/: +YR5DJ\I4I+A3& $YNC.Z??0[3E( ;LS(;/
M=^7L[)[@;LB%),!R5VUA5D:1'Q@"IU4X_,B/?G_RN3M/_G*Y.T^^Y.[<=8KG
MH[OI?#_<_Y\WIV>O1X=G_=[1BVCTK]')WL'I*#H^.=@;1</#_>CPS>O=T4D$
M7_X\/#D98O[BR^')Z)33>LZ:.KMJ+YU54[8[BR92NZHG@T*A?LB@]=4]KHVZ
M3296?#>5AC\5&>BX,=H 0PN#O;M4/96/+6@-LR(P4QAD0J>$Q3?I*'+B-+N7
M@A(5X%9IL.X-]!WR ^C#52"9@)!$71$4()R84>VX-RR^EP9D_1"$$,B],B5K
MGE7"W0*[RL)S^]3-J"@KH_%J'^7/@[KN"-+=DE2_1Q8G6P#[IK\.GM(I**FU
M1>[VC"2'3*Y;<')JU^A^:BV_.8']25*+=N[QP!.Q)\U;M(PBTR-'TDW<ORD+
MVIHQ"-C@F_QNCHL@/A7F7P[.F^.NU/X\J;ZYB<+(B":V5V:,?A%U$TR*Q7D]
M<"P>S3$3=TF7R96$G<$:#@5?[]ITJ^O !N!MK-:*_^2DVFGSP-![,G"KIL;%
M[!P=VTY&$]5K7,=DL6"S(&QDQ4=9(:ELKCV%:@9[U#H!JMRZ,AB]L#L5]T@!
M [:J&.M5,QI6N'S\+1_'\Q1QYB27*G!+UPJNZT"&MKBPC+03_$5N18989=IO
MSZ8@B-A,RK@NG-9<:_GV-S@GCS@O>AD6Y=+LCL)*=GBTT&JA)O*<CWJEL##>
MO.#&%60IWGIFJ_UH=LR!3<-LO'--IYF9&$H"MNYD+%4UN,1<W?7!634<\>JM
MQ%1$S.XC0VRR%0WSI=MEPFG2Z%ESCY O\WV3B5%'5EO&W]P.$L?4;8OB%)PS
M5;>E*#F-NJK6PG7.%'&8I<<979_S.K-27P0^,!$D,A.M+[AO'?&4BI)0F V8
M_E#A1?S4Q>Z'K<)Z?#?*_LG!CR_/3D%R'Q\=1OL'IV<G![MOS@[@#]#NAZ>G
MHS/1ZO=9@[-P#)29L0+0+O7%/-/5!,^\)*^)@=QQR!%X,8E97UZS4 922> _
MV(-+:IQ0 $EVCGU@$S_6*]#)@!C,5\4/!1X<YFXF0DZI==)PPPECJ=+ )MR&
M:8 #<<>P*L'E[)4SI=AL"C# :HXX3-AY+;PQ Z?5,_!W/(<+ ?W =$JN%W<^
M=J8"\Y?J7L6=WG0;;OK=$5UM">9C#84.SL9I8XC @0 8U'/>>04%*>B+3:>U
MH=1FADNTR>G>6%_;L=RD32],WQFK<@/&OL26+-B@%*(5"B0 8*1?NJLTX1_L
MH==(3Y4W6W1=]WT.+(L'@8N8NU0_L):(Y:O!<*PD(2F7-ZE79+!M*'EC_+.<
MJ+5EB5T:/PI(F^C.W8T=&^W/I591B+<]3+/IR1K10DR,OE"LEEA%(@R(A9>Y
MZ<7B'<- L?3S0B'ON-FY_FS0&O]W9>Z-S,3IA>S$MU5(.W#]1=Y!*AMA>\2H
MO3MB>ZXSD\?_YT+;^L1I(D_NJ$)\TJ9505G7#C?=F.7(=GSC&FG\;?55ZO>\
MJ5J4/EKYAE546E[7ZFXWA2R=B91NQ]JV(\(QVUZ]&<QNTVR>$TMH[KYA*G2C
M\9#.DR7Q*"4<'BS()0)EAJM_.6IIQ3'^*)5VS2@-A1:D=S&?-5<"..>]?G2Q
M];C=\-S P6;WYM/&2"^0/ZCF[6W+AN;L['LFNN@-$U8<)HE!H*!D",QDW0],
M_"(/ UO>$[3K(@6SI;O_FU$+X^8B.]I-8L.4V9 W@B>;]UB'72^0\<U?+I#Q
MS9= QEU;25_?C6US_.9D[^7P=-3OL97S+'KQYG!_B)&-X:OH[&1X>#K<0UN'
M39S[>W7_G!Z0=Q&=< Y+$HGAL,BZ<\$06S3Z4^#KXS)E(##J,$7>J69?JM&[
M>2J8B 8\W!BE%UH&R=Y!5""3+*LXST*:\0[@:5M-Z=0T>(:HR8.NV+RT)9:5
M]PM)AE+K#_Z!X#2QB;J$*B?ZOY81V41-]YZ?#J8[&.D&MO;34<LC;9HT8DP[
MZ<U2NFZ K<BH(9D7#!:67P=?-]&8Q];RD6$GM[%VFOYT:^Y$=VKM&,=@B[D3
M?61K!Y^[D+'%PB5@.D7I;#^I5H,H>B][Z$8KR/HJ@WE&-TPS^A FD=_S@XBW
MRS+RAV^SC?Z@KMPH 'MOVRB<ZQ\VCFQ_S!MMHF#H6QI%-\_>P5V]G5T4?02S
M:!T(B)O-X/<UBTJSPRP#@GV39P<:]\/[5&23T# *?]9J&36/1/??M9!@&E],
M)%"/OOW+F4C??C&1/M/\C1>+?() %#5#TFHLX /99X@D>%-Z1Q U\O"@35Q]
M0JDZV9*S;?4O\MMC 1TZA;@0F,O6G:A&)3',BIGH+"DO&+<$4W;QHIG8J6L7
M4!(OC45*(;-_8.I8"+@1Q"LP^Y>#,.+?Q> -C$GI2P3#[F59U&Z?IPV#_<,Q
M+K1J4E &2XH1L:)'8IBPT3>[-T(6R8R=6F!G"84Q0'%/<NHR46'K$@X.:0G0
M0/!KEJJ1F>B;03#$ !)U621Y46.'3RY'Y$D[FV:4+0?)=XTU2=B.(!3D+&.P
MF4JI^FL]4ND&U)(>H^NUBR&(1@I^D<2TS:ZHMQOP3H*NPO)G-<HV"9;<+=O0
M?7=W?> T\\/3AJ4EW+ 6_V),&RD&X$\V%.FB65_N4QCU.E?S)<!3Y(6OTL#G
MJ'E3JR#4K!+LF:H3<Z8$PZ6F0=RT-4)):(N%M559&S)E7?%XG,QKFW#DS$ES
M@NB*/-DV%59NTL=504?!!6KR_9C7@L-8T"+-N/(S;?"$KCX2IY"JWS#46B9%
M>1'GZ?^Y"0P<,);/@DRBMBPR/-9%5A6:B&-/I'G*=7=Y#?U24R\R@P)%.?J8
M+NL<]63-X^5\J??9T\X-)>Y2+68S1ERQX7!>NKD_]HJ:F9YK);2;,W)C(#XX
MHT'CA"2:_I"BZ586M ;+-Q4WQN/^\#0CIL##_%'%[1K.Q9!L?UI\')7>#8%-
M^"B7(_0+=<CX &B# ^'2K<^S#KKCNPT;IJT%'R4><9XCQ=B]S.^HN\FL=>4$
M[?L\Z'ZWH\&8DX;'UJG0L?2!=EAI:R1@_$+]7I=C""D_2$<PK9U6@\1LA@7U
M7>R"9V0*9^A*,Q$A9;@:1U&&S!'ML)14*WY'><5UJ<ZO!J8V7C&"8(>HB@D[
M,]0MT"S##,@VI_2S/?<YKZ293YL+A5N\!QW'@2(D=DH5U]DA=BPIH^R&CFJE
MEI63N=$MN/+TM>ZLX_B;U90-S,]!>VI?2VJB+9JP6>Y.7B/YNTP5%HUA#C'R
MSC Z)T 0K2@T+7:['C?7TV_LB\* 67OCL-1UU7TA6P&Q8/820V]9/LQ3W"Z=
M\V0-W39<EX)#P4PRD-D$+0:<ZPK->CT4J\2CT(:UY;5)$.X8D.(5JY0S++W+
MQ:5_6= B#-#A*N$L+AEAIE(]V;F7[<[%<QG>.&Y /(=SZ-S(VD(,&1'1Z5CG
M(AV3+=AE8X;XO[0OK0# !J."\Y I06[5ZGW=>@DFB-8?CM 5*M1EI$#8345;
M+;I\Q#5C85I2GB+M*TEWDBXGC[>Q4%QZE0QT&:P%.5>YD_N(=QZUJ5*1")TF
M(VT@5T6C_TC'VS<=H\4_L0 CZIP:(=J3</*"'/; /1;<?E?LQ#H=HV57L9<L
M:F+ZZH0-G&NT#IBK\E9W-\*=745O%D)@$$D<@6,()E6UZTRD6%[;V#@&O.U[
MC91:9&X,B.KKD3%?-:HRS,^:M4@#_](2$D!'$S(\-+])<P>Y#YPN0KI[M]FY
M@?7UULLY&5%8EJVO,6Q"DJ12RV*<G/M-<]W:B*1H8N=VXFLK@ $CVY!Q+87'
M! VBM=]=?#A0E@GD%*0"'[6IWN[<"HM7&=>!QF1A-7%[R!H,\H#%!#063:T=
M_4B7T1=WS]W($*9^9M\!28A<C(65$\0%SJ=JG-<MU^Y>H.FBQ,GJ871+/7^W
M@<67"=T,/384<G$Z42QC?W*KB9*^[1I7X]L6)T+:V+($1=.4GO;J>!IR0AQ-
M\I?3?5JI9SU1MWG38J2MB#34T.FT711=%R7!8<(X9K\;2!]T([J%&K:;XP)S
MN3<T0Y:-5&^_-PTD&0Y-X@=?9_RQ4Z0O%Z#,L)0@UDJ89%I-XOD].YG/"J(+
M&JXP5V1<OE;)ODHS\AL]!@C)UE1B&R$&'7>6.)!K0+O6YVD16ANHW4[ACXOM
M;\.([HSVB_&"D1LZ6B UD3SZO8Y,>,^#)# _QK5" Q#7YD L^7+'B0OS5,%Z
MJFF,8J@-?2:0948E,/;2(K>J-F+B4)^UM4PN$[%>:9@/%&C'GQR#[ZH;C8/$
M[MZK8KWLO.4)U3J,>6D6(BDE[!*ZD+[O6XLG6G=4\OY=7%@BN< NI;)EQB)!
M,&S6&%ILWD:](6UDDU$5W*!\'I/%0NK"<K/?<\I3U<RXJ5H@XG)O8\C? $FU
M1A+-34;Q>E3"-J+XY$)H1\F2X5H0WP/##QC\8)O"U+7)&]C3H([?4@"# D#2
MW+W=5ERQJ0V$36=I BCKW !\D7GKJAF*Z+N97$S.1; 9K#E-%=E649'@]W#%
M:\<R3H!3%S.P-YS5NKZ6+E?<;;3+33K8?L]<DRZ6U,[ /%X@F&=-;Z#QLJQ4
M<4^MN\TU%-D-1UH$$^%YPA-(:^J^B!NY416L"[$*ED^<7$6OZ^/*";1Q^]L(
M$78,.Q:T^.^,W<$-O;2$=4HHNU6=Q :Z+.0L>CJH^Q@J0MMI*3Y>TKM=1[4+
M?B9>'!:E'T9\^O?&+MU(3,Y)87@CSDEI9YDV1R6><1L==QI<@/7)YZI\]Y?+
M5?GN2Z[*GY"K,KX;K)$]VZ"$$\3[O2'9 _9C'U>VBAX-HL?$0;YV8!?0>!*&
MER<H.VNB3<%Z-Y_M?+6SO8V9(%3*CD)V$#4!Z<FG;Z2HBR+HCKYFX,?#-934
M/LIL=S'-I;TC>P)(NNC26-,"=KMN'&4MC(CV>=QCYKAV)<J3NZE$.3PZW#LX
MV7OS^J?1(1:<".V>!0+G''T@<*:$TQFV3'6EDR*94AD[-1)2OP'!UV"Q B4N
MD-IQD ?APMTE=EL?,+67Q>+BDD,28?3<=2MPEL[ 3YO2&'I'N3EF#H#$S:00
MMS7UVPEZ%"5/@Q6<*P6MBHSZ3[C(5*.1$'@V?\#Z1)645_KR>5*BHA@[NI_<
MAE;T434L4%.I44MAN#&RF"^* O2[&'6+,3R]1/IW%9D6H$U/:R&, WRQJ/F5
M.I'<)D>B=-O N2I%:F-O13^[Z0ZJG5\D>5+&+NZGZ8OGAT&,$\?+F++8O6 U
M^K&OKO8*H5FXRJR3YC$M@3N*3Z'13DJ:!T%D6_6*WGT9:78.[QTF"/@HER[$
M%V:DE*U]L'#;88GI1*#T,S!7T98GUA9-%_AO<41B0GB.]%Z9GDFM >@;=V"@
M+C!O>0/$*\\*YN,.;1J 7@J@NCF1(16Y<*:8I("TSV;[VR29.UX_I!CA"?$"
M"*@$O8Q7N,B%IW?!8TBK+E/$;DU$R3M2"]$T1P^6L::\BQ7[KPDU[1TT N>V
M=_?T]JX.NQFLYZ P+[S/V>EK"[5O[D"H_7HR.AV=_#3:_^TSV+!O[PAK9W1P
M>OIF>+@W(F!-P<[\C(I/[PK04ELQN5UN&B"6XZ!U(?DD;(C<*<MD;:C9C1=]
M)"R.C?>0B]QD>.Y'@R$32F7F]$BJV!IHXAIZH$Q6D_O^6M0'D,/I'"NGIE.#
M-N8%=)%Y(Y#S1<X=V2XX@]OO;:<^:^R7I6G>C3%])[83J839U#&V7XRD+&JR
MR,C;,UXX";ZVY2?)DPNQE^"W19DG+%4YS%0M<#$IE7-1"=N2<R=,XXGXG8.1
M:,3HC%VNZBC3Q\6GQPY1LZ'4URF=&CU*?*(206OI+T&M97!!-%&-),0@8JYM
MBH%M?JK[@\XADV!!>YMPCKK\N^)>GH:N!MJHAQQ_BH\GBK?[-P(I-9H=."$'
MUKE-RK[UIK'&(M8K/U*$"Y&(A@KIKI0*5 2K0HD&-Y%=;0WT/&S%-Z\Y%<'T
M(EG1P%O@BQII/ X=>16*>HI,+Y?+"C:3(BWFO+U)!6T6%CEV(G-?CEGJNJC
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M6KQU3Z,?.7H/Y[_(JR3["(.= 8N87P([?QIM/-GY3KC/M]\]>OCMM]O;'V'
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M,L;=@#"OTS"(6+TQ=Z84S&6$#A]1[*JHD]8.VYUU'TZ.),XM2_^SD/3*9U&
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M34EBDS*/CUL63ODW_A+5EB3W-G*B<5F\90O2.(4IT0)NT"+)4==_F]0<+)3
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MHED_OZMC^&$)/] _".-L]FW-0+*3Q-09Z.@"]PC ^<-Y&&2$CJRN?(F@8MA
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M(SZBND+W</D=MV6*VHRHA3F4>.6M1Z T<:/*"QK5076 KQ"ZVG>:FVFJ6',
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M](L;N#^D-HJ_#?R J'K'.VK&,"8 $C>3:IK6;"['G5&4/ T6\Y>*/!$9]9_
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M']X+&=5KX];VL/,YPT@3]^68?XEQ])61!;UFA +*!H0JR&EIK%@()B&W(B4
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MLT)<,3CIK'_O#<G87[  H_H<-TNFQ7/6UK^M?)'LFK,E7,%X;B#\%#5I+6X
MWJRS&QKQV/H-: .2DM'3TA$)4/^ Z@G :P+-I39Y88ZZ,_ADH1D@EVGHQ"5
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M%;^V^C]02P$"% ,4    " #]I'-:_PO$:"H#  #@"P  $0
M@ $     <&QU9RTR,#(U,#,Q.2YX<V102P$"% ,4    " #]I'-:X&T[Q_X*
M  " A@  %0              @ %9 P  <&QU9RTR,#(U,#,Q.5]L86(N>&UL
M4$L! A0#%     @ _:1S6EG%NOQ7!P  TU<  !4              ( !B@X
M '!L=6<M,C R-3 S,3E?<')E+GAM;%!+ 0(4 Q0    ( /VD<UJ7H$#HUAP
M ,*7   1              "  106  !T;3(U.3@Q-F0Q7SAK+FAT;5!+ 0(4
M Q0    ( /VD<UJG.KN3]'$  .ZE @ 4              "  1DS  !T;3(U
M.3@Q-F0Q7V5X,2TQ+FAT;5!+ 0(4 Q0    ( /VD<UHSJIP8(UL  ('? 0 4
M              "  3^E  !T;3(U.3@Q-F0Q7V5X-"TQ+FAT;5!+ 0(4 Q0
M   ( /VD<UJ_L>,;K%@   C5 0 4              "  90  0!T;3(U.3@Q
M-F0Q7V5X-"TR+FAT;5!+ 0(4 Q0    ( /VD<UH'%!_JW0H  +TJ   4
M          "  7)9 0!T;3(U.3@Q-F0Q7V5X-2TQ+FAT;5!+!08     "  (
+  P"  "!9 $    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>tm259816d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="plug-20250319.xsd" xlink:type="simple"/>
    <context id="AsOf2025-03-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093691</identifier>
        </entity>
        <period>
            <startDate>2025-03-19</startDate>
            <endDate>2025-03-19</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-03-19" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-03-19" id="Fact000004">0001093691</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-03-19" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-03-19" id="Fact000010">2025-03-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-03-19" id="Fact000011">Plug Power Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-03-19" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-03-19" id="Fact000013">1-34392</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-03-19" id="Fact000014">22-3672377</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-03-19" id="Fact000015">125 Vista Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-03-19" id="Fact000016">Slingerlands</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-03-19" id="Fact000017">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-03-19" id="Fact000018">12159</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-03-19" id="Fact000019">518</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-03-19" id="Fact000020">782-7700</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-03-19" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-03-19" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-03-19" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-03-19" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-03-19" id="Fact000025">Common     Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-03-19" id="Fact000026">PLUG</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-03-19" id="Fact000027">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-03-19" id="Fact000028">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
